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1 Introduction 
 
1.1 The immune system 
Changing environmental conditions and the continuous competition between different 
species, including host-pathogen interactions, require an ongoing evolutionary advancement 
of a species to ensure survival. Humans as well as other species are ubiquitously exposed to 
a variety of pathogens like bacteria, viruses, protozoa and other parasites, however, long 
lasting infections or life-threatening diseases tend to be the exception rather than the rule. 
This is the result of protective mechanisms that evolved as a response against the 
omnipresent threat by pathogens in the course of evolution. These mechanisms include 
simple concepts like barriers at interfaces to prevent pathogen entry but also complex 
strategies, as pathogen clearance by the cooperative activity of highly specialized cells. 
Altogether, these defense mechanisms are known as the immune system. 
In relation to evolutionary and functional aspects, the immune system can be divided into two 
systems, the innate- and the acquired immunity. The evolutionary older innate immune 
system acts immediately or shortly delayed upon primary contact with the pathogen at the 
site of entry as first line of defense. Innate defense mechanisms include physical barriers like 
the skin or the mucosa, humoral factors, such as the complement system, antimicrobial 
peptides (AMPs) or enzymes but also cellular components, which together act against a 
broad spectrum of pathogens [1,2]. Mammalian cellular innate immune responses are mainly 
carried out by phagocytes [3–5], granulocytes [6–8], mast cells (MCs) [7] and natural killer 
cells (NK cells) [9–12]. The initiation of the cellular innate immune response is primarily 
based on the recognition of evolutionary highly conserved structures on pathogens, which 
are known under the collective term of pathogen-associated molecular patterns (PAMPs), by 
a limited repertoire of germ line-encoded invariable receptors on immune cells, the pattern 
recognition receptors (PRRs) [13]. The activation of innate immune cells upon engagement 
of PAMPs by PRRs results in a timely elimination of infected cells or pathogens and leads to 
the activation of the acquired immunity as a result of antigen-presentation or stimulation by 
secreted humoral factors.  
In contrast to the innate immunity, the full establishment of the acquired immunity requires a 
number of days and the initiation is carried out distantly from the pathogen entry site in 
adjacent lymphoid organs. Acquired immune responses are carried out by lymphocytes, 
which can be subdivided into two major populations namely T- (T cells, TCs) and 
B lymphocytes (B cells, BCs). In contrast to innate immune cells, T- as well as B cells are 
characterized by the expression of individual isoforms of either T- or B cell receptors as a 
consequence of somatic recombination and hypermutation of a small number of T- or B cell 
receptor-gene segments. These processes generate a vast number of receptor specificities 
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and in turn lead to a variety of unique T- and B cells which are separately highly specific for 
one individual epitope of an antigen. Upon engagement of their cognate ligands and typically 
co-stimulatory signals, naïve T- or B cells proliferate and differentiate into effector- as well as 
memory cells, enabling the establishment of a humoral- (B cells) or cell-mediated (T cells) 
acquired immune response and the development of immunological memory [14–16].  
Innate- and acquired immunity are closely linked and jointly contribute to the achievement of 
the major tasks of the immune system, namely: (i) Inhibition of infections by pathogens 
(immunological protection) and (ii) development of memory for better protection to a 
subsequent encounter with the pathogen (immunological memory) [17]. In addition to its 
prominent role in the protection of an organism against pathogens, the immune system is 
also indispensable for the elimination of transformed cells to prevent cancer [18,19].  
The fulfillment of these tasks requires the use of powerful tools, which need an adequate 
regulation to avoid the injury of the host organism. The undue reaction against otherwise 
harmless agents in the case of allergens or the reactivity against self-antigens in the context 
of autoimmune diseases are only two examples for dysfunctions of the immune system 
which have serious impacts and result in pathology [20,21].  
As reported above, cell-mediated immune responses are an inherent part of the innate- as 
well as the acquired immunity and are carried out by various cell types. The focus of this 
thesis is on NK cells and their cytotoxic function. 
 
1.2 Natural killer cells 
In the beginning of the 1970s, a new subset of lymphocytes which was characterized by 
spontaneous cytotoxic activity against transformed cells was described independently by two 
groups. Due to their cytolytic activity these cells were named natural killer- or briefly NK cells 
[9–12]. NK cells are large granular lymphocytes which are closely related to cytotoxic T cells. 
Both, NK- as well as cytotoxic T cells share common characteristics including similarities in 
the morphology, the expression of lymphoid markers and in broader sense lytic mechanisms 
[22]. In contrast to T- or B cells, NK cells lack antigen-specific cell surface receptors that 
underlie somatic recombination [23–26]. However, NK cells express a variety of germ line 
encoded receptors that can either stimulate NK cell reactivity (activating receptors) or 
extenuate their activities (inhibitory receptors) [27–30]. Therefore, NK cells are primarily 
dedicated to the innate immunity [23].          
NK cells constitute approximately 5% - 15% of human circulating lymphocytes [31]. In 
humans and mice, mature NK cells (mNKs) are further present in the spleen, lung, liver, 
gastrointestinal tract, the uterus in the case of pregnancy and to a minor extent in lymph 
nodes and lymphoid tissues as well as in the bone marrow [32–36]. In addition to their role in 
tumor immune surveillance, NK cells have been attributed to the control of viral and 
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intracellular bacterial infections [23,37–41]. Main targets of NK cells are stressed (malignant 
or infected) cells that are characterized by down-regulated major histocompatibility complex 
(MHC) class 1 molecule expression (“missing self” hypothesis), which are normally 
expressed on almost every cell of the body (Figure 1-1) [42,43].  
 
 
Figure 1-1. Schematic overview of biological NK cell functions. 
As potent effector cells of the innate immunity, NK cells are capable to kill stressed (malignant or 
infected) cells in the presence or absence of antibodies. In addition, NK cells contribute to the 
regulation of other immune cells, such as immature DCs (iDCs), T cells and MΦ indirect via secretion 
of proinflammatory or immunosuppressive cytokines or through a direct physical contact. This 
regulatory crosstalk influences not only NK cell counterparts but also affects the effector potential of 
the NK cells that require priming by IL-15, IL-12 and/or IL-18 produced by mDCs and MΦ to achieve 
their full effector potential. Furthermore, NK cell-mediated killing of infected cells also promote the 
antigen cross-presentation to cytotoxic T cells, for instance by DCs. [Adapted from E. Vivier et al., 
Poster on NK cells: receptors and functions., Nature Reviews Immunology, Dec 2010, Vol 10 No 12] 
 
Down-regulation of MHC class 1 molecules often goes along with tumor growth and is a 
common protective mechanism of pathogens to escape from the elimination by cytotoxic T 
cells [44,45]. For this reason, the cytolytic activity of NK cells is an important defense 
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mechanism of the immune system to overcome viral evasion of the adaptive immunity. 
Importantly, NK cells are potent effector cells which are capable to kill aberrant cells in the 
absence of prior sensitization [9,11]. However, priming of NK cells by various factors 
including interleukin (IL)-15, IL-12 or IL-18 increases their effector potential and is required to 
achieve an fully activated state (Figure 1-1) [46–49].      
Besides their cytolytic function, NK cells contribute to the initiation and regulation of innate 
and acquired immune responses, not only by the secretion of humoral factors but also 
through physical contact with other immune cells (Figure 1-1) [23,50–56]. In this context, NK 
cells are important producers of interferon gamma (IFN-γ) but also of other proinflammatory 
or immunosuppressive cytokines such as tumor necrosis factor-alpha (TNF-α) or IL-10, 
respectively [57–60]. These soluble factors are crucial for the activation as well as regulation 
of other immune cells like dendritic cells (DCs) [52,61,62], T cells [51,63] and macrophages 
(MΦ) [55,64] as shown in Figure 1-1. In addition, activated NK cells secrete growth factors 
such as the granulocyte macrophage colony-stimulating factor (GM-CSF) [65] and a variety 
of chemokines including chemokine (C-C motif) ligand 3, (CCL3 or MIP1-α), CCL4 (MIP1-β), 
CCL5 (RANTES) or chemokine (CXC motif) ligand 8 (CXCL8 or IL-8) [23,66–68] that are 
important for the recruitment of other immune cells, for instance DCs, to the site of 
inflammation [69]. Furthermore, target cell debris as consequence of cytolytic NK cell 
activities likely promote antigen cross-presentation to cytotoxic T cells (Figure 1-1) [70]. 
Besides these indirect regulatory activities, NK cells also physically interact with DCs [50,62], 
MΦ [64,71], T cells [53] and neutrophils [56] in a regulatory manner to promote or extenuate 
immune responses (Figure 1-1). Thus, NK cells are not only potent effector cells of the innate 
immune system but also important modulators of acquired immune responses. 
Due to the fact that NK cell activities are mainly controlled in the context of MHC class I 
molecules, expressed by potential target cells [42,43], a proper regulation of NK cells is 
important to guarantee NK cell tolerance toward “normal” cells and in turn avoid pathology. In 
this context, recent work revealed that engagement of “self” MHC class 1 molecules by 
inhibitory NK cell receptors during NK cell development promotes the maturation of fully 
functional NK cells in humans and mice through a process called “NK cell education” [72,73]. 
The importance of this process becomes evident in MHC class 1-deficient mice and 
transporter associated with antigen processing 1 (TAP1)-deficient humans. NK cells from 
these mice or from the TAP-1-deficient patients are hyporesponsive in both cytokine 
production and cytotoxicity [74,75]. Up to now, the underlying mechanisms which are 
responsible for the induction of NK cell “self” tolerance are poorly understood and 
controversially discussed. Various models such as the “licensing”- [73], the “disarming”- [76], 
the “rheostat”- [77,78] or the “cis interaction”-model [79] have been proposed, trying to 
Introduction  5 
 
 
explain the processes which are necessary to induce NK cell tolerance, however, further 
work is required to dissolve various discrepancies.                          
Furthermore, recent work revealed that NK cells are able to generate a form of antigen-
specific immunological memory, which enables an improved NK cell-mediated immune 
response upon secondary challenge, at least for a few months [80–84]. Thus, NK cells are 
equipped with features that are attributed to both, innate- as well as acquired immunity, and 
which are crucial for their essential effector functions within the immune system. 
     
1.2.1 Stages of NK cell development 
The origin of NK cells is the bone marrow where they derive from a common lymphoid 
progenitor (CLP) as T- and B cells do [85–88]. While initial steps of NK cell development, 
including commitment to the NK cell lineage, early maturation processes as well as NK cell 
education mainly occur in the bone marrow, final steps of NK cell maturation takes place in 
the periphery [88–91]. However, NK cell development has also been reported in the thymus 
and lymph nodes, indicating other potential sites of differentiation or an access of early 
developmental NK cell stages to the circulation [92–95]. Interestingly, thymic NK cells differ 
from NK cells that derived in the bone marrow in several aspects. Thymic NK cell 
development depends on the presence of IL-7 and not on IL-15, as reported for the bone 
marrow NK cells and both subsets differ in their functionality [95]. In humans and mice, 
another NK cell subset develops and resides in the liver starting prior to birth [96–98]. These 
NK1.1+/CD49b-/TRAIL+/Mac-1-/Ly49- NK cells are maintained in the liver up to adulthood, 
however, the subset decreases over time [94,97].  
NK cell development and maturation is a multi-stage process governed by cell-intrinsic 
signals like transcription factors and the impact of environmental cues like cytokines, such as 
IL-15 and other factors produced by stroma cells [95,99,100]. Besides its crucial role during 
initial developmental steps in the bone marrow, IL-15 trans-presentation is also 
indispensable for the survival of mNKs in the periphery [101,102]. NK cell development is 
characterized by a progressive upregulation/downregulation of various activating- and 
inhibitory receptors, adhesion molecules as well as chemotactic- and cytokine receptors and 
is further accompanied by changes in NK cell functionality (Figure 1-2) [31,89,95,103,104]. 
Because this work was performed on mouse NK cells, the following overview focusses on 
NK cell development in the murine system. 
Almost ten years ago, Rosmaraki et al. described the so far earliest mouse NK cell 
committed precursor (NKP) within the bone marrow and linked NK cell commitment to the 
expression of CD122 [88]. Recently, the phenotypical definition of this NKP was further 
refined (rNKP, Figure 1-2, step I) and an NK cell committed precursor upstream of the rNKP 
was described, which lacks CD122-expression (pre-NKP) [105,106]. 
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Figure 1-2. Stages of NK cell development in the mouse. 
NK cells derive from a common lymphoid progenitor (CLP) in the bone marrow. NK cell commitment is 
associated with the upregulation of CD122 on NK cell precursors (NKPs) which can be subdivided into 
early NKPs (pre-NKP, CD122-) and the “refined” NK cell committed precursor (rNKP, CD122+, stage I). 
Immature NK cells (iNKs, stage II and III) are characterized by the expression of NK1.1 and TRAIL 
and can be further subdivided according to the expression of the surface molecules listed on the left. 
In contrast to iNKs, mature NK cells (mNKs, stage IV – VI) express CD49b and are further 
characterized by the absence of TRAIL and the stepwise downregulation of CD27 as well as the 
progressive upregulation of CD11b, CD43 and KLRG1. [Adapted from Huntington et al., Vosshenrich 
et al. [107,108].]  
 
In C57BL6-mice, the acquisition of the activating NK cell receptor NK1.1 defines a further 
step of NK cell development: the immature NK cell stage [88,89,95]. Immature NK cells 
(iNKs) are CD122+/NK1.1+/CD27+, express the TNF-related apoptosis-inducing ligand 
(TRAIL) and stepwise upregulate further surface molecules including adhesion molecules 
and activating- as well as inhibitory NK cell receptors in the course of their further maturation 
(Figure 1-2, step II and III) [91,95]. The progressive expression of CD49b represents the next 
developmental stage of NK cells and is used to define early mNKs [59,89,95]. Early mNKs, 
which are CD122+/NK1.1+/CD27+/CD49b+/Ly49+ emigrate from the bone marrow into the 
periphery and continue to adapt to their environment (Figure 1-2, stage IV - VI) 
[89,91,95,103]. Peripheral NK cell maturation includes the downregulation of TRAIL- and 
CD27-expression as well as the gradually upregulation of CD11b, CD43 and the killer cell 
lectin-like receptor 1 (KLRG1 or MAFA) [34,89,91,94,97,104,109,110] as shown in 
Figure 1-2, stage IV – VI. Fully mature NK cells are 
CLP pre-NKP rNKP iNK mNK
CD27+
CD11b-
CD27+
CD11b+
CD27-
CD11b+
Stage I II III IV V VI
CD117
CD127
CD27
CD244
NKG2D
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CD51
CD69
TRAIL
NK1.1
NKp46
Ly49s
CD49b
CD11b
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CD122+/NK1.1+/CD27-/CD49b+/Ly49+/CD11b+/CD43+/KLRG1+ (Figure 1-2, stage VI). The 
progressive upregulation/downregulation of CD11b- and CD27-expression, respectively, on 
CD49b+ NK cells in the course of their maturation affords the further division of this 
population into distinct subsets [89,91,97,110,111]. In between these subsets, there is a 
linear progression from CD11blow/CD27high (immature/early mature) over CD11bhigh/CD27high 
(double-positive; DP) to CD11bhigh/CD27low (mature) NK cells, as schematically shown in 
Figure 5-7 A [91,104,110]. As mentioned above, NK cell development and maturation is not 
only associated with phenotypic changes, this processes are also accompanied by changes 
of NK cell functionality. Kim et al. and Chiossone et al. revealed that the capacity of NK cells 
to proliferate decreases in the course of maturation [89,91]. Furthermore, CD27high NK cells 
stimulated with either IL-12 or IL-18 secrete higher amounts of IFN-γ compared to 
CD27low-subsets, not only upon stimulation with cytokines but also in response to DCs 
[104,110]. Interestingly, fully mature NK cells seem to be restricted in their capacity to 
proliferate or elicit effector function compared to more immature subsets [89,91,110]. One 
possible explanation for this discrepancy may be their tight regulation [104,110]. 
 
1.2.2 NK cell cytotoxicity and its regulation 
Human as well as mouse NK cells express multiple activating and inhibitory receptors on 
their surface [27,29,30,112]. The inhibitory NK cell receptors comprise several members out 
of the human inhibitory killer cell immunoglobulin-like family (KIR) as well as out of the 
mouse C-type lectin-like family (inhibitory Ly49-receptors), while Ly49-receptors are the 
functional mouse orthologs of the human KIRs. Further inhibitory receptors are the 
heterodimer CD94-natural killer group 2A (NKG2A)-receptor and KLRG1 which are present 
in human and mice. Activating receptors of both species include members out of the 
activating natural cytotoxicity triggering receptor-family (e.g. NKp46) or the natural killer-
receptor (NKR)-family (e.g. NKR-P1C or NK1.1), the activating KIR- and NKG2-receptors as 
well as the low-affinity Fc receptor for IgG (FcγRIII or CD16) [29,112–114]. Beside these 
receptors, various cytokine-, chemotactic- or other receptors like 2B4 (CD244) as well as 
adhesion molecules (e.g. the lymphocyte function-associated antigen 1 (LFA-1) or the 
macrophage-1 antigen (Mac-1)) are involved in the activation of NK cells [23,68,115–117]. 
Selected NK cell receptors and their reported ligands, which are particularly relevant for this 
thesis, are listed in Table 1-1.  
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Table 1-1. Selected NK cell receptors with reported ligands in mice and human 
Receptor Species 
mouse/human 
Reported ligand(s) 
Inhibitory receptors    
NKG2A (CD159A)/CD94 x x Qa-1b (mouse); HLA-E (human) 
KLRG1 x x E-, N-, and R-cadherin 
Activating receptors    
NKR-P1C (NK1.1, Ly-55, 
CD161c)* 
x  ? 
NKp46 (NCR1; CD335) x x Influenza-infected cells, Fusobacterium nucleatum 
(mouse); HSPG, heparin, vimentin, HA (IV, VV, 
ECTV), HN (SeV, NDV), PfEMP-1 (Plasmodium 
falciparum), Fusobacterium nucleatum (human)  
NKG2D (CD314) x x RAE-1a, RAE-1b, RAE-1d, RAE-1e, RAE-1g, H60a, 
H60b, H60c, MUTL1 (mouse); MICA/B, ULBP1-6 
(human) 
NKG2C (CD159C)/CD94, 
NKG2E (CD159E)/CD94  
x x Qa-1b (mouse); HLA-E (human) 
Ly49H (Klra8) x  m157 (MCMV) 
*) expressed in C57BL, FVB/N, NZB mice (Koo 1984), ECTV, Ectromelia virus; H60, histocompatibility 
antigen 60; HA, haemagglutinin; HLA, human leukocyte antigen; HN, hemagglutinin-neuraminidase; 
HSPG, heparin sulfate proteoglycan; IV, Influenza virus; MCMV, Mouse Cytomegalovirus, MIC, MHC 
class I chain-related protein; NDV, Newcastle disease virus; RAE, retinoic acid early-inducible protein; 
SeV, Sendai virus; ULBP, UL16 binding protein; VV, Vaccinia virus [Adapted from Campbell et 
al.[114]]  
 
While signals from inhibitory NK cell receptors are mainly triggered upon engagement of 
particular MHC class I-isoforms, activating NK cell receptors can be stimulated in an 
MHC class I-dependent as well as independent manner [29,114]. Inhibitory NK cell receptors 
are characterized by the presence of one or more cytoplasmic immunoreceptor tyrosin-based 
inhibition motives (ITIMs). These motives initiate the activation of downstream signaling 
molecules by recruitment and activation of the SH2-containing protein tyrosine phosphatase 
(SHP)-1 or SHP-2 or by the SH2-containing inositol polyphosphate-5-phosphatase (SHIP) 
[118–121]. These tyrosine phosphatases suppress NK cell responses by dephosphorylating 
the protein substrates of the tyrosine kinases linked to activating NK receptors [120,122]. 
Signal transduction of activating NK cell receptors occurs through immunoreceptor tyrosin-
based activation motives (ITAM)-containing adaptor molecules like the 
high-affinity Fc receptor for IgE (FcεRIγ), CD3ζ and DAP12 as well as non-ITAM-bearing 
proteins like DAP10 or the signaling lymphocytic activation molecule–associated protein 
(SAP) [27,29,30,112]. The engagement of cognate ligands by activating NK cell receptors 
initiates the recruitment and activation of various molecules involved in signal transduction 
like the spleen tyrosine kinase (Syk), phosphatidylinositide 3-kinase (PI3K), phospholipase 
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C, gamma (PLCγ), protein kinase C (PKC), Vav-1 as well as others [118,119,123–128]. This 
in turn, leads to the activation of the mitogen-activated protein kinase (MAPK)- and c-Jun N-
terminal kinase (JNK)-pathway which are involved in the initiation of the NK cell cytolytic 
responses [126–129]. 
NK cell cytotoxicity is regulated by a balance of signals derived from the activating- or 
inhibitory surface receptors mentioned above [29,30,130]. The interplay of these signals 
determines the further outcome of NK cell responses and thereby decides on the fate of the 
target cell. Under “normal” conditions (no cellular stress), NK cell counterparts are protected 
from killing since there is a balance between activating as well as inhibitory signals. 
However, in the context of missing inhibitory signals due to the downregulation of 
MHC class I molecules (“missing self” recognition) [42,43], the detection of microbial 
molecules (“infectious non-self recognition”) [131,132] or upon upregulation of stimulatory 
“self” ligands, which are rarely expressed on “normal” but increased on “stressed” cells 
(“stress-induced self recognition”) [133–135], the stimulatory signals received from 
activating receptors are unopposed, resulting in NK cell activation and target cell lysis 
[113,114,136].  
NK cells are capable to eliminate abnormal cells by various means. Killing of infected or 
transformed cells can be mediated by the release of preformed granules containing the pore-
forming protein perforin and cytotoxic serine proteases, named granzymes, in the presence 
or absence of antibodies [137–144]. While the elimination of abnormal cells lacking antibody 
opsonization can be induced by the majority of activating NK cell receptors, antibody-
dependent cell cytotoxicity (ADCC) strictly depends on FcγRIII [29,112–114,143,144]. In 
addition, the cytolytic NK cell activity can be triggered by the interaction of TRAIL and Fas 
ligand (FasL or CD95L) with their corresponding antagonists [50,56,145–147]. 
The directed exocytosis of cytotoxic granules is the result of a tightly regulated complex 
process that involves multiple stages [115–117,148,149]. The initial contact between an NK 
cell and a target cell induces the formation of an immunological/cytolytic synapse that is 
tightened in the presence of sufficient stimulatory signals [115]. In the following effector 
stage, adhesion molecules like LFA-1 or Mac-1 segregate into the outer region of the 
cytolytic synapse, known as peripheral supramolecular activation complex (pSMAC), and 
thereby contribute to the further stabilization of the conjugate [115,118,150]. In addition, 
LFA-1 initiates various signaling cascades which, among others, stimulate the reorganization 
of filamentous (F)-actin at the site of the forming cytolytic synapse 
[115,124,127,130,150,151]. In contrast to adhesion and co-stimulatory molecules which are 
found in the pSMAC-region, activating- and inhibitory NK cell receptors accumulate in the 
central supramolecular activation complex (cSMAC)-region of the cytolytic synapse 
[118,119,152–154]. Synergistic events from activating NK cell receptors stimulate the 
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reorientation of the microtubule-organizing center (MTOC), the Golgi apparatus and the 
cytotoxic granules toward the target cell [115,116,128,149,155,156]. Subsequently, the 
cytolytic granules pass through locally hypodense areas of a pervasive F-actin network within 
the cSMAC-region mediated by myosin IIA-activity [156–162]. The final docking- and fusion 
process of the granules and the plasma membrane is initiated and regulated by docking and 
priming proteins [117,163,164]. The consequent release of cytotoxic granule contents leads 
to the immediate death of the target cell by the induction of apoptosis [138,142].  
The directed exocytosis of cytolytic granules is highly regulated (reviewed in Orange et al. 
and Krzewski et al.) [116,117]. In this context, a number of studies indicate a crucial role of 
the actin cytoskeleton in the regulation of NK cell activities, including exocytic pathways 
[165–171]. 
 
1.3 The actin cytoskeleton and its function 
In animals, actin filaments (microfilaments), intermediate filaments and microtubules 
constitute an intracellular protein scaffold which is termed cytoskeleton. The cytoskeleton 
determines the shape of cells and is involved in cellular processes like cell division, cellular 
motility or the intracellular transport of vesicles and organelles [172–174].  
Actin is a highly conserved protein that is abundant in eukaryotic cells [175]. The actin 
cytoskeleton as the major component of the eukaryotic cytoskeleton is a highly dynamic 
structure which underlies a constant remodeling including branching as well as de-branching 
as reviewed by Pollard et al., 2009 [172]. It consists of bundles or networks of two helically 
arranged actin filaments (F-actin), which are polymerized from actin monomers (globular 
actin or G-actin). The assembled F-actin filaments are polar in the sense that they bear a 
fast-growing barbed end and a slower-growing pointed end [176]. F-actin polymerization 
requires the hydrolysis of G-actin bound adenosine 5'-triphosphate (ATP) to adenosine 
5'-diphosphate (ADP) that remains bound to F-actin and inorganic phosphate (Pi) mediated 
by the intrinsic ATPase-activity of actin subunits [176]. In this context, the release of the Pi is 
much slower than the hydrolysis of ATP resulting in areas of newly polymerized F-actin 
retaining the hydrolyzed Pi [177]. Release of Pi induces a conformational change of the 
assembled actin monomers which facilitates F-actin de-branching at the pointed end [172]. 
To maintain the steady-state level of the actin cytoskeleton or for quick remodeling under 
certain conditions, eukaryotic cells dispose more than 100 actin associated proteins. This 
network of actin nucleators, nucleation-promoting factors (NPFs), regulatory proteins, 
monomer-sequestering proteins and others is required to maintain a pool of actin monomers, 
initiate polymerization, restrict the length of actin filaments, regulate the assembly and 
turnover of actin filaments and cross-link filaments into networks or bundles as reviewed by 
Pollard et al., 2009 [172]. The significance of proteins associated with actin regulation and 
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the crucial role of the actin cytoskeleton for basal cellular activities of NK cells becomes 
evident upon loss of their function. In eukaryotic cells, de novo F-actin polymerization is 
mainly initiated by two classes of actin nucleators, the Arp2/3-complex and the formins. 
While Arp2/3 mediates the assembly of a branched actin network by initiating the formation 
of new “daughter” filaments at the side of existing “mother” filaments, formins interact with 
the barbed end of actin filaments and promote incorporation of new actin monomers [178–
180]. It has been shown that the activation of NK cells via signals from integrins or activating 
NK cell receptors initiates signaling cascades which in turn activates actin nucleators like the 
Arp2/3-complex [124,181,182]. NK cells lacking the Wiskott-Aldrich Syndrome protein 
(WASp), an NPF required for the activation of the Arp2/3-complex and linked to the 
Wiskott-Aldrich Syndrome, show defective polarization, F-actin assembly, migration and 
cytotoxicity [165–169]. In this context, the disruption of expression of the WASp-interacting 
protein (WIP), which is involved in the regulation of WASp but also of other actin-regulatory 
proteins, impairs granule polarization and NK cell cytotoxicity, whereas overexpression of the 
protein enhanced NK cell cytolytic capability [183]. Loss of function of the hematopoietic 
cell-specific homolog of cortactin, HS1, another NPF linked to the activation of the 
Arp2/3-complex in immune cells, results in defective lysis of target cells, and defects in cell 
adhesion, chemotaxis and F-actin assembly at the lytic synapse in NK cells [170]. As 
predicted by the data described above, loss of Arp2/3-function in NK cells leads to defects in 
cell adhesion and F-actin assembly at the lytic synapse resulting in an ineffective target cell 
lysis [171]. In contrast to Arp2/3, the loss of the formin diaphanous homolog 1 (hDia1) does 
not disrupt F-actin assembly at the lytic synapse however, leads to perturbations in the 
microtubule cytoskeleton, including the targeting of microtubules to the lytic synapse and 
therefore impairs NK cell cytotoxicity [171]. 
Another family of actin-regulatory proteins, the coronins, also interacts with the 
Arp2/3-complex [184,185]. In this context, it has been shown that coronins inhibit the 
Arp2/3-complex activity and therefore were suggested to be the first described inhibitors of 
the protein complex [185–187]. However, up to now, the role of coronins in the regulation of 
the actin cytoskeleton is poorly understood. 
 
1.4 Coronins 
Coronins constitute an evolutionary highly conserved family of actin-binding proteins that 
have been implicated in the regulation of actin cytoskeletal dynamics (reviewed in de Hostos, 
1999, Uetrecht et al., 2006 and Chan et al., 2011) [188–192]. Although coronins are known 
since more than 20 years and notable progress in their understanding has been made in the 
last decade, these proteins and their contribution in the regulation of actin-dependent 
processes are still poorly understood. 
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Coronin was originally extracted and purified from precipitated actin-myosin complexes 
isolated from the slime mold Dictyostelium discoideum. In Dictyostelium, coronin was found 
to localize to crown-like actin-rich projections of the cell cortex, leading to the name of the 
protein (corona is Latin for crown) [193]. Dictyostelium coronin-null cells showed a reduction 
in cell-migration speed and were impaired in growth, cytokinesis and fluid-phase endocytic 
uptake [194–197]. Subsequently, coronins were described in a variety of different protozoan 
and metazoan [185,188,194,198–207]. Due to the fact that coronins were discovered 
independently by several groups, which adopted their own names and classifications, 
nomenclature of coronins is confusing (see Table 1.2). In this work, the nomenclature system 
developed by the Human Genome Nomenclature Committee (HGNC) is used. 
(http://www.genenames.org/genefamilies/CORO) 
 
1.4.1 Coronins: Structure, classification and expression in mammalian tissues/cells 
Coronins can be divided according to their domain arrangement into two subtypes, namely in 
short and long coronins [208]. While up to now, several subclasses of short coronins were 
defined, only one type of long coronins was described [207]. Both, short as well as long 
coronins are characterized by the presence of a common structural core motif, which is 
highly conserved among species [207]. This coronin core motif consists of a β-propeller unit, 
the associated N- and C-terminal extensions and a unique region, as shown in Figure 1-3. 
The main structural characteristic of the coronin core motif is the presence of a tryptophan 
(W) and aspartic acid (D)-repeats (WD40-repeats) containing β-propeller, which can be found 
in a variety of signaling- and adaptor proteins and has been proposed to mediate 
protein-protein interactions [209–211]. The core WD40-repeat region of the β-propeller is 
flanked by short, highly conserved N- and C-terminal extensions, which contribute to the 
formation of the β-propeller and possibly are involved in the regulation of protein interactions 
and/or stabilization of the β-propeller [209,212]. Subsequent to the C-terminal extension, 
coronins contain a highly variable unique region that varies in length and sequence among 
these proteins [207]. Additionally to the coronin core motif, short coronins contain a classical 
coiled-coil domain located at the C-terminal end of the protein (Figure 1-3, type I/II coronins). 
This structure enables the homo-oligomerization of short coronins, which is crucial for their 
functionality [200,212–216]. Representatives of long coronins, like coronin 7 (Coro7 or POD), 
are distinct in structure compared to the other coronins, given that the proteins consists of 
two complete β-propeller units including the associated N- and C-terminal extensions and the 
unique region (coronin core motif), arranged in a tandem (Figure 1-3, type III coronins) 
[189,201,217]. Additionally, Coro7 is characterized by the absence of a coiled-coil domain. In 
contrast to short coronins, Coro7 contains a highly acidic region, situated at the C-terminal 
end of the protein [189]. Recently, another coronin subtype was defined by Eckert et al. 
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based on phylogenetic analyses [207]. For these coronins, a protein expressed in 
Dictyostelium, namely villidin, would be a representative [207,218]. According to the HGNC 
nomenclature Eckert et al. suggested to term these proteins coronin 4 (Coro4) [207]. Most 
type IV coronins consists of the classical coronin core motif followed by variable numbers of 
C-terminal pleckstrin-homology- and gelsolin domains and contain a villin headspace domain 
at the C-terminal end of the protein. Furthermore, several proteins with short sequences 
following the coronin core motif are included within this subtype [207]. 
 
 
 
Figure 1-3. Scheme of short and long coronin structural domain arrangements. 
Coronins share a conserved domain arrangement consistent of a tryptophan (W) and aspartic acid 
(D)-repeat region (β-propeller), which is flanked by an N-terminal- and a C-terminal extension followed 
by a unique region (U). Short coronins (Type I/II) contain additionally a C-terminal coiled-coil domain 
(CC). Long coronins (Type III) lack a coiled-coil domain and consist of two linked β-propeller units 
(including N- and C-terminal extensions and the unique region) and a C-terminal acidic region (A). 
 
With respect to the HGNC nomenclature, coronins can be divided into up to four subclasses 
namely I and II (short coronins), III (long coronins) and the new class IV suggested by Eckert 
et al. [189,207]. While orthologous coronins conforming to type I and III structure are present 
in the majority of species, type II coronins are unique to metazoan [207]. In contrast, class IV 
coronins are exclusively encoded in the genome of individual protozoa, amoeba and fungi 
[207]. Hence, they will here not be further referred to.  
Up to now, the best studied members of the coronin family are the mammalian ones. The 
mammalian genome encodes seven coronins, covering coronin subclasses I to III. In 
mammals, type I coronins consists of coronin 1a (Coro1a), -1b (Coro1b) and -1c (Coro1c) as 
shown in Table 1-2 for mouse coronins. Another type I coronin, coronin 6 is encoded in the 
genome. However, further data about this protein are missing. Further, coronin 2a (Coro2a) 
and -2b (Coro2b) of the type II coronin subclass and Coro7, as representative of the type III 
coronins, are expressed in mammalian tissues (Table 1-2) [189].  
Noteworthy, coronins display distinct tissue expression patterns with at least one type I 
coronin and Coro7 expressed in all tissues and cell types [190]. In contrast, type II coronins 
show a more restricted expression and are mainly associated with epithelial and neuronal 
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cells [212,219]. The current available data on their differential tissue expression (see Table 
1-2) suggests also a different cellular function. 
 
Table 1-2. The mammalian coronin family, nomenclature and tissue expression.  
Subclass Name HGNC 
gene 
symbol 
Synonyms Protein length 
(amino acids) 
mouse/human 
Main tissue expression 
(mouse and human) 
I Coronin 1a Coro1a Coronin 1 or -4*, 
(CRN4), clabp, 
clipinA,TACO, 
p57 
461/461 Haematopoietic lineage, 
liver, brain, thymus, 
spleen, bone marrow and 
lymph nodes 
[187,203,220–222] 
 Coronin 1b Coro1b Coronin 2 or -1*, 
(CRN1), 
coroninse, p66 
484/489 Ubiquitous, liver, spleen, 
kidney, lung, smooth 
muscle cells 
[187,212,222–225] 
 Coronin 1c Coro1c Coronin 3 or -2*, 
(CRN2), 
HCRNN4 
474/474 Ubiquitous, lung, kidney 
spleen 
[187,212,213,221,226,22
7] 
 Coronin 6 Coro6 Coronin 6 or -3*, 
(CRN3), ClipinE, 
Coro1d 
471/472 Up to now, only gene 
expression  
II Coronin 2a Coro2a Coronin 5*, 
(CRN5), clipinB, 
IR10, WDR2 
524/525 Prostate, testis, ovary, 
uterus and brain 
[212,219,221] 
 Coronin 2b Coro2b Coronin 6*, 
(CRN6), clipinC,  
480/480 Brain [219,221] 
III Coronin 7 Coro7 Coronin 7*, 
(CRN7), POD 
922/925 Ubiquitous, thymus, 
spleen, brain 
[187,212,217] 
*) Nomenclature Morgan & Fernandez [228] 
 
1.4.2 Coronins and the actin cytoskeleton 
Since their discovery in Dictyostelium, coronins have been implicated in the regulation of 
actin dynamics in various organisms and cell types [189–191,208]. In this context, diverse 
functions of coronins on actin filaments have been reported including F-actin 
binding/bundling, F-actin disassembly and inhibition of the Arp2/3-complex 
[185,186,200,214,229–233].  
One common functional characteristic of short coronins is their capability to bind F-actin 
[193,207,229,234,235]. Over time, various putative F-actin-binding sites have been mapped 
to nearly every part of coronin proteins [189,199,213,215,236,237]. Genetic approaches 
based on the analysis of the crystal structure of murine Coro1a revealed that a charged 
patch located on the top surface of the β-propeller seems to be crucial for high affinity F-actin 
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binding of class I coronins [209,229,234]. The mutation of a single conserved residue (Arg30 
to Asp (R30D)) located within this patch, in Coro1b or the equivalent residue in Coro1a as 
well as Coro1c resulted in the loss of high affinity F-actin binding [222,229,238,239]. 
Additionally, in a recent study, a second potential actin binding site of Coro1c was described 
[240]. In contrast to class I coronins, the R30 residue is not conserved in class II coronins. 
However, it could be recently confirmed that the class II coronin Coro2a also interacts with 
F-actin using conserved sequence features required for the interaction of murine Coro1a with 
F-actin [235]. As mentioned before, F-actin filaments are characterized by the presence of 
either ATP, ADP+Pi or ADP bound to the actin subunits of the filament [176,177]. Recently, it 
could be shown that Coro1b preferentially binds ATP/ADP+Pi F-actin over ADP-bound 
F-actin [229]. Similar observations have been made for budding-yeast coronin, thus, linking 
class I coronin F-actin binding mainly to areas of F-actin synthesis [233].  
The majority of short coronins is characterized by the expression of a C-terminal coiled-coil 
domain which is necessary for the homo-oligomerization of the proteins [200,212–216]. The 
capability to form di- and/or trimeres in connection with their F-actin-binding properties 
enables short coronins to bundle and crosslink actin filaments [186,200,214,215,229,231]. 
Additionally, class I coronins interact in an inhibitory manner with the Arp2/3-complex 
[184,186,187,241]. Similar findings were obtained for budding-yeast coronin [185]. Recently, 
for yeast coronin a concentration-dependent activation or inhibition of Arp2/3 
nucleating-activity was reported. In this context, low concentrations of coronin activated the 
Arp2/3-complex while higher concentrations resulted in the inhibition of the nucleating-activity 
[233]. For yeast coronin, the activation of the Arp2/3-complex was linked to the presence of a 
CA-like sequence, located in the unique region of the protein, which is conserved in WASp 
proteins, the principal activators of the Arp2/3-complex [242]. However, this CA-like 
sequence is not conserved in metazoan class I and II coronins, hence supporting the idea of 
a cell type and/or context-dependent actin-regulation by coronins [233].  
Up to now, the mechanisms responsible for the inhibition of the Arp2/3-complex by coronins 
are poorly understood. Cai et al. revealed that binding of Coro1b to F-actin networks promote 
debranching and recycling of the Arp2/3-complex in lamellipodia by inducing Arp2/3-complex 
dissociation and counteracting the effect of cortactin, a factor known to facilitate and stabilize 
actin nucleation by interacting with the Arp2/3-complex [230,243]. However, individual 
coronins have been implicated in various cellular functions and show diverse tissue 
expression patterns. Hence, further studies are necessary to clarify whether this is also true 
under other conditions. 
In addition to regulating the Arp2/3-complex, class I coronins were also linked with the 
regulation of the actin depolymerizing factor (ADF)/cofilin, here referred to as cofilin, in yeast 
as well as in mammals [186,200,229,232,233,244]. Cofilin and the related ADF are involved 
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in the depolymerisation of ADP-bound F-actin by severing actin filaments [245]. Up to now, 
the underlying mechanisms of coronin and cofilin interaction are poorly understood and are 
controversially discussed. So far, coronins were linked to both, the promoting as well as the 
inhibition of cofilin-mediated actin disassembly [229,246]. Interestingly, the regulation of 
Coro1b in the lamellipodia of fibroblasts was attributed, among others, to the recruitment of 
slingshot homolog 1L (SSH1L), a protein phosphatase which is known to activate cofilin 
[186,247]. A recent model for coronin-cofilin interaction, based on studies on yeast coronin, 
postulates that the binding of coronin to the ADP-actin subunits of older actin filaments 
facilitates severing of cofilin and thereby disassembly. However, the binding of coronin to 
ATP/ADP+Pi subunits in newly synthesized actin filaments protects the filaments from the 
severing action of cofilin [233]. Indeed, Gandhi et al. suggested that the binding of yeast 
coronin to ATP/ADP+Pi subunits is mediated by an actin-binding site located in the 
coiled-coil domain of the protein [233]. Importantly, the existence of this low-affinity 
actin-binding site in yeast coronin could not be confirmed by another group and there is no 
evidence for a similar site in mammalian coronins [242]. Thus, further experiments will be 
required to resolve these discrepancies. 
 
1.4.3 Regulation of coronins 
Although coronins were first recognized almost 20 years ago, it took about 10 years until a 
first mechanism for the regulation of coronins was described. Itoh et al. revealed that 
PKC-mediated phosphorylation of Coro1a triggers its dissociation from phagosomes [248]. 
Further evidence supporting a regulatory role of PKC-dependent phosphorylation of coronins 
in vivo as well as in vitro came from studies on Coro1b. It could be shown that a serine 
located at position two in Coro1b was a major target for phosphorylation by PKC-isoforms 
[212]. Furthermore, a critical role of Ser2 phosphorylation for the interaction of Coro1b with 
the Arp2/3-complex was revealed by the analysis of mutants which either prevent 
phosphorylation at Ser2 (serine to alanine mutation (S2A)) or mimic phosphorylation (serine 
to aspartic acid mutation (S2D)). In this context, the S2A mutant showed a stronger 
interaction with the Arp2/3-complex relative to wild type, whereas the S2D mutant exhibited 
weaker interaction, indicating that the interaction between Coro1b and the Arp2/3-complex is 
regulated by phosphorylation of Ser2 via PKC [212]. This effect seems to be conserved in 
Coro1a, since the interaction of the protein with the Arp2/3-complex is also controlled by 
phosphorylation of Ser2 [204]. As mentioned in the previous section, the regulation of 
Coro1b at the leading edge was attributed to the recruitment of SSH1L. It has been shown 
that Coro1b is a target for SSH1L activity since the protein was efficiently dephosphorylated 
by SSH1L in vitro as well as in vivo [186]. Recent work revealed another regulatory 
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phosphorylation event of Coro1a in T cells, involving the phosphorylation of threonine 418 by 
the cyclin-dependent kinase 5 [249]. 
Regulatory phosphorylation events of coronins control not only the interaction of the proteins 
with the Arp2/3-complex, they were also linked to the regulation of F-actin binding of coronins 
[204,212,222,250]. Observations by Oku et al. as well as Föger et al. suggest that 
phosphorylation of Ser2 of Coro1a but also Coro1b decreases the capability of the coronins 
to bind F-actin leading to a transient subcellular relocation of the proteins upon 
phosphorylation [222,250]. Recently, it was demonstrated that the interaction of Coro1a with 
the cytoskeleton additionally requires the phosphorylation/dephosphorylation of a second 
amino acid residue located in the coiled-coil domain of the protein, namely threonine 412 
[251]. Taken together, these data indicate that phosphorylation is crucial for the regulation of 
coronin function. 
 
1.4.4 Functions of coronins in the mammalian system 
Type I, II and III coronins show not only differences in the tissue expression, as mentioned 
previously, they are also characterized by a quite distinct subcellular localization. Type I 
coronins mainly localize to lamellipodia, vesicular structures and the immunological synapse 
and have been linked to the regulation of cellular motility and membrane trafficking 
[186,187,203,204,212,222,241,248,252,253]. In contrast, type II coronins are localized to 
stress fibers and focal adhesions and therefore are associated with the regulation of focal 
adhesion-turnover events but they play also a role in cellular motility and have been 
implicated in the regulation of TLR-signaling as component of the nuclear corepressor 
complex [219,235,254]. Coro7, the sole representative of type III coronins in mammalians, 
localizes to the Golgi apparatus, where it is involved in the maintenance of the Golgi 
morphology and membrane trafficking. It is important to know that mammalian Coro7, in 
contrast to other orthologous type III coronins, apparently has no F-actin binding capability 
[217]. However, the majority of mammalian coronins is poorly investigated and our current 
knowledge about these proteins is mainly based on studies examining the function of Coro1a 
and Coro1b. 
As mentioned above, coronins are highly conserved proteins. Murine Coro1a (mCoro1a) and 
its human ortholog hCoro1a as well as Coro1b, respectively are characterized by a high 
similarity (at least 94% identities for both pairs) suggesting comparable functions and 
regulatory mechanisms in human and mice (Table 10-1, Figures 10-2 and 3). Additionally, 
mCoro1a and -1b show a high amino acid sequence homology indicated by 63% identities 
and a similarity of 79% (Table 10-1, Figure 10-1). Coro1a is preferentially expressed in cells 
of the hematopoietic lineage [187,204,222,248,253,255–258]. Interestingly, in humans and 
mice, mutation or deletion of Coro1a results in a severe combined immunodeficiency (SCID) 
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that has mainly been attributed to defective actin regulation in T lymphocytes [204,259–262]. 
In this context, it has been shown that Coro1a-/- T cells are defective in chemokine-mediated 
migration and exhibit impaired thymic egress and homing to lymph nodes. Furthermore, 
Coro1a was linked to the regulation of T cell survival [204,263]. For macrophages, it has 
been shown that Coro1a as coat on phagosomes is crucial for intracellular survival of 
mycobacteria in infected cells, however, the relevant mechanisms are not fully understood 
and are a subject of controversial discussion [252,253,264,265]. Recently, it has been 
suggested that Coro1a-function is required for chemotaxis and phagocytosis in human 
neutrophils, however, seems to be dispensable for these F-actin-dependent processes in 
murine equivalents [187,257]. In this context, it is important to know that this discrepancy 
may be the result of different approaches used to block Coro1a-function, thus further studies 
are required to solve this issue. Recent work on MCs provides evidences for a role of Coro1a 
in exocytic pathways. The loss of Coro1a-function in bone marrow-derived MCs resulted in 
increased FcεRI-mediated degranulation of secretory lysosomes as well as significantly 
reduced secretion of cytokines in vitro and enhanced passive cutaneous anaphylaxis in vivo 
[222]. However, another study failed to confirm these observations utilizing another 
Coro1a-deficient mouse strain [266]. Coro1a is also expressed in B cells as well as in 
dendritic cells, however, recent work revealed no effects on fundamental mechanisms 
required for their immune cell function upon loss of Coro1a [256,258].  
In contrast to the immune specific expression pattern of Coro1a, Coro1b is ubiquitously 
expressed, indicating a more general role in the regulation of actin dynamics [187,212,222–
225]. So far, Coro1b was mainly linked to the modulation of F-actin in lamellipodia via 
Arp2/3- as well as ADF/cofilin-mediated pathways and therefore was associated with the 
regulation of the cellular motility of rat fibroblasts and human lung endothelial cell chemotaxis 
[186,212,229,267]. Additionally, Coro1b seems to be involved in the regulation of neuronal 
plasticity since Coro1b messenger ribonucleic acid (mRNA) was upregulated upon spinal 
cord injury and loss of Coro1b-function in PC-12 cells reduced neurite outgrowth [224]. A first 
evidence for a role of Coro1b in immune cell function was provided by the study on MCs by 
Föger et al. [222]. Although the single-loss of Coro1b had no impact on MC-function, the 
observed hyperdegranulation of Coro1a-/- MCs was further augmented by the additional loss 
of Coro1b, implicating an overlapping role of Coro1a and Coro1b in MCs [222]. 
Up to know, no data are available about the impact of coronin-deficiency on NK cell function. 
However, loss of Coro1a and Coro1b impairs various cellular functions of other immune cells 
which are also crucial for NK cell biology. In the context of the observed SCID phenotype in 
patients with mutated coronin 1a, a detailed analysis of the impact of coronin-deficiency on 
NK cells will reveal important new information on the physiological/pathophysiological 
function of these proteins for the immune system. 
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2 Aim of the study 
The actin cytoskeleton is a highly dynamic structure involved in various cellular processes 
like cell division, cellular motility or the intracellular transport of vesicles and organelles 
[172,174]. More than 100 accessory proteins orchestrate the maintenance as well as the 
quick remodeling of the actin cytoskeleton under certain conditions [172]. One particular 
family of proteins implicated in the regulation of actin cytoskeletal dynamics is the coronin 
family [188–192]. Coronins are evolutionary highly conserved proteins which have been 
described in a variety of species [185,188,194,198–207]. The mammalian genome encodes 
seven coronins with distinct tissue expression and function [188–190,268]. Most of our 
current knowledge about these proteins is based on studies examining the function of 
Coro1a and Coro1b. Interestingly, the loss of Coro1a-function in humans and mice results in 
a SCID which has been mainly attributed to defective actin-regulation in T lymphocytes 
[204,259–262]. A number of studies indicate a crucial role of the actin cytoskeleton in NK cell 
functions [165–171]. However, the impact of coronin-deficiency on NK cells is still unclear. 
Therefore, the aim of the present study was to investigate the role of coronin proteins and in 
turn of the actin cytoskeleton in the biology and function of NK cells by utilizing a unique 
system of Coro1a- and/or Coro1b-deficient mice. In this context, one major task of my work 
was to clarify the impact of coronin-deficiency on the development and maturation of naïve 
NK cells in vivo. Additionally, the impact of Coro1a and Coro1b on fundamental NK cell 
functions like cytotoxicity, cellular motility or exocytosis should be evaluated by in vitro 
studies on IL-15-expanded and primed coronin-deficient NK cells. Together these 
investigations may clarify the role of NK cells under pathologic conditions like the inborn loss 
of Coro1a in humans and mice and reveal the requirements on coronin proteins and the actin 
cytoskeleton for NK cell development and function. 
 
Materials and Methods  20 
 
 
3 Materials 
 
3.1 Mice and cell lines 
Coro1a-/--, Coro1b-/-- and Coro1a-/-Coro1b-/- mice were described previously [204,222]. All 
mice were backcrossed for >10 generations onto C57BL/6N background. Mice were provided 
by Dr. Niko Föger, Research Center Borstel, and housed at the Animal Care Facility of the 
Research Center Borstel under pathogen-free conditions.  
The mouse T cell lymphoma cell line YAC-1 (ACC-96) was purchased from the DSMZ, A20 
mouse B cell lymphoma cells (ATCC, TIB-208) were kindly provided by Dr. Kyeong-Hee Lee 
from the Research Center Borstel.  
 
3.2 Chemicals and reagents 
AccutaseTM PAA Laboratories, Pasching, Austria 
Acrylamide/bis-acrylamide solution, 30% Bio-Rad, Munich, germany 
Ammonium chloride (NH4Cl) Roth, Karlsruhe, Germany 
Ammonium persulfate ((NH4)2S2O8) Bio-Rad, Munich, germany 
Aqua B. Braun H2O Braun, Melsungen, Germany 
Bovine serum albumin (BSA) Biochrom AG, Berlin, Germany 
Brefeldine A Sigma-Aldrich, Steinheim, Germany 
Bromophenol blue Sigma-Aldrich, Steinheim, Germany 
CFDA-SE Life Technologies, Darmstadt, Germany 
Clean-BlotTM IP Detection Reagent (HRP) Thermo Scientific, Rockford, USA 
Complete protease inhibitor cocktail Roche, Mannheim, Germany 
Collagenase StemCell Technologies, Grenoble, France 
DAPI Life Technologies, Darmstadt, Germany 
Dispase StemCell Technologies, Grenoble, France 
Dimethyl sulfoxide (DMSO)  Sigma-Aldrich, Steinheim, Germany 
DNase I StemCell Technologies, Grenoble, France 
deoxyribonucleotide triphosphates (dNTPs) Roche, Mannheim, Germany 
Dithiothreitol (DTT) Life Technologies, Darmstadt, Germany 
eFluor® 670 eBioscience, Frankfurt, Germany 
ethylenediaminetetraacetic acid (EDTA) Roth, Karlsruhe, Germany 
ethylene glycol tetraacetic acid (EGTA) Sigma-Aldrich, Steinheim, Germany 
Ethanol  Roth, Karlsruhe, Germany 
Fetal calf serum (FCS) Biochrom AG, Berlin, Germany 
Fixable blue fluorescent reactive dye Life Technologies, Darmstadt, Germany 
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Glycerol Sigma-Aldrich, Steinheim, Germany 
Glycine Roth, Karlsruhe, Germany 
HEPES buffer PAA Laboratories, Pasching, Austria 
Hoechst 33342 Sigma-Aldrich, Steinheim, Germany 
Ibidi Mounting Medium Ibidi, Martinsried, Germany 
IC Fixation buffer eBioscience, Frankfurt, Germany 
Iscove's Modified Dulbecco's media (IMDM) PAA Laboratories, Pasching, Austria 
Immobilon™ Western Chemiluminescent 
HRP Substrate 
Merck Millipore, Billerica, USA 
Jasplakinolide Life Technologies, Darmstadt, Germany 
Ionomycin Sigma-Aldrich, Steinheim, Germany 
Latrunculin B Enzo life sciences, Lörrach, Germany 
L-Glutamine PAA Laboratories, Pasching, Austria 
Lympholyte®-M Cedarlane, Ontario, Canada 
LysoTracker® Red DND-99 and 
LysoTracker® Green DND-26 
Life Technologies, Darmstadt, Germany 
Magnesium chloride (MgCl2) Roth, Karlsruhe, Germany 
Methanol Roth, Karlsruhe, Germany 
Non-essential amino acids Life Technologies, Darmstadt, Germany 
NP-40 Roth, Karlsruhe, Germany 
Paraformaldehyde (PFA) Roth, Karlsruhe, Germany 
Penicillin/Streptomycin PAA Laboratories, Pasching, Austria 
Permeabilization Buffer (10X) eBioscience, Frankfurt, Germany 
Phalloidin Life Technologies, Darmstadt, Germany 
Phosphate buffered saline (PBS) 10x PAA Laboratories, Pasching, Austria 
PIPES buffer Sigma-Aldrich, Steinheim, Germany 
Phorbol-12- myristate-13-acetate (PMA) Sigma-Aldrich, Steinheim, Germany 
Potassium chloride (KCl) Roth, Karlsruhe, Germany 
Precise Plus Protein Dual Color Standard Bio-Rad, Munich, Germany 
Recombinant murine IL-3, IL-15, CXCL10, 
CXCL12 and GM-CSF  
R&D Systems, Wiesbaden-Nordenstadt, 
Germany 
Recombinant human M-CSF Tebu-bio, Offenbach, Germany 
RestoreTM Plus Western Blot Stripping Buffer Thermo Scientific, Rockford, USA 
Roswell Park Memorial Institute medium 
(RPMI) 
Life Technologies, Darmstadt, Germany 
Sodium dodecyl sulfate (SDS) Roth, Karlsruhe, Germany 
Sodium carbonate (Na2CO3) Roth, Karlsruhe, Germany 
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Sodium chloride (NaCl) Roth, Karlsruhe, Germany 
Sodiume fluoride (NaF) Roth, Karlsruhe, Germany 
Sodium pyruvate Life Technologies, Darmstadt, Germany 
Sodium orthovanadate (Na3VO4) Roth, Karlsruhe, Germany 
Streptavidin microspheres Polyscience, Inc., Eppelheim, Germany 
SuperBlock® T20 (TBS) Blocking Buffer Thermo Scientific, Rockford, USA 
Tetramethylethylenediamine (TEMED) Roth, Karlsruhe, Germany 
Tris(hydroxymethyl)aminomethane (Tris) Roth, Karlsruhe, Germany 
Tris hydrochlorid (Tris-HCl) Roth, Karlsruhe, Germany 
Triton X-100 Alternative Roth, Karlsruhe, Germany 
Trypanblue solution Biochrom AG, Berlin, Germany 
Tween20 Sigma-Aldrich, Steinheim, Germany 
Vitamins Life Technologies, Darmstadt, Germany 
β-Mercaptoethanol Life Technologies, Darmstadt, Germany 
 
All chemicals used, were of purity grade pro analysis (p.a.).  
 
3.3 Molecular and cell biology kits and reagents 
Kits listed below were purchased from the indicated companies and used according to 
manufacturer’s instructions.  
  
CD49b (DX5) MicroBeads Miltenyi, Bergisch Gladbach, Germany 
CytoTox 96® Non-Radioactive Cytotoxicity 
Assay 
Promega, Mannheim, Germany 
DuoSet Elisa Kit (IFN-γ, CCL5) R&D Systems, Wiesbaden-Nordenstadt, 
Germany 
LightCycler® 480 probes master Kit Roche, Mannheim, Germany 
RNase-Free DNase Set QIAGEN, Hilden, Germany 
RNeasy Plant Mini Kit  QIAGEN, Hilden, Germany 
SuperScript™ II Reverse Transcriptase Kit Life Technologies, Darmstadt, Germany 
 
3.4 Primer and UPL probes 
All primers listed in Table 3-1 were synthesized by Metabion (Martinsried, Germany), 
TaqMan probes from the Universal Probe Library (UPL) for mouse were purchased from 
Roche (Mannheim, Germany). 
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Table 3-1. Primer sequences and corresponding UPL probe IDs for real-time PCR 
Gene Primer Sequence (5’-3’ direction) UPL probe ID 
Hprt HPRT #95 left TCCTCCTCAGACCGCTTTT #95 
HPRT #95 right CCTGGTTCATCATCGCTAATC 
Coro1a Coro1a #18 left CTACTTGGGAGGGGTCACG #18 
Coro1a #18 right TTTGCTGGAGCGAACCAC 
Coro1b Coro1a #17 left TTCAGCCGCATGAGTGAAC #17 
Coro1a #17 right GTAGAGCCCCATTGCTTGAA 
Coro7 Coro7 #29 left ATCACCTGACCCTCACAAGG #29 
Coro7 #29 right TCCACATCCTGAATGTCACAC 
IFN-γ Ifng #21 left ATCTGGAGGAACTGGCAAAA #21 
Ifng #21 right TTCAAGACTTCAAAGAGTCTGAGGTA 
 
3.5 Antibodies  
 
3.5.1 Antibodies for flow cytometry and immunofluorescence microscopy 
Antibodies used for flow cytometry (Table 3-2) were fluorochrome-conjugated and were 
diluted 1:100 or as stated. For immunofluorescence microscopy, antibodies were used as 
indicated in methods (see chapter 4.3.2 and Table 3-2).  
For detection of unconjugated primary antibodies used for flow cytometry or 
immunofluorescence microscopy, 1:2000 diluted fluorochrome-conjugated source specific 
secondary antibodies were used (see Table 3-3). 
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Table 3-2. Antibodies for flow cytometry and immunofluorescence microscopy 
Antibody (clone) Company 
CD3ε (145-2C11) PE/APC eBioscience, Frankfurt, Germany 
CD11b (M1/70) FITC BioLegend, Fell, germany 
CD25 (IL-2Rα) (PC61.5) PE-Cy7 eBioscience, Frankfurt, Germany 
CD27 (LG.3A10) APC BioLegend, Fell, germany 
CD43 (S7) FITC BD Biosciences, Franklin Lakes, USA 
CD45R (B220) (RA3-6B2) PE-Cy7  eBioscience, Frankfurt, Germany 
CD49b (DX5) FITC BioLegend, Fell, germany 
CD51(Integrin alpha V) (RMV-7) PE eBioscience, Frankfurt, Germany 
CD69 (H1.2F3) PE-Cy7 BioLegend, Fell, germany 
CD107a (LAMP-1) (eBio1D4B (1D4B) Alexa 
Fluor® 488/Alexa Fluor® 647 
eBioscience, Frankfurt, Germany 
CD117 (c-Kit) (2B8) PE-Cy7 eBioscience, Frankfurt, Germany 
CD122 (IL-2Rβ) (TM-β1) PE BioLegend, Fell, germany 
CD127 (IL-7Rα) (A7R34) FITC eBioscience, Frankfurt, Germany 
CD132 (common γ chain) (TUGm2) PE BD Biosciences, Franklin Lakes, USA 
CD314 (NKG2D) (CX5) PE-Cy7  eBioscience, Frankfurt, Germany 
CD335 (NKp46) (29A1.4) PE eBioscience, Frankfurt, Germany 
Coro1a (5E10.3.7) DyLight 649  Provided by Niko Föger 
Coro1b (2E6.4.4) unconjugated Provided by Niko Föger 
Granzyme A (3G8.5) unconjugated Santa Cruz, Heidelberg, Germany 
Granzyme B (GB12) PE Life Technologies, Darmstadt, Germany 
IFN-γ (XMG1.2) Alexa Fluor® 647 eBioscience, Frankfurt, Germany 
KLRG1 (MAFA) (2F1) APC eBioscience, Frankfurt, Germany 
Ly49G2 (eBio 4D11) FITC eBioscience, Frankfurt, Germany 
Ly49H (3D10) FITC eBioscience, Frankfurt, Germany 
NK1.1(PK136) FITC, PE, PerCP-Cy5.5, APC eBioscience, Frankfurt, Germany 
NKG2A/C/E (20d5) FITC BD Biosciences, Franklin Lakes, USA 
Armenian Hamster IgG isotype control 
(eBio299Arm) PE, PE-Cy7, APC 
eBioscience, Frankfurt, Germany 
Mouse IgG1, κ isotype control (P3.6.2.8.1) FITC  eBioscience, Frankfurt, Germany 
Mouse IgG2a, κ isotype control (eBM2a) PerCP-
Cy5.5 
eBioscience, Frankfurt, Germany 
Mouse IgG2b negative control Dako, Hamburg, Germany 
Rat anti-mouse IgG2b (R12-3) Biotin  BD Biosciences, Franklin Lakes, USA 
Rat IgG1, κ isotype control PE, PE-Cy7 eBioscience, Frankfurt, Germany 
Rat IgM, κ isotype control FITC eBioscience, Frankfurt, Germany 
Rat IgG2a, κ isotype control FITC, PE, PE-Cy7 eBioscience, Frankfurt, Germany 
Rat IgG2b, κ isotype control FITC, PE, PE-Cy7 eBioscience, Frankfurt, Germany 
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Table 3-3. Secondary antibodies and reagents 
Antibody Company  
Goat anti-armenian hamster IgG (H+L) DyLight 
649-conjugated  
Jackson ImmunoResearch, Suffolk, UK 
Streptavidin-APC BioLegend, Fell, Germany 
 
3.5.2 Antibodies used for stimulation 
Listed functional grade purified or biotinylated anti-mouse antibodies were used as indicated 
in methods (4.1.10) to stimulate NK cells.  
 
Table 3-4. Antibodies used for stimulation 
Antibody (clone) Company 
NK1.1 Biotin (PK136) eBioscience, Frankfurt, Germany 
NK1.1 Functional Grade Purified (PK136) eBioscience, Frankfurt, Germany 
CD314 (NKG2D) Biotin (A10) eBioscience, Frankfurt, Germany 
CD314 (NKG2D) Functional Grade Purified (A10) eBioscience, Frankfurt, Germany 
 
3.5.3 Antibodies for Western blotting 
Listed antibodies for immunoblot analysis (Table 3-5) were purchased from the indicated 
companies and used according to manufacturer’s instructions or as stated.  
 
Table 3-5. Primary antibodies for Western blotting 
Antibody (clone) Source Company  
ACTIN (I-19) Goat Santa Cruz, Heidelberg, Germany 
Akt (55/PKBa/Akt) Mouse BD Biosciences, Franklin Lakes, USA 
Coro1a (5E10.3.7) Hamster Provided by Niko Föger 
Coro1b (2E6.4.4) Hamster Provided by Niko Föger 
Coro1b (C-terminus) Rabbit ECM Biosciences, Versailles, USA 
Erk-2 (C-14), Rabbit Santa Cruz, Heidelberg, Germany 
GAPDH (6C5) Mouse Santa Cruz, Heidelberg, Germany 
p-Akt (Ser473) (D9E) Rabbit Cell Signaling, Danvers, USA 
p-p44/42 MAPK (Erk1/2) 
(Thr202/Tyr204) (D13.14.4E) 
Rabbit Cell Signaling, Danvers, USA 
p-Ser2-Coro1b Rabbit ECM Biosciences, Versailles, USA 
Perforin (eBioOMAK‐D) Rat eBioscience, Frankfurt, Germany 
Vimentin (RV202) Mouse BD Biosciences, Franklin Lakes, USA 
 
For detection of primary antibodies, following horseradish peroxidase-conjugated source 
specific secondary antibodies were used:  
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Table 3-6. Secondary antibodies 
Antibody Company  
Rabbit anti-goat IgG, HRP-conjugated Thermo Scientific, Rockford, USA  
Goat anti-armenian hamster IgG (H+L) Jackson ImmunoResearch, Suffolk, UK 
Sheep anti-mouse IgG, HRP-conjugated GE Healthcare, Munich, Germany 
Goat anti-rabbit IgG (H&L), HRP-conjugated Cell Signaling, Danvers, USA 
Goat anti-rat IgG, HRP-conjugated Thermo Scientific, Rockford, USA 
 
Secondary antibodies were diluted 1:30000. Alternatively, Clean-BlotTM IP Detection Reagent 
(HRP) (1:2000) was used for detection of primary antibodies. 
 
3.6 Laboratory equipment 
Analytical Balance SBC 31 Denver Instrument, Göttingen, Germany 
AutoMACS® Miltenyi, Bergisch Gladbach, Germany 
Bench MSC Advantage Thermo Scientific, Rockford, USA 
BioPhotometer Eppendorf, Hamburg, Germany 
Centrifuge 5810 R Eppendorf, Hamburg, Germany 
Centrifuge 5415 R Eppendorf, Hamburg, Germany 
Centrifuge 4K15 Sigma, Osterode am Harz, Germany 
Confocal laser scan microscope SP5 Leica, Wetzlar, Germany 
ELISA reader Infinite M200 Tecan, Männedorf, Switzerland 
ELISA washer Anthos fluido Anthos Microsystems, Krefeld, Germany  
FACS Calibur BD Biosciences, Franklin Lakes, USA 
FACS LSRII BD Biosciences, Franklin Lakes, USA 
Incubator Hera Cell 150 Thermo Scientific, Rockford, USA 
Intelli-Mixer RM-2M ELMI Ltd., Riga, Latvia 
Kodak M35 X-OMAT processor Kodak, Rochester, USA 
LightCycler 480 System Roche, Mannheim, Germany 
Microscope CK40 Olympus, Hamburg, Germany 
Mini Protean® Tetra Cell System Bio-Rad, Munich, Germany 
Mini Trans-Blot® Electrophoretic Transfer 
Cell System 
Bio-Rad, Munich, Germany 
ph meter sevenEasy Mettler-Toledo, Greifensee, Switzerland 
Pipettes Eppendorf, Hamburg, Germany 
Precision Balance 440-45 N Kern, Balingen-Frommern, Germany 
Power supply (Power PAC Universal) Bio-Rad, Munich, Germany  
Thermoblock Grant Instruments, Hillsborough, USA 
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Thermomixer comfort Eppendorf, Hamburg, Germany 
Shaker Duomax 1030 Heidolph Instruments, Schwabach, Germany 
Shaker MS3 basic IKA, Staufen, Germany 
Shaker PMR-30 Grant Instruments, Hillsborough, USA 
Water bath Memmert, Schwabach, Germany 
 
3.7 Laboratory supplies 
Amersham Hyperfilm® ECL® GE Healthcare, Munich, Germany 
Cell strainer (40 µm, 70 µm); BD Falcon BD Biosciences, Franklin Lakes, USA 
Centrifugation tubes (15 ml, 50 ml) Sarstedt, Nümbrecht, Germany 
FACS tubes Sarstedt, Nümbrecht, Germany 
HTS Transwell®-96 permeable supports plate 
with 5 µm pore size 
Corning, Corning, USA 
ibiTreat µ-Slide VI0,4 Ibidi, Martinsried, Germany 
ImmobilonTM-P PVDF membrane Merck Millipore, Billerica, USA 
LightCycler® 480 Multiwell Plate 96, white Roche, Mannheim, Germany 
LS Columns  Miltenyi, Bergisch Gladbach, Germany 
Microcentrifuge tubes (0.5 ml, 1.5 ml, 2 ml) Sarstedt, Nümbrecht, Germany 
Needles BD Biosciences, Franklin Lakes, USA 
6-/24-/96-well cell culture plates Nunc, Rochester, USA 
Petri dish (92 x 16 mm, sterile) Sarstedt, Nümbrecht, Germany 
Petri dish (100 x 15 mm, bacterial grade, 
non-adherent, sterile); BD Falcon® 
BD Biosciences, Franklin Lakes, USA 
Pipette tips Sarstedt, Nümbrecht, Germany 
Plastic pipettes (5 ml, 10 ml, 25 ml) Sarstedt, Nümbrecht, Germany 
Tissue culture flasks  Sarstedt, Nümbrecht, Germany 
Syringe (1 ml, 5 ml, 10 ml) BD Biosciences, Franklin Lakes, USA 
Whatmann paper GE Healthcare, Munich, Germany 
 
3.8 Software 
FlowJo (version 7.6.5) Tree Star, Inc., Ashland, USA 
ImageJ (version 1.43u) National Institutes of Health, Bethesda, USA 
Leica LAS AF (version 2.4.1) Leica, Wetzlar, Germany 
LightCycler® 480 software (version 1.5 SP4) Roche, Mannheim, Germany 
Magellan (version 6.6) Tecan, Männedorf, Switzerland 
Prism (version 5.03) GraphPad, La Jolla, USA 
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4 Methods 
 
4.1 Cell isolation, cultivation and stimulation 
 
4.1.1 Isolation of cells from spleen, lymph nodes, bone marrow and liver 
Mice were sacrificed by euthanasia and spleen, lymph nodes, liver as well as the femurs and 
tibiae were excised. To generate a single-cell suspension, spleen and lymph nodes were 
mashed through a 40 µm pore size nylon mesh cell strainer using a 5 ml syringe pestle. Cells 
were centrifuged at 400 x g for 5 minutes (min) at 4°C and erythrocytes were lysed with 2 ml 
ice cold erythrocyte lysis buffer (0.83% (w/v) NH4Cl, 0.168% (w/v) Na2CO3, 1 mM 
ethylenediaminetetraacetic acid (EDTA), pH 7.3) for 10 min at room temperature (RT). Cells 
were washed with YAC-1 medium (RPMI 1640, 10% inactivated fetal calf serum (FCS), 
2 mM L-glutamine, 100 µg/ml streptomycin and 100 U/ml penicillin) and counted. All cell 
washing steps were performed at 400 x g for 5 min at 4°C. For counting, cells were diluted 
1:10 in trypan blue solution (0.05% trypan blue in 0.9% NaCl-solution) to enable dead cell 
exclusion and living cells were counted using a Neubauer counting chamber and an optical 
microscope. Total spleen cells were used for further analysis or for NK- and B cell 
purification. Cells obtained from lymph nodes were used together with spleen cells to enrich 
T cells.  
Bone marrow (BM) was flushed out of the femurs and tibiae of mice with phosphate buffered 
saline (PBS). Cells were centrifuged at 400 x g for 5 min at 4°C and erythrocytes were lysed 
with 2 ml ice cold erythrocyte lysis buffer for 15 min at RT. Cells were washed with YAC-1 
medium and counted. BM cells were used for further analysis or for the generation of bone 
marrow-derived mast cells (BMMCs), bone marrow-derived dendritic cells (BMDCs) and 
bone marrow-derived macrophages (BMMΦs).  
To isolate liver lymphocytes, the gall bladder was removed from the liver and the organ was 
cut into small pieces within a petri dish on ice. The liver pieces were portioned into three 15 
ml centrifuge tubes and 5 ml collagenase-dispase-medium (IMDM, 5% inactivated FCS, 
0.2 mg/ml collagenase, 0.2 mg/ml dispase and 10 µg/ml DNase I; enzymes all from Stemcell 
Technologies) was added to each tube. The tubes were incubated at 37°C in a water bath for 
45 min. Every 3 to 5 min the solution was mixed by pipetting using a Pasteur pipette. The 
solution was subsequently passed through a 70 µm pore size nylon mesh cell strainer and 
PBS was added up to 50 ml. Cells were centrifuged at 400 x g for 5 min at 4°C and 
resuspended in 15 ml YAC-1 medium. Lymphocytes were isolated using Lympholyte®-M 
according to manufacturer’s instructions. In brief, 5 ml cell suspension was layered over 5 ml 
Lympholyte®-M in a 15 ml centrifuge tube. Tubes were centrifuged at 1250 x g for 20 min at 
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RT. After centrifugation the interface was removed from the gradient and transferred into a 
new tube. Lymphocytes were washed three times with YAC-1 medium and counted. Isolated 
liver lymphocytes were used for further analysis. 
 
4.1.2 Cell cultivation 
All primary cells and cell lines were maintained at 37°C, 5% CO2 and a humidity of 95% in 
the incubator unless otherwise stated. 
 
4.1.3 Purification and expansion of NK cells 
Total spleen cells were isolated as described in 4.1.1. NK cells were enriched by 
MACS®-separation using CD49b MicroBeads and LS columns according to the 
manufacturer’s instructions. In brief, spleen cells were centrifuged at 300 x g for 10 min at 
4°C. The supernatant was discarded and cells were resuspended in 90 µl of MACS®-buffer 
(PBS, pH 7.2, 0.5% bovine serum albumin (BSA) and 2 mM EDTA) per 107 cells. In addition, 
10 µl CD49b MicroBeads were added per 107 cells, the cell suspension was mixed and 
incubated for 20 min at 4°C, every 5 min the suspension was mixed by hand. Cells were 
washed by adding 12 ml MACS®-buffer and centrifuged at 300 x g for 10 min at 4°C. Pellet 
was resuspended in 500 µl MACS®-buffer and transferred into the equilibrated LS column. 
Columns were washed three times with MACS®-buffer and then NK cells were eluted. 
MACS®-buffer was removed by centrifugation and enriched NK cells were cultured in a 
12-well cell culture plate in 3 ml NK medium (RPMI 1640, 10% inactivated FCS, 2 mM 
L-glutamine, 100 µg/ml streptomycin, 100 U/ml penicillin, 1 mM sodium pyruvate, 50 µM 
β-mercaptoethanol and 10 mM HEPES) supplemented with 50 ng/ml IL-15 (R&D Systems, 
Wiesbaden-Nordenstadt) for 2 days. At day 2, NK cells were split 1:2. To that end, 1 ml NK 
medium was removed, adherent cells were detached by pipetting and 1 ml of the cell 
suspension was transferred to another 12-well. Two ml NK medium supplemented with 
50 ng/ml IL-15 was added to each well. On day 3 NK cells were transferred to a 6-well cell 
culture plate and 3 ml NK medium supplemented with IL-15 (50 ng/ml) were added to each 
well. The cells were maintained for additional 3 days in the incubator. Phenotypical analysis 
and functional assays were performed using 6-9 days old NK cells. Within this period, NK 
cells were cultured at a concentration of about 0.75 x 106 cells/ml in a 6-well cell culture plate 
in the presence of IL-15. Purity was routinely >90% as determined by flow cytometric 
analysis of CD3 and NK1.1 expression. 
 
4.1.4 Purification of CD4+ and CD8+ T cells 
Total spleen cells and cells from the lymph nodes were isolated as described in 4.1.1 and 
CD4+ or CD8+ T cells were enriched by depletion of unwanted cells. In brief, mixed total 
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spleen cells and cells from the lymph nodes were centrifuged at 300 x g for 10 min at 4°C. 
The supernatant was discarded and the pellet was resuspended in MACS®-buffer 
(1 x 108 cells/ml). Cells were incubated with FITC-conjugated monoclonal antibodies (mAbs, 
0.5 µl per 107 cells) directed against CD11b, CD11c, B220, DX5, F4/80 and CD4 or CD8 to 
label all cells with the exception of CD4+ or CD8+ cells, for 15 min on ice, every 5 min the 
suspension was mixed. Cells were washed with MACS®-buffer and incubated with anti-FITC 
MicroBeads (8 μl MicroBeads per 1 x 107 cells) as described before. Cells were washed with 
MACS®-buffer, the supernatant was discarded and the pellet was resuspended in 1-2 ml 
MACS®-buffer. Non-T cells and CD4+ or CD8+ cells were depleted using the program 
“depletes” of the autoMACS®. Purity was routinely >90% as determined by flow cytometric 
analysis of CD4 and CD8 expression. 
 
4.1.5 Purification of B cells 
Total spleen cells were isolated as described in 4.1.1. B cells were enriched by depletion of 
non-B cells. In brief, total spleen cells were centrifuged at 300 x g for 10 min at 4°C. The 
supernatant was discarded and the pellet was resuspended in MACS®-buffer 
(1 x 108 cells/ml). Spleen cells were incubated with FITC-conjugated mAbs (0.5 µl per 
107 cells) directed against Thy1.2, CD11b, CD11c and NK1.1 to label non-B cells, for 15 min 
on ice, every 5 min the suspension was mixed. Cells were washed with MACS®-buffer and 
incubated with anti-FITC MicroBeads (8 μl MicroBeads per 1 x 107 cells) as described before. 
Cells were washed with MACS®-buffer, the supernatant was discarded and the pellet was 
resuspended in 1-2 ml MACS®-buffer. Non-B cells were depleted using the program 
“depletes” of the autoMACS®. Purity was routinely between 85% and 90% as determined by 
flow cytometric analysis of CD4, CD8, CD11b, CD11c, NKp46 and CD45R expression.  
  
4.1.6 Generation of bone marrow-derived mast cells 
BMMCs were prepared as described previously [269]. In brief, BM cells were isolated as 
described in 4.1.1 and the BMMCs were selectively grown in BMMC medium (IMDM, 10% 
inactivated FCS, 2 mM L-glutamine, 100 µg/ml streptomycin, 100 U/ml penicillin, 1 mM 
sodium pyruvate, 50 µM β-mercaptoethanol, non-essential amino acids and vitamins) in the 
presence of 10 ng/ml rmIL-3 for 5-10 weeks. Cell purity was routinely determined by flow 
cytometric analysis of c-Kit, FcεRI-α and T1/ST2 cell surface expression. 
 
4.1.7 Generation of bone marrow-derived macrophages 
BMMΦs were generated as described previously [270]. Briefly, bone marrow cells were 
isolated as described in 4.1.1. Cells were seeded (1 x 106 cells/ml) in bacterial grade, non 
adherent petri dishes in 10 ml BMMΦ medium (RPMI 1640, 10% inactivated FCS, 4 mM 
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L-glutamine, 50 µg/ml streptomycin, 50 U/ml penicillin, 1 mM sodium pyruvate and 
non-essential amino acids) supplemented with 20 ng/ml rhM-CSF to induce differentiation. At 
day 3, 10 ml fresh medium containing 20 ng/ml rhM-CSF was added to the plate. At day 6, 
10 ml cell-free culture medium was exchanged by fresh medium containing 10 ng/ml 
rhM-CSF. After 8 days of culture, cells were harvested using AccutaseTM and washed twice 
with medium. Purity was routinely >95% as determined by flow cytometric analysis of F4/80, 
CD11c, CD45R, CD3 and NK1.1 expression. 
 
4.1.8 Generation of bone marrow-derived dendritic cells 
BMDCs were generated as described previously [271]. In brief, bone marrow cells were 
isolated as described in 4.1.1. Cells were seeded (0.3 x 106 cells/ml) in bacterial grade, 
non-adherent petri dishes in 10 ml BMDC medium (RPMI 1640, 10% inactivated FCS, 2 mM 
L-glutamine, 100 µg/ml streptomycin, 100 U/ml penicillin and 50 µM β-mercaptoethanol) 
supplemented with 20 ng/ml rmGM-CSF to induce differentiation. At day 3, 10 ml medium 
containing 20 ng/ml rmGM-CSF was added to the plate. At day 6, 10 ml cell-free culture 
medium was exchanged by fresh medium containing 10 ng/ml rmGM-CSF. After 8 days of 
culture, cells were harvested using AccutaseTM and washed twice with medium. Purity was 
routinely >95% as determined by flow cytometric analysis of CD11c expression. 
 
4.1.9 Culture of YAC-1 and A20 cells  
YAC-1 cells were thawed and propagated in YAC-1 medium. Cells were cultured in YAC-1 
medium within a T25 or T75 cell culture flask in the incubator. After 2-3 days of culture, 
medium was completely exchanged and cells were split in a 1:15 to 1:20 ratio. Aliquots of 
2 x 106 cells were frozen in 10% dimethyl sulfoxide (DMSO) in FCS. For the use in functional 
assays, cells were thawed at least one week before the assay and maintained as described 
above for no longer than 4 weeks. 
A20 cells were maintained in BMDC medium within a T75 cell culture flask in the incubator. 
Cells were seeded at a density of 4 x 104 cells/ml and passaged every 2-3 days. 
 
4.1.10 NK cell stimulation 
IL-15-expanded NK cells were stimulated either with plate-bound (mRNA-production, 
intracellular FACS staining, enzyme-linked immunosorbent assay (ELISA) or bead-bound 
mAbs against NK1.1 or NKG2D (Western blot (WB) analysis, fractionation), 500 ng/ml 
phorbol-12-myristate-13-acetate (PMA) plus 5 µM ionomycin or left untreated. In brief, for 
stimulation with plate-bound mAbs, a 24-well cell culture plate was coated with 2.5 µg/ml 
NK1.1 or NKG2D mAbs in PBS over night at 4°C. The wells were washed three times with 
PBS and 500 µl NK medium was added. In addition, non-coated wells containing 500 µl NK 
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medium (medium control) or NK medium supplemented with 2x concentrated 
PMA/ionomycin were prepared. 1 x 106 NK cells were added within 500 µl NK medium 
containing 10 ng/ml IL-15. The plate was centrifuged at 250 x g for 3 min and incubated at 
37°C and 5% CO2 for the time indicated in each experiment. Cells and cell free supernatants 
were collected and used for further analysis. 
For stimulation with bead-bound NK1.1 mAbs, streptavidin microspheres (6 µm) were coated 
with mAbs according to manufacturer’s instructions. In brief, streptavidin conjugated 
microspheres (beads) were incubated with biotinylated NK1.1 mAb (10 µg/ml) in binding 
buffer (PBS, 1% (w/v) BSA) for 30 min at 4°C in a rotating shaker. The beads were washed 
three times with binding buffer (6000 x g for 5 min at 4°C), counted and adjusted to a 
concentration of 10 x 106/ml. 1 x 106 NK cells in 200 µl NK medium supplemented with 
10 ng/ml IL-15 were pre-incubated for at least 15 min in a thermo shaker at 37°C. 200 µl 
NK1.1-coupled beads, NK medium supplemented with 2x concentrated PMA/ionomycin or 
NK medium (medium control) were added and cells were incubated at 37°C for the time 
indicated in each experiment. Stimulated cells were lysed and used for SDS-PAGE or 
subcellular fractionation. 
 
4.2 Quantitative real-time PCR analysis 
 
4.2.1 Total RNA isolation 
Total ribonucleic acid (RNA) from resting IL-15-expanded NK cells and other immune cells (B 
cells, BMDCs, BMMCs, BMMΦs and T cells) or IL-15-expanded NK cells, stimulated with 
plate-bound mAbs against NK1.1, PMA/ionomycin or left untreated for 1 hour (see 4.1.10) 
was extracted using the RNeasy Plant Mini Kit according to the manufacturer’s instructions. 
 
4.2.2 cDNA synthesis 
Total RNA was reverse transcribed to complementary deoxyribonucleic acid (cDNA) using 
oligo(dt)-primers and SuperScript™ II Reverse Transcriptase according to the manufacturer’s 
instructions. In brief, 1 µg RNA was mixed with 1.25 µl cDNA-synthesis-primer (10 pmol/µl) 
and H2O was added to obtain a total volume of 12.5 µl. The mixture was incubated at 70°C 
for 10 min. To each sample, 12.5 µl of a mixture of 5x first strand reaction buffer, dithiothreitol 
(DTT), deoxyribonucleotide triphosphates (dNTPs), RNase inhibitor, SuperScript™ II and 
H2O (see Table 4-1) were added and reverse transcription was performed at 42°C for 3 
hours, following 15 min at 70°C. cDNA was diluted 1:3 with H2O. 
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   Table 4-1. Mastermix for cDNA synthesis 
Components Volume [µl] 
5x first strand reaction buffer 5.0 
DTT (0,1 M) 2.5 
dNTPs (10 mM) 1.25 
RNase inhibitor 0.5 
H2O 2.75 
SuperScript™ II (200 U/µl) 0.5 
Σ 12.5 
 
4.2.3 Quantitative real-time PCR 
To assess Coro1a and Coro1b gene expression in IL-15-expanded NK cells and other 
immune cells or Interferon gamma (IFN-γ) gene expression upon stimulation of 
IL-15-expanded NK cells, quantitative real-time polymerase chain reaction 
(quantitative real-time PCR) using TaqMan probes from the Universal Probe Library (UPL, 
Roche) was performed. For this, cDNAs from resting or stimulated cells were mixed with 
fluorescent labeled TaqMan probes and target gene-specific primers (for both see section 
3.4) as indicated in Table 4-2. 
 
   Table 4-2. Mastermix for TaqMan real-time PCR 
Components Volume [µl] 
LC 480 probes master 5 
Primermix (10 µM) 1 
UPL probe 0.1 
H2O 1.9 
Σ 8 
 
To this mix, 2 µl diluted cDNA was added and the quantitative real-time PCR was performed 
in a Roche LightCycler® 480 using the following conditions: 
 
        Table 4-3. Conditions for quantitative real-time PCR 
  Step Temperature [°C]  Time    
Pre-incubation  Initial denaturation 95 10 min   
Amplification  Denaturation 95 10 sec 
 55 cycles   Annealing 56 30 sec 
  Elongation 72 1 sec 
Cooling   40 ∞   
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Coro1a, Coro1b and IFN-γ gene expression was measured relative to hypoxanthine 
phosphoribosyltransferase (Hprt) in duplicates. Data were analyzed using the LightCycler® 
480 software. 
 
4.3 Flow cytometry and intracellular staining 
 
4.3.1 Analysis of surface molecules 
For surface staining, 2 x 106 total spleen cells or BM cells, 0.5 x 106 liver lymphocytes or 
0.25 x 106 IL-15-expanded NK cells were incubated with Mouse BD Fc BlockTM (anti-mouse 
CD16/CD32, diluted 1:200) for 15 min at 4°C in a total volume of 50 µl FACS buffer (PBS, 
2% (v/v) FCS) within a 96-well round bottom plate. 50 µl FACS buffer supplemented with 
fluorochrome-conjugated mAbs or corresponding isotype controls (see section 3.5.1) were 
added and cells were incubated for additional 20 min at 4°C in the dark. After incubation, 
cells were washed three times with PBS and fixed in 2% (w/v) paraformaldehyde (PFA) in 
PBS. To exclude dead cells, cells were stained in addition with fixable blue fluorescent 
reactive dye (diluted 1:500) according to manufacturer’s instructions. Flow cytometric 
analysis of living NK1.1+/CD3- cells was performed on a FACSCaliburTM or a LSRII. To 
separate living NK1.1+/CD3- single cells, gates were set as shown exemplarily in section 
10.2. Data were analyzed using the FlowJo software. Cells stained with isotype controls were 
used as controls. 
 
4.3.2 Intracellular FACS staining 
To analyze intracellular contents of Coro1a, Coro1b, F-actin or granzymes, untreated 
IL-15-expanded NK cells were fixed, permeabilized and incubated with 
fluorochrome-conjugated mAbs or phalloidin. Briefly, 0.5 x 106 cells were stained for NK1.1 
and CD3 as described in 4.3.1, fixed in 4% (w/v) PFA in PBS for 45 min at RT and 
permeabilized with 0.2% (v/v) Triton X-100 in PBS for 5 min at RT. After blocking with 
blocking buffer (PBS, 1% (w/v) BSA) for 45 min at 4°C, cells were incubated with the 
following mAbs: Directly fluorescence-labeled mAbs against Coro1a (1:4000) and against 
granzyme B (GrzB, 1:100), unconjugated mAb against Coro1b (1:10000) + anti-hamster 
IgG-DyLight 649 secondary Ab (sec. Ab, 1:2000) and mAb against granzyme A (GrzA, 
1:100) + anti-mouse IgG2b-Biotin (1:100) + streptavidin-APC (1:200) or phalloidin (1:100). 
Staining was performed in a total volume of 100 µl blocking buffer within a 96-well round 
bottom plate and cells were washed with blocking buffer in between incubation with primary 
and sec. Abs. In addition to the described method, intracellular FACS staining was also 
performed using fixation- and permeabilization buffers from eBioscience, according to the 
standard protocol provided by the company. To assess intracellular IFN-γ content upon 
Materials and Methods  35 
 
 
activation, IL-15-expanded NK cells were stimulated with plate-bound NK1.1 mAbs, 
PMA/ionomycin or left untreated for 6 hours, as described in 4.1.10. To block cytokine 
secretion, 3.0 µg/ml brefeldin A was added after 1 hour of stimulation. Cells were harvested, 
stained for NK1.1 and CD3, fixed, permeabilized and incubated with fluorescence-labeled 
mAbs against IFN-γ (1:100) according to standard procedures. Flow cytometric analysis of 
living NK1.1+/CD3- cells and data analysis were performed as described before (4.3.1). Either 
cells stained with isotype controls or sec. Abs or corresponding knockout cells were used as 
control. 
 
4.4 SDS polyacrylamide gel elektrophoresis (SDS-PAGE) and Western 
blot (WB) 
 
4.4.1 Sample preparation 
To investigate cellular proteins, 1 x 106 resting IL-15-expanded NK cells or cells stimulated 
with bead-bound mAbs against NK1.1 (5 + 20 min), PMA/ionomycin (20 min) or left untreated 
(see 4.1.10) were lysed in 100 µl lysis buffer (1% (v/v) NP-40, 50 mM Tris-HCl, pH 8.0, 
150 mM NaCl, 1 mM Na3VO4, 10 mM NaF and protease inhibitors (complete protease 
inhibitor cocktail) for 20 min on ice. After centrifugation at 15000 x g at 4°C for 15 min, 
lysates were collected and used for SDS-Page or were stored at -80°C for further analysis. 
Prior to electrophoresis, samples were diluted with 4x Laemmli buffer (62.5 mM Tris-HCl, 
pH 6.8, 20% (v/v) glycerol, 2% (w/v) SDS, 5% (v/v) β-mercaptoethanol, 0.025% (w/v) 
bromophenol blue) and denaturated at 95°C for 5 min.  
 
4.4.2 SDS-PAGE 
For protein separation according to their size, SDS-PAGE was used. In brief, whole cellular 
lysates were prepared as described in section 4.4.1 and 20 µl of each sample were loaded 
onto a 4% stacking gel, an 8% gel was used for separating the proteins by size. Gels were 
prepared as described in Table 4-4. 
Gel electrophoresis was performed in the Mini Protean® Tetra Cell System using running 
buffer (25 mM Tris, 192 mM glycine, 3.5 mM SDS) at 60 V for 20 min followed by 125 V for 
75 min. Precise Plus Protein Dual Color Standard was used as molecular weight standard.  
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        Table 4-4. Gel formulations for SDS-PAGE 
Components Stacking gel (4%) 
Volume [ml] 
Separating gel (8%) 
Volume [ml] 
0.5 M Tris-HCl, ph 6.8 0.375  - 
1.5 M Tris-HCl, ph 8.8 - 1.875 
SDS (10% (w/v)) 0.015  0.075 
30% acrylamide/bis-acrylamide solution, 37,5:1 0.200  2.0 
Ammonium persulfate (10% (w/v); APS) 0.025 0.050 
Tetramethylethylenediamine (TEMED) 0.010 0.010 
H2O 0.875 3.5 
Σ 1.5 7.5 
 
4.5 Western blotting  
For detection, proteins separated by SDS-PAGE were transferred to ImmobilonTM-P PVDF 
membranes (Millipore) using the Mini Trans-Blot® Electrophoretic Transfer Cell System and 
blotting buffer (25 mM Tris, 192 mM glycine, 0.9 mM SDS, 10% (v/v) methanol, pH 8.3) at 
100 V, constant, 350 mA for 1 hour. Following transfer, membranes were blocked with 
SuperBlock® T20 (TBS) Blocking Buffer for 1 hour at RT and incubated with the indicated 
primary antibodies (see section 3.5), diluted in SuperBlock®, over night at 4°C on a shaker. 
Membranes were washed three times with washing buffer (145 mM NaCl, 10 mM Tris-HCL, 
ph 7.4, 0.05% Tween-20) and incubated with peroxidase-conjugated sec. mAbs, diluted in 
washing buffer, for 1 hour at RT on the shaker. Membranes were washed again, and proteins 
were visualized using Immobilon™ Western Chemiluminescent HRP Substrate, Amersham 
Hyperfilm™ ECL™ and Kodak M35 X-OMAT processor. If necessary, membranes were 
stripped with RestoreTM Plus Western Blot Stripping Buffer according to manufacturer’s 
instructions and further proteins were analyzed as described above.  
  
4.6 Immunofluorescence microscopy 
To visualize the subcellular distribution of Coro1a and Coro1b in conjugated and 
unconjugated IL-15-expanded NK cells, confocal microscopy was used. 6 x 104 NK cells 
were transferred in 30 µl NK medium containing 5 ng/ml IL-15 into a channel of an ibiTreat 
µ-Slide VI0.4 and allowed to attach to the bottom for 30 min at 37°C and 5% CO2 in the 
incubator. For the analysis of single cells, NK cells were fixed immediately using 4% PFA in 
PBS for 45 min at RT. To form NK cell-YAC-1-conjugates, slides were washed with NK 
medium and YAC-1 cells were added in a NK-YAC-1-ratio of 1:3. Cells were co-cultured for 
30 min at 37°C, 5% CO2 in the incubator and fixed as described before. After 
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permeabilization with 0.2% Triton X-100 in PBS for 5 min at RT, cells were blocked with 
blocking buffer and immunofluorescence labeling was performed as described before (4.3.2). 
Specificity of the coronin-staining was confirmed by using Coro1a-/-Coro1b-/- NK cells as 
controls. In addition, cells were incubated with phalloidin and 4',6-Diamidino-2-Phenylindole, 
Dihydrochloride (DAPI) to visualize F-actin and DNA. Slides were mounted with Ibidi 
Mounting Medium and stored at 4°C. 
To investigate granule polarization, IL-15-expanded NK cells were cultured in NK medium 
supplemented with 5 ng/ml IL-15 and 10 µM LysoTracker® Red DND-99 or LysoTracker® 
Green DND-26 in a ibiTreat µ-Slide VI0.4 for 2 hours at 37°C and 5% CO2 in the incubator. 
Conjugates were generated as described before, cells were fixed and permeabilized by 
incubation with ice cold methanol (5 min at -20°C) followed by treatment with ice cold 
acetone for 1 min at -20°C. DNA was visualized by staining with bisbenzimide H 33342 
trihydrochloride (Hoechst 33342). Specificity of the LysoTracker®-labeling was confirmed by 
staining with fluorochrome-conjugated mAbs against CD107a, as control. Cells were 
analyzed using a scanning confocal microscope (TSC SP5). Image analysis was performed 
using Leica LAS AF Lite software. 
 
4.7 Transwell migration assay 
To assess chemokine-mediated migration of IL-15-expanded NK cells a transwell system 
was used. In brief, NK cells were washed twice with serum free NK medium (RPMI 1640 
supplemented with 5 ng/ml IL-15 and 0.5% BSA and adjusted to a concentration of 1.3 x 106 
cells/ml. 235 µl serum free NK medium with or without recombinant mouse chemokine 
(C-X-C motif) ligand (CXCL)-10 or CXCL12 in different concentrations were added to the 
reservoir plate of a HTS Transwell®-96 permeable supports plate with 5 µm pore size. In 
addition, some wells of the reservoir plate were filled with 25 µl NK cell suspension (33% of 
the input) and 210 µl serum free NK medium as input control. Finally, 75 µl of the NK cell 
suspension were added to the 96-well permeable support inserts and the plate was 
incubated for 4 hours at 37°C and 5% CO2. For each condition, triplicates were performed. 
Subsequent to the incubation, the 96-well permeable support inserts were removed, cells 
were resuspended thoroughly and transferred into FACS tubes. Cells were counted using an 
LSRII flow cytometer by measuring for a period of 45 sec. The amount of cells, which 
migrated towards the chemokines was calculated as percentage of the input. 
 
4.8 In vitro lactate dehydrogenase (LDH)-based killing assay 
To measure cytotoxicity of IL-15-expanded NK cells in vitro, CytoTox 96® Non-Radioactive 
Cytotoxicity Assay was performed according to a standard protocol provided by the 
company. In brief, YAC-1 cells were plated at a density of 1 x 104 cells/well in a volume of 
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50 µl NK medium supplemented with 5% FCS and 5 ng/ml IL-15 in a 96-well round bottom 
plate. NK cells, adjusted to effector-target-ratios of 4:1 to 1:1 were added in a volume of 50 µl 
medium, composed as described before, in triplicates. As controls, wells containing only 
indicated numbers of NK cells or YAC-1 cells or only medium were prepared. The plate was 
centrifuged at 250 x g for 3 min and incubated for 4 hours at 37°C and 5% CO2. Forty-five 
min prior to harvesting cell free supernatants, 10 µl of 10x lysis solution, provided with the kit, 
was added to the corresponding wells to obtain target cell maximum LDH release. Following 
incubation, plate was centrifuged at 250 x g for 3 min and 50 µl of supernatant was 
transferred into a 96-well flat bottom plate. To assess release of cytoplasmic LDH as a 
measure of cytotoxicity colorimetric, 50 µl of reconstituted LDH Substrate Mix, provided with 
the kit, was added and plates were incubated for 30 min at RT in the dark. The reaction was 
stopped and absorbance at 490 nm was recorded using an Infinite® M200 reader. 
Cytotoxicity was calculated as suggested by the manufacturer according to the following 
formula: % specific lysis = (experimental lysis - effector spontaneous lysis - target 
spontaneous lysis)/(target maximum lysis - target spontaneous lysis) x 100. 
 
4.9 Flow cytometric conjugate assay 
Intercellular conjugate formation of IL-15-expanded NK cells was investigated by two-color 
flow cytometry as described previously [272]. Briefly, 4 x 106 NK cells were labeled with 
0.25 µM carboxyfluorescein diacetate succinimidyl ester (CFDA-SE, Molecular Probes) and 
15 x 106 YAC-1 cells with 2 µM eFluor® 670, according to manufacturer’s instructions. 
Labeled cells were adjusted to a concentration of 1 x 106 cells/ml (NK cells) and 2 x 106 
cells/ml (YAC-1) with NK medium supplemented with 5% FCS and 5 ng/ml IL-15 and stored 
for 15 min on ice. 100 µl NK- and YAC-1 cell suspension were added to a FACS round 
bottom tube, respectively. Cells were mixed and immediately centrifuged at 20 x g for 1 min 
at 4°C. Tubes were incubated at 37°C in a water bath for the indicated time points. Following 
incubation, cells were mixed at 2500 rpm for 3 s on a vortexer and immediately fixed by 
adding 300 µl ice-cold 0.5% PFA in PBS. For each time point triplicates were performed. 
Flow cytometric analysis of intercellular conjugates was performed using an LSRII flow 
cytometer. Data were analyzed as described in 4.3.1. Single labeled NK- and YAC-1 cells 
were used to set up the gates. To assess the specificity of the assay, NK cells were 
co-cultured with labeled BMMCs or A20 cells as described above for YAC-1.  
  
4.10 Cytoskeleton-rich fraction isolation 
For the isolation of the cytoskeleton-containing detergent-insoluble and the cytosolic 
detergent-soluble fraction, stimulated IL-15-expanded NK cells were subjected to subcellular 
fractionation as previously described by Gatfield et al. [215]. In brief, NK cells (1 x 106 cells) 
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were stimulated with bead-bound mAbs against NK1.1 (2, 5, 20 and 60 min), PMA/ionomycin 
(20 min) or left untreated as described in 4.1.10. Alternatively cells were treated with 10 µM 
latrunculin B for 30 min to depolymerize the cellular F-actin. Cell pellets were suspended in 
0.3 ml ice-cold cytoskeleton isolation buffer (1% (v/v) TritonX-100 in 80 mM Pipes, pH 6.8, 
5 mM ethylene glycol tetraacetic acid (EGTA) and 1 mM MgCl2) and immediately centrifuged 
at 3000 x g for 3 min to obtain the detergent-insoluble cytoskeleton-containing fraction (P) 
and the detergent-soluble cytosolic fraction (S). Equal cell equivalents were subjected to 
SDS-PAGE and Western blotting (see 4.4 and 4.5). 
 
4.11 CD107a-degranulation assay 
To assess NK cell degranulation, the surface expression of the lysosome-associated 
membrane protein 1 (LAMP-1, CD107a) upon activation was measured by flow cytometry. In 
resting cells, CD107a is predominantly expressed intracellularly on the membrane of 
secretory lysosomes and endosomes. Upon activation, secretory lysosomes are released 
and CD107a becomes accessible for antibody-binding on the surface of NK cells due to 
fusion of the lysosomal membrane with the outer cell membrane [273]. Therefore, CD107a 
was used as a marker for NK cell degranulation. 
1 x 105 IL-15-expanded NK cells were co-cultured with or without 2 x 104 YAC-1 cells in 
100 µl NK medium supplemented with 5% FCS, 5 ng/ml IL-15 and 2 µg/ml 
AlexaFluor 647-labeled anti-mouse CD107a mAbs within a 96-well round bottom plate for 
3 hours at 37°C and 5% CO2 in the incubator. The plate was centrifuged at 250 x g for 3 min 
after all components had been added. Following incubation, the reaction was stopped by 
adding cold FACS buffer. Surface staining of NK1.1 and CD3 was performed as described in 
4.3.1 and degranulation of NK1.1+/CD3- NK cells was analysed by flow cytometry using an 
LSRII flow cytometer as mentioned before. 
To investigate the role of the actin cytoskeleton during degranulation, 1 x 105 IL-15-expanded 
NK cells were co-cultured with or without 5 x 104 YAC-1 cells in the presence of 10 µM 
latrunculin B for depolymerization of F-actin, 1 µM jasplakinolide for stabilizing actin filaments 
or left untreated for 2 hours and analyzed as described above. Drugs were added directly or 
after 10 min of incubation. As control, cells were treated with carrier (ethanol (EtOH) for 
latrunculin B and DMSO for jasplakinolide). 
  
4.12 Cytokine measurement by ELISA 
For the analysis of cytokine secretion, 1 x 106 IL-15-expanded NK cells were stimulated with 
plate-bound mAbs against NK1.1 and NKG2D, PMA/ionomycin or left untreated for 20 hours 
as described in 4.1.10. Cell free supernatants were collected and subjected to ELISA. For 
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this, DuoSet ELISA Development Kits were used and IFN-γ and CCL5 (RANTES) 
concentration was measured according to manufacturer’s instructions. 
 
4.13 Statistical analysis 
All parametric data are presented as mean ± standard error of the mean (SEM) for pooled 
data from at least three independent experiments or mean ± standard deviation (SD) for 
representative experiments, performed in duplicates or triplicates, as indicated in the 
legends. One experiment includes data from at least one mice of each genotype. FACS data 
from one representative experiment of at least three are shown. The Mann-Whitney test was 
used for statistical analysis, unless stated otherwise. A p-value of <0.05 was considered 
statistically significant. (* p < 0.05; ** p < 0.01). 
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5 Results 
 
Coro1a and Coro1b are members of the evolutionary highly conserved family of 
actin-regulatory coronin proteins. Both proteins have been implicated in various 
actin-mediated cellular functions in leukocytes like cell migration and motility [187,204], 
degranulation [222] and phagocytosis [187,248,250,252]. The loss of Coro1a-function in 
humans and mice as consequence of mutation or deletion results in a SCID, which is 
associated with defective actin-regulation in T lymphocytes [204,259–262]. SCIDs are a 
heterogeneous group of inborn genetic disorders which are mainly characterized by impaired 
T-, B- and NK cell development and function leading to opportunistic infections and early 
death unless treated [274,275]. Furthermore, Coro1a is also required for the survival of 
mycobacteria in phagosomes of infected macrophages [252,265]. However, up to now little is 
known about the impact of coronin-deficiency on NK cell development and function. 
Therefore, in the present study, the role of Coro1a and Coro1b in the biology and function of 
NK cells was investigated utilizing as a model Coro1a- and/or Coro1b-deficient mice. 
 
5.1 Coro1a and Coro1b are co-expressed in NK cells 
Coronins exhibit heterogeneous expression patterns. While Coro1a is mainly expressed in 
cells of the hematopoietic lineage and has been described in neutrophils, macrophages, 
dendritic cells, T- and B cells as well as mast cells [184,187,204,222,248,253,256–258], 
Coro1b shows ubiquitous expression and likely assumes a more general regulatory function 
within and outside the hematopoietic cell lineage [187,212,222–225].  
To investigate the impact of Coro1a and Coro1b on NK cell function, the expression patterns 
of both proteins were analyzed. As a first step, real-time PCR analysis was performed to 
determine gene expression levels in NK cells (see section 4.2). Levels of Coro1a- and 
Coro1b gene expression were measured and normalized to the expression of the 
housekeeping gene hypoxanthine phosphoribosyltransferase (Hprt) in each sample. To 
evaluate the level of Coro1a- and Coro1b mRNA expression in NK cells, other immune cell 
types were used for comparison. Coro1a- as well as Coro1b mRNA was detected in wild type 
NK cells (gray bars) and in all other wild type immune cells investigated (Figure 5-1, left 
panel). As expected, the analysis of Coro1a-/- (green bars), Coro1b-/- (blue bars) and 
Coro1a-/-Coro1b-/- NK cells (red bars) revealed no expression of either Coro1a- or Coro1b 
mRNA in the corresponding knockout NK cells (Figure 5-1, right panel), demonstrating the 
specificity of the assay. The expression levels of Coro1a mRNA in Coro1b-deficient NK cells 
and Coro1b mRNA in Coro1a-deficient NK cells were comparable to wild type amounts. The 
additional analysis of Coro7 gene expression, a further member of the coronin-family, used 
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as internal control, revealed similar mRNA expression levels for all genotypes of NK cells 
(data not shown).  
Together these data indicate the co-expression of Coro1a and Coro1b in NK cells, at least at 
the mRNA level. 
 
             Immune cells 
 
           NK cells 
 
g 
 
 
 
Figure 5-1. Expression of Coro1a- and Coro1b mRNA in NK cells and other immune cells.  
RNA from wild type IL-15-expanded NK cells (NK), purified mouse primary CD8+- (CD8+ TC) and 
CD4+ T cells (CD4+ TC) as well as B cells (BC) and bone marrow-derived macrophages (BMMΦ), 
dendritic cells (BMDC) and mast cells (BMMC) (left panels) as well as from wild type (WT), 
Coro1a-/- (C1a KO), Coro1b-/- (C1b KO) and Coro1a-/-Coro1b-/- (DKO) IL-15-expanded NK cells (right 
panels) was isolated and cDNA was synthesized. Quantitative real-time PCR analysis using Coro1a- 
and Coro1b specific primers was performed to investigate Coro1a- (A) and Coro1b mRNA (B) 
expression. Data are relative to Hprt and show the mean ± SD of one representative experiment in 
duplicate out of three experiments performed for the NK cells or one experiment for the other immune 
cells. 
 
In the next step, the cellular Coro1a- and Coro1b protein content in NK cells was 
investigated. To this end, two different approaches were used. The protein levels were either 
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section 4.3. (Figure 5-2 A) or by an immunoblot assay of whole NK cell lysates (see section 
4.4 and 4.5) as shown in Figure 5-2 B.  
 
 
 
 
 
 
 
Figure 5-2. Coro1a and Coro1b protein expression in NK cells. 
(A) Cellular Coro1a or Coro1b content of IL-15-expanded wild type (WT, gray), Coro1a-/- (C1a KO, 
green), Coro1b-/- (C1b KO, blue) and Coro1a-/-Coro1b-/- (DKO, red) NK1.1+/CD3- NK cells was 
assessed by flow cytometry. NK cells were fixed, permeabilized and stained with specific antibodies 
for either Coro1a (left panel) or Coro1b (right panel). Data shown are representative of at least three 
independent experiments. Solid lines show protein staining and filled histograms with dashed lines 
show either the matching isotype control (Coro1a) or single staining with the secondary antibody 
(Coro1b). 
(B) Immunoblot analysis of Coro1a (upper panel) and Coro1b expression (middle panel) in 
IL-15-expanded NK cells of the indicated genotype. Data are representative for at least three 
independent experiments. Protein loading was assessed by analysis of β-actin expression (lower 
panel).  
 
Results from these studies confirmed the expression of Coro1a and Coro1b in wild type NK 
cells (WT), as shown by the gray histograms in Figure 5-2 A (upper panel) and the 
corresponding protein bands in Figure 5-2 B (upper and middle panel). In addition, Coro1a or 
Coro1b were detected in wild type amounts in the non-corresponding NK cell knockout 
genotypes shown by the green (Coro1a-/-) and blue histograms (Coro1b-/-) of Figure 5-2 A, 
thus indicating the absence of a compensatory counter-regulation. No protein expression of 
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Coro1a or Coro1b was found in the corresponding NK cell knockout genotypes (Figure 5-2 
A). Furthermore, neither Coro1a nor Coro1b was detected in Coro1a-/-Coro1b-/- NK cells 
(DKO) by flow cytometry (Figure 5-2 A, red histograms) or Western blotting (Figure 5-2 B).  
In conclusion, these data confirmed the co-expression of Coro1a and Coro1b at the protein 
level in NK cells and thus suggest a potential role of both proteins in the regulation of 
actin-dependent processes in NK cell development and function. 
 
5.2 Subcellular localization of Coro1a and Coro1b in NK Cells 
Subject to the various functions, coronins have been described to be localized at different 
sites within mammalian cells. Coro1a colocalizes with the F-actin surrounding phagocytic 
vesicles in neutrophils and macrophages, as well as the F-actin-rich cortex of T cells and 
mast cells and accumulates at the leading edge of migrating neutrophils 
[187,203,204,222,252,255]. In contrast to Coro1a, only little is known about the subcellular 
localization of Coro1b. It localizes with the Arp2/3-complex to the leading edge of migrating 
fibroblast, however, further data indicate a distribution which is distinct from the one of 
Coro1a [212,222,224]. Since no information is available on the subcellular distribution of 
Coro1a and Coro1b in NK cells, the cellular localization of both proteins was investigated by 
confocal microscopy. NK cells were fixed, permeabilized and stained for either Coro1a or 
Coro1b and treated with phalloidin to stain F-actin as described in materials and methods 
(section 4.6). Confocal microscopy revealed that Coro1a was mainly localized at the cortex 
of NK cells, where it colocalized with F-actin as indicated by the yellow color in the overlay 
image (Figure 5-3 A, left panel). Additionally, Coro1a also exhibits some punctate 
cytoplasmic staining. As depicted in the left panel of Figure 5-3 B, Coro1b staining resulted in 
a more punctate staining distributed throughout the entire cytoplasm with only minor 
colocalization with the F-actin-rich cell cortex. No Coro1a- and Coro1b staining was detected 
in Coro1a-/-Coro1b-/- NK cells, which were used as negative control (Figure 5-3, A and B, right 
panel).  
In summary, these data indicate a differential subcellular distribution of Coro1a and Coro1b 
in NK cells. Coro1a was mainly localized to the F-actin-rich cell cortex, while Coro1b was 
found throughout the entire cytoplasm. 
In addition, confocal microscopy analysis interestingly revealed that the loss of Coro1a and 
Coro1b resulted in a more pronounced phalloidin (F-actin) staining, indicating a role of the 
coronins in actin-regulation in NK cells. 
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Figure 5-3. Subcellular localization of Coro1a and Coro1b in NK cells. 
Subcellular localization of Coro1a or Coro1b was revealed in wild type (WT) and 
Coro1a-/-Coro1b-/- (DKO) IL-15-expanded NK cells by confocal microscopy. NK cells were stained for 
either Coro1a (A, red) or Coro1b (B, red), F-actin (phalloidin, green) and DNA (DAPI, blue) after 
fixation and permeabilization. Representative individual or overlay fluorescence and DIC images of at 
least three independent experiments are shown. Bars, 5 µm. 
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5.3 Increased cellular F-actin levels in Coro1a-deficient NK cells 
As loss of Coro1a greatly affects basal F-actin contents in T cells but only minimally affects 
them in mast cells, coronin-driven actin-regulation seems to be cell type and/or context 
dependent [204,222,259,260]. This is true for mammalian but has also been described for 
yeast coronins [233]. In accordance to T cells, the steady-state F-actin level in 
Coro1a-/-Coro1b-/- NK cells appeared to be notably increased as observed by confocal 
microscopy and described in the previous section. 
To gain further insights on the quantitative differences, the basal F-actin levels in wild type 
(WT) and Coro1a- and/or Coro1b-deficient NK cells were analyzed in greater detail. NK cells 
were fixed, permeabilized and incubated with phalloidin (stains F-actin) as described in 
section 4.3.2. After that, cellular F-actin levels were assessed by flow cytometry. As shown in 
Figure 5-4 A and B, the analysis revealed a significant, at least two-times higher steady-state 
level of F-actin in Coro1a-/- (green, C1a KO) and Coro1a-/-Coro1b-/- NK cells (red, DKO) 
compared to wild type (gray). Only slight differences in cellular F-actin levels were observed 
between wild type and Coro1b-/- NK cells (blue, C1b KO, Figure 5-4, A and B).  
In summary, these findings confirmed the accumulation of F-actin in Coro1a-/- and 
Coro1a-/-Coro1b-/- NK cells, indicating the actin-regulatory role of Coro1a in these cells. 
 
 
 
 
 
Figure 5-4. Increased cellular F-actin levels in Coro1a-/- and Coro1a-/-Coro1b-/- NK cells. 
Cellular F-actin content of IL-15-expanded wild type (WT, gray), Coro1a-/- (C1a KO, green), 
Coro1b-/- (C1b KO, blue) and Coro1a-/-Coro1b-/- (DKO, red) NK1.1+/CD3- NK cells was assessed by 
flow cytometry. NK cells were fixed, permeabilized and treated with phalloidin to stain F-actin. Data 
show a representative FACS staining (A) and results from at least 4 independent experiments (B) 
(Mean ± SEM; WT n=7, C1a KO n=4, C1b KO n=4, DKO n=6), ** p<0,01, n.s. - not significant. 
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5.4 CXCL10 and CXCL12- induced migration of Coro1a-/- and 
Coro1a-/-Coro1b-/- NK cells is impaired by the loss of Coro1a 
One important property of immune cells, which has been directly linked to the actin 
cytoskeleton, is cell migration [276]. Since early days of coronin research it is known that 
Coro1a is required for cellular motility of D. discoideum [194]. Furthermore, it has been 
shown that the loss of Coro1a-function in T cells results in defective chemokine-mediated 
migration and impaired thymic egress [204]. Thus, the functional impact of Coro1a- and/or 
Coro1b-deficiency on NK cell migration was analyzed. 
 
 
 
 
 
Figure 5-5. Defective migration of Coro1a-/- and Coro1a-/-Coro1b-/- NK cells. 
Migratory response of wild type (gray bars), Coro1a-/- (green bars), Coro1b-/- (blue bars) and 
Coro1a-/-Coro1b-/- (red bars) IL-15-expanded NK cells was investigated using a transwell assay. NK 
cells were incubated with either CXCL12 (A) or CXCL10 (B) at the indicated concentrations for 4 
hours. The numbers of migrated cells were counted by flow cytometry. Data shown (Mean ± SD) are 
representative of at least three independent experiments in triplicates. 
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The chemokine-mediated migratory response of NK cells was assessed using a classical 
transwell migration assay as described in section 4.7. NK cells were exposed to the indicated 
concentrations of CXCL10 and CXCL12 chemokines or left untreated (Figure 5-5). After 4 
hours of incubation, cells which migrated through the transwell-membrane towards the 
chemokines were recovered from the lower reservoir of the plate and were counted. 
Migration was calculated as percentage of cells originally seeded in the transwell-insert 
(input). Results from this study revealed a defective chemokine-mediated migration of 
Coro1a-/- (green bars) and Coro1a-/-Coro1b-/- NK cells (red bars) as shown in Figure 5-5 A 
and B. Both genotypes showed a more than 50% decreased migratory response towards 
CXCL12 and CXCL10 compared to wild type levels (gray bars). Spontaneous migration was 
equally impaired as shown in Figure 5-5 (Medium-control). While in wild type NK cells the 
migratory response to chemokines strongly increased in a dose-dependent manner (Figure 
5-5 A), the dose-dependent effect of the chemokines on the migration of Coro1a-/- and 
Coro1a-/-Coro1b-/- NK cells was only minimal. Chemokine-mediated- and spontaneous 
migration of Coro1b-/- NK cells (blue bars) was almost comparable to wild type levels, 
suggesting no major role of Coro1b in the regulation of actin-dependent processes during 
chemotaxis in NK cells.  
Together these findings demonstrate a critical role of Coro1a in chemokine-mediated NK cell 
migration which correlates with an actin-regulatory function of Coro1a in these cells. In 
contrast, Coro1b seems to play only a minor role in these processes. 
 
5.5 Coro1a-deficiency affects absolute numbers of naïve NK cells in 
the bone marrow but not in the spleen 
In humans and mice, loss of Coro1a-function results in a strong reduction in the number of 
peripheral T cells, while only a limited amount of data suggests that NK cell numbers seem to 
be unaffected [204,259–262]. Hence, absolute numbers of naïve NK cells in the bone 
marrow and in the spleen of Coro1a- and/or Coro1b-deficient mice were analyzed in greater 
detail.  
To this end, freshly isolated single cells from bone marrow and spleen of six to ten weeks old 
mice, were stained for NK1.1 and CD3 (see section 4.1.1 and 4.3.1) and percentages of 
naïve NK cells, defined as NK1.1+/CD3- cell population, were assessed by flow cytometry 
(Figure 5-6 A). In addition, total numbers of viable bone marrow- and spleen cells were 
determined and absolute cell numbers were calculated by multiplying the total viable cell 
number by the percentage of NK1.1+/CD3- cells. Low percentages of naïve NK cells were 
present in the bone marrow (BM), which increased in the spleen in all genotypes (Figure 5-6 
A). Interestingly, the percentage and absolute number of naïve NK cells, was higher in the 
bone marrow of Coro1a-/- mice (C1a KO), compared to wild type (WT) controls (Figure 5-6, A 
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and B, BM). A similar increase of NK cells was also observed in the bone marrow of 
Coro1a-/-Coro1b-/- mice (DKO), while the analysis of the bone marrow from Coro1b-/- mice 
(C1b KO) revealed no differences to wild types (Figure 5-6, A and B, BM).  
 
 
 
 
 
 
 
Figure 5-6. Absolute naïve NK cell numbers in bone marrow and spleen. 
Total cell numbers of viable freshly isolated bone marrow- and spleen cells from 6 to 10 weeks old wild 
type (WT), Coro1a-/- (C1a KO), Coro1b-/- (C1b KO) and Coro1a-/-Coro1b-/- (DKO) mice were 
determined by cell counting after trypan blue staining. In addition, bone marrow and spleen cells were 
stained with antibodies directed against NK1.1 and CD3. (A) Percentages of NK1.1+/CD3- naïve NK 
cells in the bone marrow (BM) and in the spleen were assessed by FACS analysis. Absolute naïve NK 
cell numbers in the bone marrow (B) or in the spleen (C) were calculated by multiplying the total viable 
cell number by the percentage of NK1.1+/CD3- cells. Plots show the absolute naïve NK cell numbers 
from four (bone marrow) or six (spleen) individual mice of each genotype. Horizontal bars show the 
mean values. n.s. – not significant. 
 
Remarkably, the observed differences in NK cell numbers in the bone marrow did not 
translate into differences in the number of peripheral NK cells in the spleen. Although, 
increased numbers of naïve NK cells were detected in the bone marrow of Coro1a-/- and 
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in Coro1a-/- and/or Coro1b-/- mice, as compared to controls (Figure 5-6 B, Spleen), despite 
slightly reduced or heightened percentages of splenic NK cells in these mice, respectively 
(Figure 5-6 A). 
In summary, the analysis of absolute NK cell numbers in the bone marrow and in the spleen 
of Coro1a-/- and/or Coro1b-/- mice revealed normal splenic NK cell numbers, despite 
differences in the bone marrow, where increased numbers were found in Coro1a- and 
Coro1aCoro1b-deficient mice. 
 
5.6 Impaired NK cell maturation in Coro1a- and Coro1aCoro1b-
deficient mice 
NK cells derive from a CLP in the bone marrow, however, NKPs and iNKs were also found in 
lymphoid organs as well as the liver, indicating other potential sites of differentiation or 
access to the circulation [85–89,92,93,103,277]. NK cell differentiation and maturation is a 
multistep process accompanied by changes in the expression of various surface molecules 
[95,103]. Since the loss of Coro1a seems to influence NK cell development in mice, as 
indicated by increased numbers of NK cells in the bone marrow, NK cell maturation in 
Coro1a-/- and/or Coro1b-/- mice was analyzed in further detail. 
To this end, the surface expression of selected maturation- and activation markers, as well 
as activating and inhibitory NK cell receptors on naïve bone marrow-, spleen- and liver NK 
cells was assessed by flow cytometry as described in section 4.3.1. 
In the murine system, CD11b and CD27 surface expression is used to characterize NK cell 
developmental stages [89,97,110,111]. It has been proposed that NK cell maturation in mice 
occurs from the CD11blow/CD27high (immature) over CD11bhigh/CD27high (double-positive; DP) 
to the CD11bhigh/CD27low (mature) stage, as schematically shown in Figure 5-7 A 
[91,104,110]. The flow cytometric analysis of CD11b and CD27 surface expression on naïve 
NK1.1+/CD3- bone marrow- (BM), spleen- (Spleen) and liver NK cells (Liver) from wild type 
(WT), Coro1a-/- (C1a KO), Coro1b-/- (C1b KO) and Coro1a-/-Coro1b-/- mice (DKO), pointed out 
differences in the maturation status of the NK cell populations located in the analyzed 
tissues/organs (Figure 5-7 B). In accordance to previous reports [91,110], NK cells in the 
bone marrow of wild type mice were found primarily immature or showed characteristics of 
the intermediate (DP) stage. In spleen and liver the percentage of immature wild type NK 
cells was relatively lower and accompanied by an increase of mature NK cells (Figure 5-7 B, 
WT). Interestingly, Coro1a-/-Coro1b-/- NK cells consistently showed a more immature 
phenotype compared to controls, as indicated by an increase of CD11blow/CD27high and a 
decrease of DP and CD11bhigh/CD27low NK cells in all tissues/organs investigated 
(Figure 5-7 B). Similar to Coro1a-/-Coro1b-/-, Coro1a-deficient NK cells displayed a more 
immature phenotype, as shown in Figure 5-7 B. However, the relative shift in CD11b and 
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CD27 surface expression on Coro1a-/- NK cells was not as pronounced as observed for 
Coro1a-/-Coro1b-/- NK cells and therefore the maturation status of Coro1a-/- NK cells ranged 
somewhere in between wild type and Coro1a-/-Coro1b-/- NK cells.  
Consistent with these data, both, bone marrow and splenic NK cells from Coro1a-/- and 
Coro1a-/-Coro1b-/- mice showed an increased expression of early maturation markers which 
are the stem cell growth factor receptor (CD117), the IL-7 receptor-α (CD127) and CD51 
[95], compared to wild type NK cells (Figure 5-8, bone marrow and spleen). The single loss 
of Coro1b in Coro1b-/- NK cells had no significant impact on the maturation status compared 
to wild type NK controls as shown in Figure 5-7 B and 5-8 for all tissues/organs. In addition to 
the maturation markers described above, the level of CD49b surface expression, which is 
highly expressed on NK cells starting from late developmental stages [103], was increased 
on Coro1a-/- and Coro1a-/-Coro1b-/- bone marrow and splenic NK cells (Figure 5-8, bone 
marrow and spleen), as well as liver NK cells (Figure 5-11 B) compared to wild type and 
Coro1b-/- levels. Remarkably, two subsets of NK cells, one with low and one with high CD49b 
expression were detected in the liver (Figure 5-11 B). The CD49blow subset was unique for 
the liver and likely represents remaining fetal NK cells [94,97] since this population was not 
present in the bone marrow or the spleen. These restricted CD49blow NK cells were 
increased in Coro1a-/- and Coro1a-/-Coro1b-/- mice compared to wild type and Coro1b-/- mice 
(Figure 5-11 B). In contrast to CD11b and CD49b, the expression of CD43, another adhesion 
receptor expressed on later developmental stages, was comparable between bone marrow 
and splenic NK cells of all genotypes (Figure 5-8, bone marrow and spleen). 
The further analysis of selected activating and inhibitory NK cell receptors as well as 
activation markers on naïve bone marrow-, spleen- and liver NK cells revealed a comparable 
tissue-/organ-specific expression for the majority of investigated receptors on NK cells of all 
genotypes. The activating respectively inhibitory NK cell receptors NKG2D, Ly49H and 
NKG2A, -C and -E, the IL-2 receptor α-, β-chain as well as the common γ-chain (CD25, 
CD122 and CD132, respectively) and CD45R (B220) were either equally expressed or only 
minor differences were detected on bone marrow- an splenic NK cells isolated from Coro1a-/-, 
Coro1b-/- and Coro1a-/-Coro1b-/- mice compared to wild type controls (Figures 5-9 and 10, 
bone marrow and spleen).  
Contrary to the majority of analyzed receptors, which were equally expressed on 
Coro1a-/- and Coro1a-/-Coro1b-/- NK cells, expression of the activating NK cell receptor NKp46 
was normal on Coro1a-/- and Coro1b-/- NK cells, but significantly increased on 
Coro1a-/-Coro1b-/- NK cells isolated from bone marrow, spleen and liver (Figure 5-9 and 5-11 
B). The killer cell lectin-like receptor 1 (KLRG1) is generally expressed at higher levels on 
later developmental NK cell stages [95]. In accordance with the maturation status of the 
analyzed NK cells, lower expression of KLRG1 was detected on Coro1a-/- and 
Results  52 
 
 
Coro1a-/-Coro1b-/- NK cells, while higher expression was found on wild type and Coro1b-/- NK 
cells (Figure 5-9, bone marrow and spleen). Finally, bone marrow NK cells from Coro1a-/- and 
Coro1a-/-Coro1b-/- mice showed an increased expression of CD69 compared to wild type and 
Coro1b-/- NK cells, while no differences in CD69 expression of splenic NK cells were detected 
for all analyzed genotypes (Figure 5-10, bone marrow and spleen). 
In summary, the analysis of maturation- and activation markers as well as activating and 
inhibitory NK cell receptors defined a more immature phenotype of Coro1a-/- and 
Coro1a-/-Coro1b-/- bone marrow-, spleen- and liver NK cells compared to wild type and 
Coro1b-/- NK cells, suggesting a role of Coro1a in the regulation of NK cell maturation. 
 
 
 
 
 
 
Figure 5-7. Naïve Coro1a-/- and Coro1a-/-Coro1b-/- NK cells display a less mature phenotype. 
Surface expression of CD11b and CD27 on naïve wild type (WT), Coro1a-/- (C1a KO), Coro1b-/- (C1b 
KO) and Coro1a-/-Coro1b-/- (DKO) NK1.1+/CD3- NK cells from bone marrow (BM), spleen or liver was 
assessed by flow cytometry. Shown are: (A) A scheme illustrating CD27 and CD11b surface 
expression on NK cells during maturation and (B) representative contour plots depicting CD27 and 
CD11b expression of at least three (bone marrow), ten (spleen) and four (liver) independent 
experiments. Numbers indicate the percentage of cells within the quadrant.  
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Figure 5-8. Surface expression of maturation markers on naïve NK cells. 
Surface expression of the indicated molecules on naïve wild type (WT, gray), Coro1a-/- (C1a KO, 
green), Coro1b-/- (C1b KO, blue) and Coro1a-/-Coro1b-/- (DKO, red) NK1.1+/CD3- NK cells either from 
the bone marrow (upper panel) or the spleen (lower panel) was assessed by flow cytometry. Shown 
histograms are representative of at least three independent experiments. Solid lines show receptor 
staining and filled histograms with dashed lines depict staining with matching isotype controls. 
Numbers in the histograms indicate the mean of fluorescence intensity (MFI, italic) or the percentage 
of positive cells. 
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Figure 5-9. Surface expression of activating and inhibitory NK cell receptors on naïve NK cells. 
Surface expression of the indicated molecules on naïve wild type (WT, gray), Coro1a-/- (C1a KO, 
green), Coro1b-/- (C1b KO, blue) and Coro1a-/-Coro1b-/- (DKO, red) NK1.1+/CD3- NK cells either from 
the bone marrow (upper panel) or the spleen (lower panel) was assessed by flow cytometry. Shown 
histograms are representative of at least three independent experiments. Solid lines show receptor 
staining and filled histograms with dashed lines depict staining with matching isotype controls. 
Numbers in the histograms indicate the MFI (italic) or the percentage of positive cells. 
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Figure 5-10. Surface expression of IL-2 receptor chains and other molecules on naïve NK cells. 
Surface expression of the indicated molecules on naïve wild type (WT, gray), Coro1a-/- (C1a KO, 
green), Coro1b-/- (C1b KO, blue) and Coro1a-/-Coro1b-/- (DKO, red) NK1.1+/CD3- NK cells either from 
the bone marrow (upper panel) or the spleen (lower panel) was assessed by flow cytometry. Shown 
histograms are representative of at least three independent experiments. Solid lines show receptor 
staining and filled histograms with dashed lines depict staining with matching isotype controls. 
Numbers in the histograms indicate the MFI (italic). 
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Figure 5-11. Expression of NK1.1, NKp46 and CD49b on naïve liver NK cells. 
Surface expression of CD3, NK1.1, CD49b and NKp46 on naïve wild type (WT), Coro1a-/- (C1a KO), 
Coro1b-/- (C1b KO) and Coro1a-/-Coro1b-/- (DKO) NK1.1+/CD3- NK cells isolated from the liver was 
assessed by flow cytometry. Shown dot blots depict percentages of NK1.1+/CD3- NK cells in the liver 
(A) and the surface expression of NKp46 and CD49b on NK1.1+/CD3- NK cells (B). Data are 
representative of four independent experiments. Numbers shown are the percentage of NK1.1+/CD3- 
NK cells (A) or the percentages of cells within the quadrant (B). 
 
 
5.7 IL-15-expanded wild type, Coro1a-/- and/or Coro1b-/- NK cells show 
a similar phenotype  
Cytokines, such as IL-2 or IL-15 are important for NK cell development and function 
[101,102,278–282]. Studies on cancer immunotherapy revealed that IL-15 promotes NK cell 
activation as well as proliferation [283–285]. As the purification of NK cells from the spleen 
results in only a limited number of cells, purified NK cells were expanded and activated with 
IL-15. This is a widely used and well established method to obtain sufficient numbers of 
activated NK cells for functional in vitro studies [286] (see section 4.1.3). As shown in Figure 
5-12, purity of IL-15-expanded wild type (WT), Coro1a-/- (C1a KO), Coro1b-/- (C1b KO) and 
Coro1a-/-Coro1b-/- NK cells (DKO) was routinely >95%, as assessed by flow cytometric 
analysis of NK1.1 and CD3 surface expression (upper left figure). Since the ratio of mature 
versus immature NK cell populations was significantly shifted towards more immature NK 
cells in Coro1a- and Coro1aCoro1b-deficient mice, the phenotype of IL-15-expanded NK 
cells was investigated in greater detail. To this end, the surface expression of CD11b, CD27 
and selected maturation- and activation markers as well as activating and inhibitory NK cell 
receptors was investigated by flow cytometry as described in the previous section (Figure 
5-12). 
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Figure 5-12. IL-15-expanded NK cells have a similar phenotype. 
Surface expression of the indicated surface molecules on IL-15-expanded wild type (WT, gray), 
Coro1a-/- (C1a KO, green), Coro1b-/- (C1b KO, blue) and Coro1a-/-Coro1b-/- (DKO, red) NK1.1+/CD3- 
NK cells was assessed by flow cytometry. Shown dot blots or histograms are representative of at least 
three independent experiments. Solid lines show receptor staining and filled histograms with dashed 
lines depict staining with the matching isotype control. Numbers in the dot blots show percentages of 
cells within the quadrant, numbers in the histograms indicate the MFI (italic) or the percentage of 
positive cells. 
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The analysis of CD11b and CD27 surface expression on cytokine expanded NK cells 
revealed only slight differences in the maturation status between the different genotypes 
(Figure 5-12, lower left figure). The majority of wild type (WT), Coro1a-/- (C1a KO), 
Coro1b-/- (C1b KO) and Coro1a-/-Coro1b-/- NK cells (DKO) showed an immature phenotype, 
as indicated by the expression of low levels of CD11b and high levels of CD27. Noteworthy, 
mature DP NK cells were found in higher numbers in wild type and Coro1b-/- NK cell cultures 
compared to the Coro1a-/- and Coro1a-/-Coro1b-/- ones. Here, DP NK cells were almost 
absent. However, it is noteworthy that the expression of selected activating and inhibitory NK 
cell receptors (Figure 5-12, upper right figure) as well as maturation- or activation markers 
(lower right figure), with exception of NKp46, was comparable between all NK cell genotypes. 
IL-15-expanded NK cells expressed NKG2D, high levels of CD117, CD51, CD49b and high 
levels of CD69 (Figure 5-12, upper and lower right panel). About 50% of the cells were 
positive for Ly49H and almost 40% expressed NKG2A, -C or -E (Figure 5-12, upper right 
panel). NKp46 expression patterns were similar to those detected on naïve NK cells (Figure 
5-9 and 11) and were indistinguishable between wild type, Coro1a-/- and Coro1b-/- NK cells, 
while heightened levels of NKp46 were detected on Coro1a-/-Coro1b-/- NK cells (Figure 5-12, 
upper right figure). 
In summary, despite the observed differences in the maturation state of naïve NK cells, wild 
type, Coro1a-/-, Coro1b-/- and Coro1a-/-Coro1b-/- IL-15-expanded NK cells display a similar 
and relatively homogeneous phenotype. 
 
5.8 Coro1a-/- and Coro1a-/-Coro1b-/- NK cells show decreased 
cytotoxicity 
Major NK cell activity is the killing of virus/bacteria-infected or transformed cells [9,11,23,37–
41]. NK cell cytotoxicity is the result of a complex process, which includes the formation and 
stabilization of the lytic synapse and the initiation of the cytolytic response, promoted by 
various signaling and scaffolding proteins [115,148,165,287]. Since in human cells the actin 
cytoskeleton plays a critical role in the stabilization of the lytic synapse [288], the contribution 
of the actin-regulatory proteins Coro1a and Coro1b in this process was studied.  
To this purpose, the cytotoxicity of IL-15-expanded NK cells was investigated by measuring 
the release of Lactate dehydrogenase (LDH) from target cells. YAC-1 cells were co-cultured 
with NK cells at the indicated ratios (Figure 5-13) and release of cytoplasmic LDH as a 
measure of cytotoxicity was quantified by colorimetric means as described in section 4.8. 
As shown in Figure 5-13, Coro1a-/- NK cells (green line) exhibited a decreased cytotoxicity 
compared to wild type controls. This was further lowered by the additional loss of Coro1b in 
Coro1a-/-Coro1b-/- NK cells (red line). Depending on the ratio of effector- to target cells, the 
specific lysis of target cells was reduced from 30.4% to 36.1% of wild type levels for 
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Coro1a-/-Coro1b-/- NK cells and from 40.3% to 57.3% of wild type levels for Coro1a-/- NK cells. 
In contrast, NK cell cytotoxicity was only slightly reduced in Coro1b-/- cells compared to wild 
type controls (69.5% to 97.8% of wild type levels, suggesting a possible compensatory 
function of Coro1b in Coro1a-/- NK cells.  
Thus, these findings point out the critical role of the actin-regulatory proteins Coro1a and 
Coro1b for NK cell cytotoxicity.  
 
 
Figure 5-13. Impaired cytotoxicity of Coro1a-/- and Coro1a-/-Coro1b-/- NK cells. 
IL-15-expanded NK cells from wild type (gray line), Coro1a-/- (green line), Coro1b-/- (blue line) and 
Coro1a-/-Coro1b-/- (red line) mice were co-cultured with Yac-1 target cells at the indicated ratios. NK 
cell-mediated lysis of YAC-1 cells was determined by colorimetric measurement of LDH-release. Data 
shown are representative of at least four independent experiments with triplicates. (Mean ± SD). 
 
 
5.9 The impact of Coro1a- and Coro1b-deficency on NK cell activities 
and their modulators 
Since Coro1a- and Coro1b-deficiency was shown to affect NK cell cytotoxicity the 
mechanism of action of the proteins was investigated. 
 
5.9.1 Intercellular conjugate formation is not affected by the loss of Coro1a or 
Coro1b 
The formation of a stable intercellular conjugate between an NK cell and its target is required 
for NK cell activation and the initiation of the cytolytic response [130,287]. Since remodeling 
of F-actin is critical for the stabilization of the lytic synapse [115], the impact of Coro1a- and 
Coro1b-deficiency on conjugate formation was investigated.  
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To this purpose, a previously described two-color-flow cytometry assay was used [272]. Due 
to the defective motility of Coro1a-/- and Coro1a-/-Coro1b-/- NK cells, a setup which largely 
avoids the contribution of motility-dependent processes was chosen as described in section 
4.9. To assess conjugate formation, CFDA-SE labeled NK cells and eFluor® 670-labeled 
YAC-1 target cells were co-cultured for the indicated time points (Figure 5-14 A) at a ratio of 
1:2 and adhesion was analyzed upon fixation by flow cytometry as shown by the dot-blots in 
Figure 5-14 A. To measure conjugate formation, percentages of NK-YAC-1-conjugates 
(Figure 5-14 A, upper right quadrants) of total NK cells (Figure 5-14 A, lower right + upper 
right quadrants) were calculated (Figure 5-14, B and C). The flow cytometric analysis of 
co-cultured NK- and YAC-1 cells revealed a time dependent increase of 
NK-YAC-1-conjugates for all genotypes, as indicated by the representative dot blots in Figure 
5-14 A for wild type (WT) and Coro1a-/-Coro1b-/- NK cells (DKO). For instance, on average, 
17.9% ± 2.1 (wild type, gray line), 20.3% ± 1.4 (Coro1a-/-, green line), 16.6% ± 1.3 (Coro1b-/-, 
blue line) and 19.9% ± 1.5 (Coro1a-/-Coro1b-/-, red line) of the NK cells were found 
conjugated after 15 min of co-culture (Figure 5-14 B). Importantly, no significant differences 
in the ability to form intercellular conjugates were detected in Coro1a-/- and/or Coro1b-/- NK 
cells compared to wild type counterparts (Figure 5-14, A and B). 
To confirm the specificity of the assay, wild type NK cells were co-cultured with YAC-1 target 
cells, the cancer cell line A20 or BMMCs derived from C57BL6 mice with the same genetic 
background (used here as control). As indicated in Figure 5-14 C, specific intercellular 
conjugates were formed by the NK cells with the two cancer cell lines and 34.3% ± 0.7 (A20) 
and 29.4% ± 2.3 (YAC-1) of the NK cells were found conjugated after 15 min of co-culture. In 
contrast, only minor percentages of conjugated NK cells were found after co-culture with 
BMMCs, bearing the same MHC molecules as the NK cells (4.1% ± 0.1, for 15 min), 
confirming the specificity of the assay. 
In conclusion, these data indicate that the formation of intercellular conjugates is not 
dependent on Coro1a and Coro1b. 
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Figure 5-14. Comparable intercellular conjugate formation of wild type and Coro1a-/-and/or 
Coro1b-/- NK cells. 
NK cell-YAC-1-conjugate formation of wild type (WT, grey line), Coro1a-/- (C1a KO, green line), 
Coro1b-/- (C1b KO, blue line) and Coro1a-/-Coro1b-/- (DKO, red line) IL-15-expanded NK cells was 
assessed by flow cytometry. CFDA-SE stained NK cells were co-cultured with eFluor® 670 stained 
YAC-1 cells at a ratio of 1:2 for the indicated time points. Shown are: (A) Flow cytometric data of one 
representative experiment, numbers indicate the percentage of cells within the quadrant. (B) 
calculated percentages of NK-YAC-1-conjugates to total NK cells from at least 4 independent 
experiments (Mean ± SEM; WT n=6, C1a KO n=4, C1b KO n=4, DKO n=6) and (C) percentages of 
NK-YAC-1-, NK-A20- and NK-BMMC-conjugates to total NK cells (Mean ± SD) of one experiment. 
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5.9.2 Akt and Erk phosphorylation in Coro1a-/- and/or Coro1b-/- NK cells upon 
cellular activation  
Engagement of activating- and inhibitory NK cell receptors by cognate ligands results in 
signaling events which determine the further outcome of NK cell responses and thereby 
decide on the fate of the target cell. These processes require the clustering of involved 
receptors at the site of the forming synapse, which strictly depends on the rearrangement of 
the actin cytoskeleton [115,124,151–154]. In this context, among others, the initiation of the 
MAPK-cascade and the PI3K-pathway are crucial for the cytolytic response [129,289–292].  
To study whether a defect in cellular activation may explain the impaired cytolytic response 
of Coro1a-/- and Coro1a-/-Coro1b-/- NK cells, cells were stimulated for the indicated time via 
crosslinking the activating NK cell receptor NK1.1 as described in section 4.1.10 (Figure 
5-15). Immunoblot analysis of whole NK cell lysates was performed to assess protein kinase 
Akt and extracellular signal-regulated kinase (Erk) 1 and -2 phosphorylation, activated via the 
PI3K- and MAPKs-pathway, respectively. Figure 5-15 shows Akt phosphorylation, Akt 
expression, which was used as loading control (upper two panels), MAPKs Erk1 and -2 
phosphorylation as well as total Erk2 as loading control (two middle panels). As shown, 
activation of wild type NK cells (WT) via crosslinking the NK1.1 receptor results in a transient 
phosphorylation of Akt and the MAPKs Erk1 and -2 (Figure 5-15, WT). The phosphorylation 
was highest after 5 min of stimulation and decreased over time. After 20 min of stimulation, 
only low levels of Akt and Erk1 and -2 phosphorylation were detectable. While Coro1b-/- NK 
cells (C1b KO) showed Akt and Erk phosphorylation kinetics and levels similar to wild type 
NK cells, subtle differences in Akt, Erk1 and -2 phosphorylation in Coro1a-/- (C1a KO) and 
Coro1a-/-Coro1b-/- (DKO) NK cells compared to wild type controls were detected. In contrast 
to wild type NK cells, phosphorylation of Akt was longer sustained in Coro1a-/- and 
Coro1a-/-Coro1b-/- NK cells (Figure 5-15, p-Akt), while the induction of early Erk1 and -2 
phosphorylation was slightly impaired in these cells (Figure 5-15, p-Erk1 and -2). In this 
context, Erk1 and -2 phosphorylation levels in Coro1a-/- and Coro1a-/-Coro1b-/- NK cells were 
lower after 5 min of stimulation, but were similar at 20 min compared to wild type controls. In 
addition, total Erk1 protein expression was a little lower in Coro1a- and 
Coro1aCoro1b-deficient NK cells compared to wild type cells (Figure 5-15, Erk2). The lower 
panel of Figure 5-15 shows that the expression of β-actin, used here as additional loading 
control, was comparable in all samples.  
Altogether, the activation of the PI3K-pathway and the MAPK-cascade in wild type, Coro1a-/-, 
Coro1b-/- or Coro1a-/-Coro1b-/- NK cells upon crosslinking of the NK1.1 receptor show minimal 
differences. 
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Figure 5-15. NK cell activation upon NK1.1-crosslinking. 
Wild type (WT), Coro1a-/- (C1a KO), Coro1b-/- (C1b KO) and Coro1a-/-Coro1b-/- (DKO) IL-15-expanded 
NK cells were stimulated with streptavidin-microspheres coated with specific antibodies against NK1.1 
at a ratio of 1:2 for the indicated time points. Immunoblot analysis of whole cell lysates was performed 
using specific antibodies against p-Akt, Akt, p-Erk1/2 and Erk2. Data are representative for at least 
three independent experiments. Protein loading was assessed by β-actin expression (lower panel). 
 
5.9.3 Subcellular localization of Coro1a and Coro1b in NK cells upon cellular 
activation. 
Recent studies show that activation of MCs or MΦs initiates a transient subcellular relocation 
of Coro1a and Coro1b upon phosphorylation [222,250]. Therefore, the subcellular distribution 
of Coro1a and Coro1b upon NK cell activation was investigated next by biochemical 
fractionation of activated NK cells.  
To this purpose, wild type NK cells were stimulated via crosslinking of the activating NK cell 
receptor NK1.1, with PMA/ionomycin or left untreated (see section 4.1.10) for the indicated 
time (Figure 5-16) and were subjected to subcellular fractionation as described in section 
4.10. In non-stimulated NK cells, Coro1a and Coro1b were mainly detected in the 
cytoskeleton-containing detergent-insoluble fraction (P, cytoskeleton-rich fraction, Figure 
5-16, Coro1a and Coro1b). Interestingly, no major changes in the subcellular distribution of 
Coro1a were detected upon activation of NK cells by PMA/ionomycin (P/I) or crosslinking of 
NK1.1 (NK1.1) (Figure 5-16, Coro1a). Only a minor relocation of Coro1a from the 
cytoskeleton-rich- into the cytosolic detergent-soluble fraction (S, cytosolic fraction) was 
observed after activation via NK1.1 for 5 or 20 min. In contrast, stimulation of NK cells with 
PMA/ionomycin or crosslinking of NK1.1 resulted in a transient relocation of Coro1b from the 
cytoskeleton-rich- into the cytosolic fraction, particularly at later time points (Figure 5-16, 
Coro1b). Furthermore, activation of NK cells resulted in a long-lasting phosphorylation of 
Coro1b on Ser2, which was detectable early upon activation and showed the highest levels 
between 5 and 20 min of stimulation (Figure 5-16, p-Ser2-Coro1b). In addition, the analysis 
revealed that phosphorylated Coro1b was mainly located in the cytosolic fraction. The 
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depolymerization of cellular F-actin by latrunculin B resulted in the relocation of Coro1a, 
Coro1b and β-actin from the cytoskeleton-rich- into the cytosolic fraction as shown in Figure 
5-16 (Coro1a, Coro1b and β-actin), indicating an association of the coronins with F-actin in 
NK cells. The subcellular localization of vimentin, glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and total Erk2 was assessed to control the purity of the single 
fractions and loadings. Vimentin, as constituent of the cytoskeleton, was detected exclusively 
in the cytoskeleton-rich fraction and GAPDH was found in the cytosolic fraction, revealing a 
proper separation of the fractions (Figure 5-16). To verify the activation of NK cells, Erk1 and 
-2 phosphorylation was also investigated. Both, stimulation via crosslinking of NK1.1 or with 
PMA/ionomycin, were sufficient to activate NK cells, as indicated by the phosphorylation of 
Erk1 and -2 (Figure 5-16, p-Erk1/2 and Erk2). 
  
 
Figure 5-16. Subcellular distribution of Coro1a and Coro1b upon stimulation. 
Wild type IL-15-expanded NK cells, were stimulated with PMA/ionomycin (P/I, left panel), beads 
coated with mAbs against NK1.1 (right panel) at a ratio of 1:2 for the indicated time points or left 
untreated. Subsequently, samples were fractionated with cytoskeleton isolation buffer as described in 
methods. Detergent-soluble fraction (S, cytosolic fraction) and detergent-insoluble precipitate (P, 
cytoskeleton-containing fraction) were analyzed by immunoblotting using the indicated antibodies. As 
control, NK cells were treated with latrunculin B (30 min). Protein loading was assessed by β-actin 
expression. Purity of the fractions was controlled by GAPDH (S) and vimentin (P) expression. Shown 
data are representative of two independent experiments. 
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In summary, Coro1a as well as Coro1b were found to be primarily associated with the 
cytoskeletal fraction in non-stimulated NK cells. The cellular activation by crosslinking of the 
activating NK cell receptor NK1.1 led to a relocation of Coro1b from the cytoskeleton-rich- 
into the cytosolic fraction correlating with a long-lasting phosphorylation of the protein. In 
contrast, only minor changes in the localization of Coro1a were detected upon cellular 
activation. 
 
5.9.4 Coro1a and Coro1b localize to F-actin-rich areas in the pSMAC of the cytolytic 
synapse 
As described previously, the activation of NK cells by crosslinking of NK1.1 led not only to 
minor changes in the subcellular distribution of Coro1a and Coro1b, but also resulted in a 
long-lasting phosphorylation of Coro1b on Ser2. Since Ser2 phosphorylation of coronin is 
known to be important for the actin regulatory function of Coro1a and Coro1b [204,212,222], 
the contribution of both coronins in the actin-dependent formation of a stable cytolytic 
synapse was investigated.  
To this end, the cellular localization of both proteins was investigated in NK cells upon 
conjugation with target cells by confocal microscopy. NK cell-YAC-1-conjugates were 
generated and stained for either Coro1a or Coro1b and treated with phalloidin to stain F-actin 
subsequent to fixation and permeabilization as described in materials and methods (see 
section 4.6). As shown in Figure 5-17, confocal microscopy revealed no considerable 
changes in the subcellular distribution of Coro1a and Coro1b compared to unconjugated NK 
cells in NK cell areas which were not directly connected to target cells (A and B and 
previously described in section 5.2). In these areas, Coro1a was mainly localized at the 
cortex of NK cells, where it colocalized with F-actin (Figure 5-17 A, left panel). In contrast, 
Coro1b showed a more punctate distribution throughout the entire cytoplasm with only 
marginal colocalization with the F-actin-rich cell cortex (Figure 5-17 B, left panel). 
Interestingly, changes in the subcellular distribution of Coro1a and Coro1b were found at the 
site of the lytic synapse, compared to unconjugated areas. Coro1a and Coro1b were 
enriched in the actin-rich pSMAC region where they colocalized with the F-actin as shown in 
the overlay image (Figure 5-17, A and B, left panels). In contrast, almost no Coro1a was 
found in the largely actin-dim cSMAC region, the inner part of the lytic synapse as shown in 
Figure 5-17 A (Coro1a and phalloidin). At the site of the cSMAC, Coro1b was present in the 
cytoplasm but appeared to be decreased at the cell cortex of the NK cells (Figure 5-17 B, 
Coro1b and phalloidin). No Coro1a- and Coro1b staining was detected in 
Coro1a-/-Coro1b-/- NK cells which were used as negative control (Figure 5-17, A and B, right 
panel).  
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Figure 5-17. Localization of Coro1a and Coro1b in the cytolytic synapse. 
Subcellular localization of Coro1a or Coro1b upon contact with target cells was revealed in wild type 
(WT) and Coro1a-/-Coro1b-/- (DKO) IL-15-expanded NK cells by confocal microscopy. NK cells were 
co-cultured with Yac-1 cells at a ratio of 1:3 for 30 min and were stained for either Coro1a (A, red) or 
Coro1b (B, red), F-actin (phalloidin, green) and DNA (DAPI, blue) after fixation and permeabilization. 
Representative individual or overlay fluorescence and DIC images of at least three independent 
experiments are shown. Bars, 10 µm. 
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In accordance with my previously described finding that conjugate formation is unaffected by 
the loss of Coro1a and Coro1b (Figure 5-14, A and B), also no major differences in the 
morphology of lytic synapses formed by wild type or Coro1aCoro1b-deficient NK cells (Figure 
5-17, A and B) were observed by confocal microscopy. 
In conclusion, Coro1a and Coro1b were both found in the actin-rich pSMAC region of the 
lytic synapse where they colocalized with F-actin and only minor amounts were detected in 
the largely actin-dim cSMAC region. Furthermore, synapse formation seems to be unaffected 
by the loss of Coro1a and Coro1b, given that no morphological differences between 
synapses formed by wild type or Coro1aCoro1b-deficient NK cells were found by confocal 
microscopy. 
 
5.9.5 Granule content is not affected by the loss of Coro1a or Coro1b 
NK cell cytotoxicity is mediated by the release of granules containing the pore-forming 
protein perforin and cytotoxic serine proteases named granzymes [137–142]. Since the 
altered cytolytic response found in coronin-deficient NK cells could be due to abnormal 
granule contents, the cellular contents of granzyme A (GrzA) or –B (GrzB) and perforin of 
Coro1a- and/or Coro1b-deficient NK were investigated by flow cytometry after intracellular 
staining or immunoblot analysis of whole NK cell lysates.  
For this purpose, resting IL-15-expanded NK cells were fixed, permeabilized and 
intracellularly stained for GrzA or GrzB (see section 4.3.2) or lysates were prepared and 
subjected to immunoblot analysis as described in section 4.4 and 4.5. Flow cytometry 
revealed no differences in the cellular content of GrzA (left panel) or GrzB (right panel) 
between wild type (gray histograms), Coro1a-/- (green histograms), Coro1b-/- (blue 
histograms) and Coro1a-/-Coro1b-/- NK cells (red histograms) as shown in Figure 5-18 A 
(solid lines). Both proteases were detected in at least 97% of the analyzed NK cells for all 
genotypes. Moreover, no differences in the cellular amounts of perforin were detected by 
immunoblot analysis as shown by the equal intensity of protein bands in Figure 5-18 B 
(upper panel). The lower panel of Figure 5-18 B shows that the expression of β-actin, used 
here as loading control, was comparable in all samples.  
In summary, comparable GrzA, GrzB and perforin were found in all NK cell genotypes, thus, 
excluding alterations in the content of cytotoxic molecules as the underlying cause for the 
decreased cytotoxicity of Coro1a- and Coro1aCoro1b-deficient NK cells. 
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Figure 5-18. Normal granule content in WT, Coro1a-/-, Coro1b-/- and Coro1a-/-Coro1b-/- NK cells. 
(A) Cellular granzyme A (GrzA) or granzyme B (GrzB) content of IL-15-expanded wild type (WT, gray), 
Coro1a-/- (C1a KO, green), Coro1b-/- (C1b KO, blue) and Coro1a-/-Coro1b-/- (DKO, red) NK1.1+/CD3- 
NK cells was assessed by flow cytometry. NK cells were fixed, permeabilized and stained with specific 
antibodies for either GrzA (left panel) or GrzB (right panel). Data shown are representative of at least 
three independent experiments. Solid lines show protein staining and filled histograms with dashed 
lines shows the matching isotype. Numbers depicted are the percentage of GrzA-/GrzB-positive cells. 
(B) Immunoblot analysis of perforin expression (upper panel) in IL-15-expanded NK cells of the 
indicated genotype. Data are representative for at least five independent experiments. Protein loading 
was assessed by analysis of β-actin expression (lower panel). 
 
5.9.6 Impaired granule polarization in Coro1aCoro1b-deficent NK cells 
The activation of NK cells upon target cell recognition initiates cellular polarization, the 
second stage of the cytolytic response of NK cells. Polarization involves several steps 
including F-actin accumulation at the NK-target contact site and the reorientation of the 
microtubule-organizing center (MTOC), the Golgi apparatus and the cytotoxic granules 
toward the target cell [115,116,128,149,155,156]. For these processes, cytoskeletal 
remodeling is critical since inhibition of F-actin or microtubule dynamics by pharmacologic 
drugs blocks granule polarization and target cell lysis [115,116,288,293]. Since 
Coro1a-deficient NK cells exhibited dysregulated F-actin contents, which correlates with an 
impaired cytolytic response, I investigated whether coronins are involved in controlling NK 
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cell polarization. To this purpose, the reorientation of cytotoxic NK cell granules following 
conjugate formation was analyzed by confocal microscopy after labeling of granules with 
Lysotracker® Red DND-99 or -Green DND-26, which stains acidic cell compartments, as 
previously described [159,294,295]. As a first step, the specificity of the Lysotracker®-labeling 
was assessed (Figure 5-19). For this purpose, Lysotracker®-labeled wild type NK cells were 
fixed, permeabilized and stained for CD107a (LAMP-1) and DNA (Hoechst) as described in 
section 4.6. Confocal microscopy experiments revealed a colocalization of CD107a 
(LAMP-1), which is predominantly expressed intracellularly in the membrane of secretory 
lysosomes and endosomes in resting cells, with the Lysotracker® Green DND-26 staining 
(LTgreen), as shown by the overlay pictures in Figure 5-19 A or drawn to a larger scale in 
Figure 5-19 B. Almost all cytotoxic granules of the NK cells were efficiently labeled with 
Lysotracker® (Figure 5-19 A), thus, providing a valid experimental tool to investigate granule 
polarization in NK cells upon contact with target cells.  
 
 
 
Figure 5-19. Colocalization of LysoTracker® Green and LAMP-1. 
Subcellular localization of CD107a (LAMP-1, red) and cytotoxic granules (stained with LysoTracker® 
Green) was revealed in wild type IL-15-expanded NK cells by confocal microscopy. NK cells were 
loaded with LysoTracker® Green (LTgreen, green) for 2 hours. Cells were fixed with methanol/acetone 
and stained for CD107a and with Hoechst as DNA-marker (blue). Shown are individual or overlay 
fluorescence and DIC images (A) or a part of the image drawn to a larger scale (B). Bars, 10 µm. 
A B 
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Next, the reorientation of NK cell granules subsequent to NK-target-conjugation was 
investigated in detail. NK cells were labeled with Lysotracker® Red DND-99 (LTred) and 
co-cultured with YAC-1 target cells at a ratio of 1:3 for 30 min, followed by fixation, 
permeabilization and staining for DNA with Hoechst-dye as described in section 4.6. Different 
degrees of reorientation of the cytotoxic granules toward the site of the synapse were 
observed by confocal microscopy in wild type as well as in Coro1a-/-Coro1b-/- NK cells. Figure 
5-20 A exemplarily shows fully polarized wild type (WT) and Coro1a-/-Coro1b-/- NK cell (DKO) 
granules of conjugated NK cells. Lysotracker® Red DND-99 labeled cytolytic granules are 
depicted by the red staining located at the site of the lytic synapse. For the quantification of 
the granule reorientation, conjugated NK cells were subdivided into areas, enabling a 
classification of NK cells in polarized or non-polarized stages as schematically shown in 
Figure 5-20 B. Fully polarized NK cells were calculated as percentages of total analyzed NK 
cell conjugates.  
 
 
 
 
 
 
 
Figure 5-20. Coro1a-/-Coro1b-/- NK cells show an impaired granules polarization. 
Subcellular localization of cytotoxic granules was revealed in wild type (WT) and 
Coro1a-/-Coro1b-/- (DKO) IL-15-expanded NK cells upon contact with target cells by confocal 
microscopy. NK cells were incubated with LysoTracker® Red (LTred, red) for 2 hours. Afterwards cells 
were co-cultured with Yac-1 cells at a ratio of 1:3 for 30 min, fixed and stained for DNA (Hoechst, 
blue). Shown are: Representative fluorescence and DIC overlay images of polarized cells (A), a 
scheme depicting characteristics of polarized versus non-polarized NK cells (B) and calculated 
percentage of fully polarized NK cells of three independent experiments (C). (Mean ± SEM; n=3 with 
162 WT and 170 DKO conjugates analyzed in total; Bars, 5 µm.)  
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The analysis of 162 conjugated wild type (WT) and 170 conjugated Coro1a-/-Coro1b-/- NK 
cells (DKO), originated from three independent experiments for granule polarization, 
revealed an impaired reorientation of the cytotoxic granules of Coro1a-/-Coro1b-/- NK cells 
towards the target cell compared to wild type cells (Figure 5-20 C). While 60.7% ± 1.0 of the 
conjugated wild type NK cells were polarized, fully reoriented cytotoxic granules at the site of 
the cytolytic synapse were detected only in 46.6% ± 1.9 of the Coro1a-/-Coro1b-/- NK cells. 
These observations provide a possible mechanistic explanation for the impaired cytotoxicity 
of Coro1a-/-Coro1b-/- NK cells. In addition, the further subdivision of non-polarized NK cells 
into partially polarized and non-polarized cells showed no indication for a stagnation of the 
granules reorientation within a special stage of polarization, as no significant difference in the 
frequency of these subgroups were found between wild type and Coro1a-/-Coro1b-/- NK (data 
not shown).  
In conclusion, the analysis of granule polarization in NK cells subsequent to the conjugation 
with a target cell, revealed an impaired reorientation of cytotoxic granules in 
Coro1aCoro1b-deficient NK cells compared to wild type cells, possibly contributing to the 
decreased cytotoxicity of Coro1a-/- and Coro1a-/-Coro1b-/- NK cells. 
 
5.9.7 NK cell degranulation depends on F-actin remodeling and is impaired by the 
loss of Coro1a 
The final stage of the cytolytic activity of NK cells is the secretion of cytotoxic granule 
contents at the site of the synapse to kill aberrant cells. The fusion of polarized granules with 
the plasma membrane and the associated release of perforin and granzymes occur in locally 
hypodense areas of the actin network and strictly require F-actin remodeling at the site of the 
cytolytic synapse [115,116,159]. In this context, the impact of the actin cytoskeleton on 
regulating NK cell degranulation was mainly demonstrated by employing actin-modulatory 
drugs [115,124,159,165,296]. Hence, only little is known about the impact of actin regulatory 
proteins on degranulation. To study to what extend F-actin remodeling and coronins in 
particular contribute to the regulation of NK cell degranulation, Coro1a- and/or 
Coro1b-deficient NK cells were investigated for their ability to degranulate. 
To this end, wild type NK cells were co-cultured with target cells, to induce NK cell 
degranulation, in the presence of a mAb directed against CD107a (LAMP-1) and surface 
expression of CD107a was used as read-out. Cells were treated with drugs that prevented 
F-actin assembly (latrunculin B and cytochalasin D) or disassembly (jasplakinolide), with the 
respective carrier or left untreated and degranulation was assessed by flow cytometric 
analysis (see section 4.11). Since the remodeling of cortical F-actin is crucial for receptor 
clustering and the accumulation of F-actin at the site of the synapse, both early processes in 
the NK cell activation cascade, as well as for later steps, e.g. the degranulation of NK cells 
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[115,159], drug treatment was performed independently at two time points. The inhibitors 
were added at time zero to inhibit the activation and thereby later processes, or after 10 min 
of co-culture allowing activation but impairing degranulation by inhibiting cortical F-actin 
remodeling as shown by the time scale in Figure 5-21 A. 
 
 
 
 
 
 
Figure 5-21. Pharmacologic manipulation of the actin cytoskeleton results in decreased 
degranulation. 
Degranulation of wild type IL-15-expanded NK cells treated with actin-modulatory drugs was analyzed 
by flow cytometry. NK cells were cultured either without target cells (dashed line) or co-cultured with 
Yac-1 cells (solid line) at a ratio of 2:1 in the presence of a CD107a mAb for 2 hours. At time 0 or after 
10 min of culture latrunculin B or jasplakinolide was added to destroy or stabilize the actin cytoskeleton 
of the cells, respectively. Carrier was added as control. Numbers shown are the percentage of 
CD107a-positive NK1.1+/CD3- cells. Data are representative of three independent experiments. (A) 
Time scheme of the experiment, (B) Medium-only control, (C) NK cell degranulation upon treatment 
with latrunculin B or jasplakinolide. 
 
The addition of latrunculin B, cytochalasin D (data not shown) or jasplakinolide at time zero 
completely inhibited degranulation upon contact with the target cells (Figure 5-21 C). Only 
4% of drug treated NK cells resulted CD107a-positive compared to circa 48% of the 
untreated control counterpart (Figure 5-21, B and C). In contrast, treatment with the 
corresponding control drug carrier had no impact on NK cell degranulation, as comparable 
percentages of degranulated cells were measured for treated and untreated conditions 
(Figure 5-21, B and C). Exposure of NK cells to actin-modulatory drugs 10 min after the 
activation (10 min, lower panel) still significantly reduced degranulation. The analysis 
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revealed frequencies of CD107a-positive cells below 20% upon treatment as shown in Figure 
5-21 C. However, the inhibitory effect was not as strong as when actin modulatory drugs 
were added at time zero. Again carrier treatment at 10 min had no effect on degranulation 
(Figure 5-21, B and C, upper panel).  
Altogether, these results provide additional evidence for the proposed requirement of an 
initial F-actin remodeling for the synapse formation and a crucial role for actin-reorganization 
during NK cell degranulation.  
Since the loss of Coro1a results in increased cortical F-actin levels in NK cells, which 
potentially influence the exocytosis of cytolytic granules, the impact of Coro1a- and/or 
Coro1b-deficiency on NK cell degranulation was investigated next. To this end, NK cells 
were co-cultured for 3 hours with or without target cells and degranulation was assessed by 
CD107a staining and flow cytometry. As shown in Figure 5-22, the loss of Coro1a (C1a KO) 
resulted in a decreased degranulation compared to wild type (WT) levels (23% CD107a 
positive Coro1a-/- NK cells vs. 36% wild type NK cells). Interestingly, degranulation was 
unaffected in Coro1b-/- NK cells (C1b KO) and Coro1a-/-Coro1b-/- NK cells (DKO) 
degranulated comparably to Coro1a-deficient NK cells (Figure 5-22) indicating a minor 
contribution of Coro1b in the degranulation processes. 
In summary, the actin-regulatory protein Coro1a participates in modulating NK cell 
degranulation, possibly by influencing the remodeling of the actin cytoskeleton. 
 
 
Figure 5-22. Coro1a-/- and Coro1a-/-Coro1b-/- NK cells show decreased degranulation. 
Degranulation of wild type (gray lines), Coro1a-/- (green lines), Coro1b-/- (blue lines) and 
Coro1a-/-Coro1b-/- (red lines) IL-15-expanded NK cells was analyzed by flow cytometry. NK cells were 
cultured either without target cells (dashed line) or co-cultured with Yac-1 cells (solid line) at a ratio of 
5:1 in the presence of a CD107a mAb for 3 hours. Numbers shown are the percentage of 
CD107a-positive NK1.1+/CD3- cells. Data are representative of at least five independent experiments. 
 
 
5.10 Impaired cytokine secretion in Coro1a-/- and Coro1a-/-Coro1b-/- NK 
cells  
Besides being cytolytic, activated NK cells secrete a variety of different soluble mediators, 
including interleukins, interferons, growth factors and chemokines [52,57–60,65,66,297–301]. 
As the secretion of these mediators by NK cells is important for an adequate immune 
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response under several circumstances (e.g. a viral infection) [38,40,57,58,302], it is 
important to understand whether coronins are involved in the control of the NK cell cytokine 
expression and secretion.  
To this end, NK cells were stimulated with plate-bound mAbs directed against NK1.1 or 
NKG2D, PMA/ionomycin or left untreated (see section 4.1.10) and used for further analysis. 
In a first step IFN-γ gene expression in stimulated NK cells was determined by real-time PCR 
analysis (see section 4.2). The level of IFN-γ  gene expression was measured and 
normalized to the expression of the housekeeping gene Hprt in each sample. As shown in 
Figure 5-23 A, crosslinking of the activating NK cell receptor NK 1.1 (NK1.1), resulted in a 
comparable induction of IFN-γ  mRNA in wild type (gray), Coro1a-/- (green), Coro1b-/- (blue) 
and Coro1a-/-Coro1b-/- NK cells (red). Similar results were obtained upon PMA/ionomycin 
stimulation (data not shown). No IFN-γ  gene expression was detected in non-stimulated cells 
(Figure 5-23 A, Medium), which were used as control, confirming an activation-specific 
induction of the IFN-γ  mRNA. 
Next, possible differences in the cellular IFN-γ protein content of Coro1a- and/or 
Coro1b-deficient NK cells were investigated. To this purpose, intracellular IFN-γ  staining in 
stimulated NK cells was assessed by flow cytometry as described in section 4.3. and shown 
in Figure 5-23 B. Results from these studies demonstrate a comparable production of 
IFN-γ in wild type (gray), Coro1a-/- (green), Coro1b-/- (blue) and Coro1a-/-Coro1b-/- NK cells 
(red) as shown by the percentages of IFN-γ-positive NK cells in the histograms (Figure 5-23 
B). After 6 hours of stimulation, 78.8% of the wild type, 80.2% of the Coro1a-/-, 82.0% of the 
Coro1b-/- and 75.3% of the Coro1a-/-Coro1b-/- NK cells were positive for IFN-γ-staining (Figure 
5-23 B, NK1.1). Similar results were obtained upon stimulation via NKG2D or with 
PMA/ionomycin (data not shown). Consistent with the data obtained on IFN-γ gene 
expression (Figure 5-23 A), no IFN-γ protein expression was detected in non-stimulated wild 
type, Coro1a-/-, Coro1b-/- and Coro1a-/-Coro1b-/- NK cells (Figure 5-23 B, Medium). 
Altogether, these data indicate that the loss of Coro1a and/or Coro1b does not affect the 
IFN-γ-production in NK cells. 
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Figure 5-23. Normal IFN-γ production in wild type, Coro1a-/-, Coro1b-/- and Coro1a-/-Coro1b-/- NK 
cells. 
IL-15-expanded NK cells from wild type (gray bars/line), Coro1a-/- (green line/bars), Coro1b-/- (blue 
line/bars) and Coro1a-/-Coro1b-/- (red line/bars) mice were stimulated with plate-bound specific 
antibodies against NK1.1. or left untreated. (A) RNA was isolated after 1 hour of stimulation and cDNA 
was synthesized. Quantitative real-time PCR analysis using IFN-γ  and hprt specific primers was 
performed to assess IFN-γ mRNA expression. Data are relative to hprt and show the mean ± SD from 
one representative experiment in duplicates. (B) Cellular IFN-γ content of NKp46+/CD3- NK cells was 
assessed by flow cytometry. NK cells were stimulated for 6 hours in the presence of Brefeldin A. Cells 
were fixed, permeabilized and stained with specific antibodies for either IFN-γ (solid lines) or the 
corresponding isotype (filled histograms with dashed lines). Numbers depicted are the percentage of 
IFN-γ-positive cells. Data are representative of three independent experiments. 
 
Secretory processes are known to depend on the remodeling of the cytoskeleton 
[222,303,304]. To address the question whether loss of Coro1a- and/or Coro1b-function 
impairs the cytokine secretion in NK cells, release of IFN-γ  and CCL5 upon activation of NK 
cells was assessed by ELISA. Wild type and Coro1a- and/or Coro1b-deficient NK cells were 
stimulated via crosslinking of NK1.1 (NK1.1) or NKG2D (NKG2D), with PMA/ionomycin (P/I) 
or left untreated for 20 hours as described in section 4.1.10 and supernatants were subjected 
to ELISA (Figure 5-24).  
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Figure 5-24. IFN-γ and CCL5 secretion is impaired in Coro1a-/- and Coro1a-/-Coro1b-/- NK cells. 
Wild type (gray bars), Coro1a-/- (green bars), Coro1b-/- (blue bars) and Coro1a-/-Coro1b-/- (red bars) 
IL-15-expanded NK cells were stimulated with plate-bound specific antibodies against either NK1.1 or 
NKG2D, PMA and ionomycin (P/I) for 20 hours or left untreated. The release of IFN-γ (A) and CCL5 
(B) into the supernatant was measured by ELISA. Data (Mean ± SD) are representative of three 
independent experiments in triplicates. N.d. – not detectable. 
 
Differently to the intracellular cytokine expression, the loss of Coro1a (green bars) resulted in 
a dramatically impaired secretion of IFN-γ (Figure 5-24 A) and CCL5 (Figure 5-24 B) 
compared to the release by wild type (gray bars) or Coro1b-deficient NK cells (blue bars) for 
all stimuli. Only minimal differences in the cytokine secretion were found between wild type 
and Coro1b-/- NK cells while cytokine release impairment was comparable between 
Coro1a-/- and Coro1a-/-Coro1b-/- NK cells (red bars), indicating a marginal role of Coro1b in 
this process. It is known that cytokine-activated NK cells produce and secrete moderate 
amounts of CCL5 without further activation [66,67]. Consistent with these reports, low 
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concentrations of CCL5 were found in the supernatants of non-stimulated wild type and 
Coro1b-/- NK cells, while no CCL5 was detectable in the supernatants of Coro1a-/- and 
Coro1a-/-Coro1b-/- NK cells, indicating a secretory defect of these cells even in the absence of 
a receptor-mediated activation, as shown in Figure 5-24 B for the medium control (Medium). 
In contrast to CCL5, no secreted IFN-γ was detected in the supernatants of non-stimulated 
NK cells of all genotypes (Figure 5-24 A, Medium).  
In conclusion, Coro1a-deficient activated NK cells display a normal expression but an 
impaired secretion of IFN-γ  and CCL5. 
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6 Discussion 
NK cells have been attributed to the control of viral and intracellular bacterial infections as 
well as to tumor immune surveillance [9–12,23,37–41]. In addition, NK cells have also been 
implicated in the regulation of other immune cells, not only by the secretion of humoral 
factors but also via controlling their homeostasis [50,53,55]. In this context, a crucial role for 
dynamic actin reorganization has been described for various cellular processes required for 
NK cell functionality [165–171,183]. The dynamic reorganization of F-actin filaments is 
achieved by a variety of different actin nucleators and their associated regulators [172]. One 
part of the complex network of proteins involved in actin regulation is represented by 
coronins. These proteins constitute an evolutionary highly conserved family and 
representatives have been described in a variety of different species [185,193,198–207]. 
Coronins have been linked to diverse functions on actin filaments, including actin 
binding/bundling, actin disassembly and activation/inhibition of the Arp2/3-complex 
[185,186,229–233,242,244]. The mammalian genome encodes seven coronin family 
members [189]. Two of them, namely Coro1a and Coro1b, formed the primary focus of this 
work, as both proteins have been implicated in various actin-mediated cellular functions in 
leukocytes [187,204,222,248,250,252,253,265]. Importantly, loss of Coro1a-function in 
humans and mice results in a SCID, which so far has mainly been attributed to defective 
actin-regulation in T cells [204,259–262]. However, up to now almost nothing is known about 
the impact of coronin-deficiency on the development and function of NK cells. Therefore, in 
the present study the role of Coro1a and Coro1b in the biology and function of NK cells was 
investigated. 
Utilizing a system of Coro1a- and/or Coro1b-deficient mice I demonstrated for the first time 
that Coro1a and, to a lesser degree, Coro1b are critically involved in the regulation of NK cell 
development and function. Coro1a and Coro1b are co-expressed in NK cells and the loss of 
Coro1a-function could be directly linked to altered F-actin regulation in NK cells. A detailed 
study of NK cell development revealed a generally impaired maturation of Coro1a-/- and 
Coro1a-/-Coro1b-/- NK cells compared to wild type counterparts, which was associated with 
developmental alterations in the bone marrow. In addition, I could show that central NK cell 
functions like killing of aberrant cells, chemokine-mediated migration and cytokine secretion 
are impaired in IL-15-expanded Coro1a-/- and Coro1a-/-Coro1b-/- NK cells. My data 
demonstrate that decreased cytotoxicity of Coro1a-/- and Coro1a-/-Coro1b-/- NK cells was 
associated with an impaired polarization of cytolytic granules and a decreased capability of 
NK cells to degranulate, whereas early steps of the cytolytic response including the formation 
of the cytolytic synapse and the consequent activation of the NK cells appeared to be 
unaffected. Together, these data demonstrate a crucial role of coronins in the regulation of 
NK cell development and function.  
Discussion  79 
 
 
Although coronins are known for more than 20 years the majority of mammalian coronins is 
poorly investigated. The limited number of studies investigating the role of mammalian 
coronins reported heterogeneous expression patterns of the various coronin family members 
(see Table 1-2). While Coro1a is mainly expressed in cells of the hematopoietic lineage and 
has been described in neutrophils, macrophages, T cells, B cells, dendritic cells and mast 
cells [187,204,222,248,253,255–258], Coro1b shows an ubiquitous expression and likely a 
more general regulatory function within and outside the hematopoietic cell lineage [212,222–
225]. 
Since no expression data were available for NK cells, mRNA- as well as protein levels of 
Coro1a and -1b were examined first. Real-time PCR analysis revealed a co-expression of 
both coronins on the mRNA level in NK cells. Co-expression could be confirmed on protein 
level by immunoblot analysis and flow cytometry, indicating a potential role of these proteins 
in the regulation of actin-dependent processes in NK cells. No Coro1a or Coro1b protein 
expression was detected in the corresponding knockout genotypes, while normal amounts of 
either Coro1a or Coro1b were found in the non-corresponding knockout NK cell genotypes, 
indicating a successful knockout of the coronins and the absence of a compensatory 
counter-regulation upon knockout of either of them, respectively. 
Consistent with previous reports on resting T cells, MCs, neutrophils, macrophages, B cells 
and HL60 cells [204,222,250,252,253,255,256], confocal microscopy of resting NK cells 
revealed that Coro1a primarily localizes to the F-actin rich cell cortex where it colocalizes 
with F-actin, but also exhibits some punctate cytoplasmic localization. In contrast to Coro1a, 
Coro1b showed a more punctate staining distributed throughout the entire cytoplasm of the 
NK cells with only minor colocalization with the F-actin-rich cell cortex. While a similar 
distribution of Coro1b was described for resting mast cells a more pronounced cortical 
Coro1b localization combined with a distribution throughout the entire cytoplasm was found 
in vascular smooth muscle cells, confirming the idea of cell type and/or context-specific 
differences in the actin-regulatory activities of coronins [222,225,233]. No Coro1a or Coro1b 
staining was detected in Coro1a-/-Coro1b-/- NK cells, which served as a negative control, 
indicating a high specificity of the antibodies.  
Additional to staining for Coro1a respectively Coro1b, NK cells were treated with phalloidin 
which stains F-actin. As first evidence of a potential actin-regulatory function of coronins in 
NK cells, cellular F-actin contents of Coro1a-/-Coro1b-/- NK cells appeared to be more 
pronounced compared to wild type counterparts. Interestingly, recent studies linked Coro1a 
to the control of the cellular steady-state F-actin content in T cells but not in MCs 
[204,222,259,260]. Using an approach enabling the quantification of cellular F-actin contents 
in greater detail, I demonstrated that the steady-state level of F-actin in Coro1a-/- and 
Coro1a-/-Coro1b-/- NK cells was at least two-times higher as in wild type controls. This 
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significant increase in the F-actin content was observed for Coro1a-/- and 
Coro1a-/-Coro1b-/- NK cells but not for Coro1b-/- NK cells. Thus, these data demonstrate an 
important role of Coro1a but not of Coro1b in the regulation of the steady-state F-actin 
contents in NK cells and therefore link the effect observed in Coro1a-/-Coro1b-/- NK cells to 
the loss of Coro1a-function. These data again support the idea of cell type and/or 
context-specific differences in the actin regulatory activities of coronins [233]. Both, NK- as 
well as T cells are dedicated to the lymphoid lineage of immune cells. All lymphocytes share 
common lymphoid characteristics and utilize common mechanisms to fulfill effector functions 
like the cytolytic activity of NK- and CD8+ T cells [100,305]. Hence, a common mechanism 
controlling F-actin remodeling in NK- and T cells is likely and may explain the similar 
actin-regulatory functions of Coro1a in these related cell types. In contrast, MCs are 
dedicated to the myeloid lineage and therefore other mechanisms may be involved in the 
regulation of the steady-state F-actin level in these cell types [306]. 
 
6.1 Coronins and NK cell development 
NK cells arise from a CLP in the bone marrow [85–88]. While initial steps of NK cell 
development, including commitment to the NK cell lineage, early maturation processes as 
well as NK cell education, occur in the bone marrow, final maturation steps take place in the 
periphery [88–91]. However, NKPs and iNKs have been also found in the thymus, indicating 
other potential sites of differentiation or an access of early developmental NK cell stages to 
the circulation [89,92,93,95,98]. In humans and mice, mNKs are trackable in a number of 
different tissues and organs including spleen and liver [32–34,36]. In addition to mNKs, the 
liver maintains a fetal NK cell population into adulthood. These cells phenotypically differ 
from mNKs and the size of this population reduces over time [94,97]. So far, little is known 
about the impact of the actin cytoskeleton on NK cell development and maturation. In this 
context, limited data suggested normal numbers of peripheral NK cells in patients with an 
inborn defect of Coro1a and in Coro1a-/- mice [259,260,262]. Consistent with these reports, 
my analysis revealed that the loss of Coro1a had no impact on NK cell numbers in the 
periphery. In contrast, increased absolute NK cell numbers were detected in the bone 
marrow of Coro1a-/- and Coro1a-/-Coro1b-/- mice compared to wild type counterparts, which in 
turn leads to the question about the underlying mechanisms responsible for this discrepancy. 
Up to now, it is unclear whether only early developmental NK cell stages, which have no 
access to the circulation, are increased upon loss of Coro1a-function or if there is a block in 
the egress of Coro1a-deficient NK cells from the bone marrow towards the periphery. 
Another possible explanation would be an increased susceptibility for apoptosis of circulating 
peripheral NK cells in Coro1a-/- and Coro1a-/-Coro1b-/- mice as described for T cells 
[204,260,307]. However, data confirming one of these theories or providing further 
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explanations remain elusive so far. To this end, additional research is needed to dissolve this 
discrepancy. Contrary to Coro1a, loss of Coro1b-function had no impact on NK cell numbers 
in the bone marrow or the periphery. Thus, my data indicate that Coro1a and in turn likely the 
actin cytoskeleton are crucial for proper NK cell development in the bone marrow. An 
important role of the actin cytoskeleton in developmental processes is further supported by 
the fact that the loss of function of various actin-regulatory proteins is associated with early 
embryonic lethality [308–310]. Furthermore, effects on the integrity of the actin cytoskeleton 
as a consequence to the loss of function of diverse actin-regulatory proteins often affects 
numbers of peripheral immune cells including B- and T cells as reviewed by 
Wickramarachchi et al. [311]. 
NK cell development and maturation is a multistep process accompanied by changes in the 
expression of various surface molecules as well as changes in NK cell functionality 
[31,89,95,103,104]. The implied developmental steps resulting in mNKs are orchestrated by 
cell-intrinsic signals like transcription factors and environmental cues including activation via 
cytokines and other factors [95,100,312]. Interestingly, so far there is no evidence for an 
involvement of the actin cytoskeleton in developmental processes in NK cells as described 
for other immune cells [311]. As mentioned above, loss of Coro1a-function resulted in an 
increased number of Coro1a- and Coro1a/Coro1b-deficient NK cells in the bone marrow, 
therefore indicating a regulatory function of coronins and in turn of the actin cytoskeleton in 
early NK cell development. Further evidence for this theory came from a detailed analysis of 
various maturation- and activation markers as well as activating- and inhibitory receptors 
expressed on naïve NK cells located in the bone marrow but also in the periphery. In this 
context, the analysis of CD11b- and CD27-surface expression is a well-established method 
to determine the maturation status of murine NK cells [89,91,97,110,111]. By analyzing 
CD11b/CD27-surface expression on Coro1a-/- and/or Coro1a-/-Coro1b-/- NK cells I could 
show, that loss of Coro1a-function impairs not only the NK cell development in the bone 
marrow but also in the periphery. Independent of their tissue origin (bone marrow, spleen or 
liver), Coro1a-/- NK cells showed a more immature phenotype compared to wild type 
counterparts. This could be concluded from the expression levels of CD11b and CD27 and 
other cell surface markers including stem cell growth factor receptor (CD117), IL-7 receptor-α 
(CD127) and the integrin alpha chain-V (CD51), all markers that are exclusively expressed 
on early developmental stages [95]. Interestingly, loss of Coro1a-function had no effect on 
the expression level of CD43, a surface molecule which is known to be gradually upregulated 
in the course of maturation of CD11b+ NK cells [81,89,91]. However, Coro1a-deficiency 
resulted in an increased expression of another integrin alpha subunit, CD49b. In this context, 
it should be noted that loss of Coro1a had practically no effect on the expression levels of 
various other receptors that have been analyzed, including activating- and inhibitory NK cell 
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receptors as well as IL-2-receptor-chains. In contrast to Coro1a, the single loss of 
Coro1b-function had no impact on NK cell development and maturation, however the 
immature phenotype of Coro1a-/- NK cells was further strengthened by the additional loss of 
Coro1b in Coro1a-/-Coro1b-/- mice. Thus, my data likely implicate a counter regulation or a 
compensatory effect of Coro1a in Coro1b-/- NK cells. As mentioned above, so far the actin 
cytoskeleton has not been implicated in developmental processes in NK cells. Thus, the 
observation that Coro1a-/- and Coro1a-/-Coro1b-/- NK cells exhibit developmental/maturation 
defects represents a novel finding, as it suggests a crucial role of coronins and likely of the 
actin cytoskeleton in maturation processes in NK cells. Though, the underlying mechanisms 
remain elusive so far. As NK cell development and maturation strictly depends on the proper 
regulation via transcription factors [93,313–316], a dysregulated activation of these factors 
due to impaired signaling events is a potential explanation for the developmental defects of 
NK cell observed in the context of Coro1a- and Coro1a/Coro1b-deficiency. Furthermore, 
recent work demonstrated that NK cells require a special bone marrow microenvironment 
and contact to stromal cells for initial developmental steps [100,103,317,318] and are 
localized to restricted areas of the spleen and liver under steady-state conditions [319,320]. 
However, so far the requirements for peripheral NK cell maturation are still poorly 
investigated. In this context, an alternative explanation for the developmental impairment of 
Coro1a- and Coro1a/Coro1b-deficient NK cells may be defects in cell migration and/or cell 
adhesion that could result in limited maturation signals. Defective migratory responses of 
Coro1a-/- and Coro1a-/-Coro1b-/- NK cells are described in this thesis. Furthermore, observed 
alterations of actin cytoskeletal structures in these cells may affect adhesion to 
developmental niches, as this activity strictly depends on a proper F-actin reorganization 
[321]. 
As different maturation stages of NK cell have been linked to differences in NK cell effector 
functions, including cytotoxicity and cytokine production [31,89,104,110], it is tempting to 
speculate that the reduced maturation status of Coro1a- and Coro1a/Coro1b-deficient NK 
cells may be associated with differences in NK cell responsiveness and/or function.  
Altogether, my data demonstrate that although loss of coronin-function had no impact on 
peripheral NK cell numbers, Coro1a-/- and Coro1a-/-Coro1b-/- spleen- and liver NK cells exhibit 
a developmental impairment indicated by a more immature phenotype compared to wild type 
controls which potentially affects their functionality.  
 
6.2 The role of Coro1a and -1b in the regulation of NK cell functions 
The encounter of an NK cell with a target cell lacking adequate inhibitory ligands initiates 
different signaling cascades leading to the release of cytolytic granules and in turn to the 
death of the target cell and additionally induces the secretion of cytokines [116,126–
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129,322]. Various studies have linked NK cell activation with F-actin remodeling at the 
cell-cell contact site and pointed out a critical role of Arp2/3-complex-mediated F-actin 
polymerization for NK cell cytotoxicity [124,151,165,167,170,171,181,182]. Class I coronins 
like Coro1a and -1b co-sediment with components of the Arp2/3-complex and are known to 
negatively interfere with its function [184,186,187,204,241]. Since loss of Coro1a-function 
increased steady-state F-actin level in NK cells, adverse effects on NK cell functionality 
appeared possible. As the purification of murine NK cells from the spleen results in only a 
limited number of suitable cells, purified NK cells were expanded and activated with IL-15 as 
previously described by Salagianni et al. to obtain sufficient numbers of activated NK cells for 
functional in vitro studies [286]. In contrast to naïve NK cells, IL-15-expanded 
Coro1a-/- and/or Coro1b-/- NK cells displayed a similar and relatively homogeneous 
phenotype concerning the expression of selected maturation markers including CD11b and 
CD27 as well as activating and inhibitory NK cell receptors. Since NK cell functionality is 
strongly determined by the maturation status of the cell [31,89,91,104,110], IL-15-expanded 
cells were utilized to examine potential functional impairments of Coro1a- and/or 
Coro1b-deficient NK cells, as those cells showed a relatively comparable maturation 
phenotype between all genotypes as compared to freshly isolated naïve NK cells. 
Since early days of coronin research, coronins have been linked to cellular motility [194]. 
Mammalian class I coronins have been implicated in both, the impairment as well as the 
promotion of cellular motility in distinct cell types. For NK cells, I demonstrated that the loss 
of Coro1a-function resulted in a dramatically decreased spontaneous- as well as 
chemokine-mediated migration of Coro1a-/- and Coro1a-/-Coro1b-/- NK cells, while the 
disruption of only Coro1b expression had no effect on the cellular motility. These data are 
consistent with the observation that loss of Coro1a-function results in a defective 
chemokine-mediated migration and an impaired thymic egress of T cells and impaired 
chemotaxis of human neutrophils [187,204,263]. Moreover, in vascular smooth muscle cells 
the down regulation of Coro1b resulted in increased platelet-derived growth factor-induced 
migration [225]. While the silencing of Coro1c had no impact on vascular smooth muscle 
cell-migration, an increased cellular motility, cell-matrix adhesion and enhanced cell 
spreading was observed in intestinal epithelial cells, whereas overexpression of Coro1c 
antagonized cell adhesion and spreading in intestinal epithelial cells [225,323]. Together, my 
data on the impact of Coro1a- and/or Coro1b-deficiency on cellular motility of NK cells 
provide further evidence for cell type and/or context-specific differences in the 
actin-regulatory activities of coronins as postulated by Gandhi et al. [233]. Recent work has 
linked Coro1b with the inhibition of Arp2/3-complex-mediated F-actin assembly as well as the 
regulation of cofilin-activity by recruiting SSH1L at the leading edge of rat fibroblasts 
[186,230]. Similar regulatory functions and properties have been also reported for Coro1a 
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[187,204,229,246,260]. In this context, a dysregulated F-actin reorganization at the leading 
edge as result of the regulatory function of Coro1a likely explains the impaired cellular 
motility of Coro1a-/- and Coro1a-/-Coro1b-/- NK cells. 
As reported for other regulators of the Arp2/3-complex including WASp, WIP and HS1 
[165,167,170], loss of Coro1a-function resulted in decreased NK cell cytotoxicity indicated by 
a reduced killing of YAC-1 target cells. Cytotoxicity was further diminished upon additional 
loss of Coro1b in Coro1a-/-Coro1b-/- NK cells. However, the single loss of Coro1b-function had 
no effect on the capability of Coro1b-/- NK cells to kill target cells. These data implicate an 
overlapping role of Coro1a and Coro1b in NK cells. Since NK cell cytotoxicity is a tightly 
regulated process which strictly depends on early as well as late actin-mediated mechanisms 
[115,152–154,159], the functional impairment of NK cell cytotoxicity by the loss of coronins 
could have several reasons that are further discussed in the next paragraphs: 
 
Coro1a- as well as Coro1b-function is dispensable for intercellular conjugate formation and 
cellular activation of NK cells. 
The initial step of NK cell cytotoxicity following the recognition of a target is the formation of a 
stable conjugate between NK- and target cell [115]. This process requires the segregation of 
adhesion molecules like LFA-1 into the outer region of the cytolytic synapse known as 
pSMAC [115,130,151]. There, they mediate the formation of a tight conjugate and initiate 
various signaling cascades which, among others, stimulate F-actin reorganization 
[115,124,127,150,151]. Recent work demonstrates that loss of Arp2/3-function as well as 
disruption of expression of HS1, an NPF linked to the activation of the Arp2/3-complex, 
negatively affects NK cell adhesion [170,171]. In contrast to Arp2/3 or HS1, I demonstrated 
that Coro1a- and/or Coro1b-function seems to be dispensable for the formation of a stable 
intercellular conjugate given that no differences in the ability to form intercellular conjugates 
were detected between wild type, Coro1a- and/or Coro1b-deficient NK cells. This idea was 
further supported by the fact that no apparent differences in the morphology of cytolytic 
synapses formed upon conjugation of wild type or Coro1a-/-Coro1b-/- NK cells with YAC-1 
target cells were revealed by microscopy indicating an expendable role of both proteins for 
this process.  
NK cell activation initiates F-actin accumulation at the site of the pSMAC likely in a WASp- 
and Vav-1-dependent manner [115,118,124,165,322,324]. In contrast, F-actin is almost 
cleared from the inner region of the cytolytic synapse known as cSMAC upon activation 
[156,157,159]. By utilizing confocal microscopy I demonstrated that the localization of 
Coro1a as well as Coro1b at the site of the cytolytic synapse resembles the distribution of 
F-actin. Both coronins were found enriched in the actin-rich pSMAC-region where they 
colocalized with F-actin and were almost cleared from the largely actin-dim cSMAC-region. In 
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contrast, localization of both proteins was not altered in unconjugated NK cell areas, thus 
linking potential coronin-regulatory functions upon NK cell activation to processes at the 
cell-cell contact site.  
Further evidence for coronin-regulatory events following NK cell activation and a tight 
interaction of Coro1a as well as Coro1b with the actin cytoskeleton came from biochemical 
fractionation experiments. While in non-stimulated NK cells, Coro1a and -1b were mainly 
recovered in the cytoskeleton-rich fraction, β-actin and both coronins were mainly located in 
the cytosolic fraction upon treatment of the cells with the actin-modulatory drug latrunculin B, 
which disrupts the actin cytoskeleton. Furthermore, activation of the cells via crosslinking of 
the activating NK cell receptor NK 1.1 leads to a long-lasting phosphorylation of Coro1b on 
Ser2 correlating with a relocation of the protein from the cytoskeleton-rich- into the cytosolic 
fraction. Comparable effects on Coro1b but also on Coro1a were previously reported for MCs 
following FcεRI-mediated activation [222]. However, in contrast to Coro1b only minor 
changes in the localization of Coro1a were detected upon cellular activation of NK cells not 
only subsequent to NK1.1 mediated stimulation but also upon treatment with PMA/ionomycin 
that resulted in a substantial relocation of the protein in MΦs and MCs [222,250]. Importantly, 
the described differences between NK cells and MCs with respect to Coro1a may be the 
result of the different strategies used to activate cells as well as general differences between 
these cell types. While the stimulation of MCs with Abs and the associated antigen affects 
the whole cell surface and in turn the underlying cortical F-actin cytoskeleton, stimulation of 
NK cells utilizing beads mimics the interaction with a target cell and therefore involves cell 
polarization processes which limit activating events to restricted areas. Thus, 
coronin-regulatory events in NK cells upon stimulation with bead-bound Abs are likely 
located to the site of activation as demonstrated for NK cell-YAC-1-conjugates and therefore 
affect only minor portions of the overall cellular coronin content. As demonstrated for 
fibroblasts, T cells and MΦs, phosphorylation of coronins strictly regulates the interaction of 
Coro1a and Coro1b with the Arp2/3-complex as well as F-actin and in turn F-actin 
reorganization [204,212,222,250,251]. Thus, even minor effects on coronins located at the 
site of activation could be crucial for NK cell function. Nevertheless, it should be mentioned 
that enrichment of Coro1a and -1b in the pSMAC-region is possibly only a side effect 
provoked by the F-actin-binding activity of both proteins upon F-actin accumulation in these 
area. Furthermore, clearance of coronins from the cSMAC-region may be the result of 
F-actin disassembly during synapse formation. However, independent of the question about 
the underlying mechanisms leading to the changes in the localization of Coro1a and Coro1b 
at the site of the forming cytolytic synaps, my data indicate a dispensable role of both 
coronins for intercellular conjugate formation and the subsequent NK cell activation. 
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In contrast to adhesion and co-stimulatory molecules which are found in the pSMAC-region, 
activating- and inhibitory NK cell receptors accumulate in the cSMAC-region of the cytolytic 
synapse [118,119,152–154]. The formation of microclusters of NK cell receptors strictly 
depends on actin-mediated lipid raft reorganization and for this reason might be influenced 
by the loss of Coro1a and/or Coro1b [124,158,325,326]. The engagement of cognate ligands 
by activating NK cell receptors initiates the recruitment of various molecules involved in 
signal transduction like PI3K, PLCγ, PKC or Vav-1 and in turn leads to the activation of the 
MAPK- and JNK-pathway which are involved in the regulation of the cytolytic response 
[118,119,126–129]. In this context, I could demonstrate that loss of Coro1a-function only 
minimally affects the activation of the PI3K-pathway and the MAPK-cascade in Coro1a-/- and 
Coro1a-/-Coro1b-/- NK cells upon activation via crosslinking of NK1.1 as indicated by 
immunoblot analysis of Akt- and Erk1/2-phosphorylation. In contrast to Coro1a, loss of 
Coro1b-function had no impact on signaling events. Despite the slight alterations in the Akt- 
and Erk1/2 phosphorylation levels and kinetics that were observed in Coro1a- and 
Coro1aCoro1b-deficient NK cells compared to wild type controls, the activation of NK cells of 
all genotypes via NK1.1 crosslinking resulted in a comparable induction of IFN-γ mRNA and 
following protein production. Thus, the small effects of Coro1a on NK cell signaling seem to 
be functionally irrelevant, at least in regards to IFN-γ-production.  
 
Loss of coronin-function results in impaired polarization of cytotoxic granules.  
NK cell cytotoxicity is mainly mediated by the release of granules containing the pore-forming 
protein perforin and cytotoxic serine proteases named granzymes, including GrzA and -B 
[137–142]. Comparable amounts of GrzA, GrzB and perforin were found in all NK cell 
genotypes, thus excluding alterations in the content of cytotoxic molecules as the underlying 
cause for the decreased cytotoxicity of Coro1a- and Coro1aCoro1b-deficient NK cells. In 
response to the engagement of NK cell-activating receptors and the induction of signaling 
events linked to the MAPK- and JNK-pathway, cytotoxic granules translocate to the site of 
the cytolytic synapse [115,128,149,155]. The translocation occurs in two steps including the 
initial dynein-mediated transport of the cytotoxic granules along the microtubules directed to 
the MTOC and the following polarization of both, MTOC as well as the granules, towards the 
cytolytic synapse [115,149,155]. A critical role of the actin cytoskeleton for MTOC 
polarization has been pointed out by various studies. In this context, the loss of function of 
proteins involved in the F-actin regulation including WASp or WIP as well as proteins which 
link microtubules and the actin cytoskeleton like CIP4, IQGAP1 and hDia1 or the inhibition of 
F-actin dynamics by utilizing pharmacologic drugs, blocks MTOC-polarization and in turn 
severely impairs NK cell cytotoxicity [115,116,171,183,327,328]. In contrast to the 
dispensable role of coronins for early steps of the NK cell cytolytic response, loss of 
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Coro1a/Coro1b-function visually impaired the translocation of cytotoxic granules towards the 
cell-cell contact site. While 61% of conjugated wild type NK cells were polarized, fully 
reoriented cytotoxic granules at the site of the synapse were only detected in 47% of the 
Coro1a-/-Coro1b-/- NK cells. As mentioned above, the integrity of the actin network at the site 
of the cytolytic synapse seems to be indispensable for the polarization of the MTOC and in 
turn polarization of the cytotoxic granules towards the cell-cell contact site. Although 
obviously no major differences in the morphology of cytolytic synapses and in particular of 
the distribution of F-actin within the synapse formed by wild type or Coro1a/Coro1b-deficient 
NK cells were revealed by confocal microscopy, non-visible differences in the architecture of 
the actin cytoskeleton are likely. Thus, a potentially disturbed interaction of the microtubules 
with the actin cytoskeleton may explain the reduced polarization of cytotoxic granules upon 
loss of Coro1a/Coro1b in Coro1a-/-Coro1b-/- NK cells.  
 
NK cell degranulation is impaired upon loss of Coro1a. 
Studies on various types of secretory cells have suggested that the actin cytoskeleton acts 
as a barrier to exocytosis. However, in many of these cells it became apparent that F-actin 
additionally acts as a facilitator of secretion [329–334]. A barrier function of the actin 
cytoskeleton on secretory processes was also described in MCs and neutrophils [222,304]. 
In T- as well as NK cells the polarized MTOC docks at the synapse membrane within the 
cSMAC region, however recent work of Rak et al. as well as Brown et al. demonstrate that 
release of cytotoxic granules in NK cells, in contrast to T cells, occurs through locally 
hypodense areas of a pervasive F-actin network within the cSMAC-region in an 
myosin IIA-dependent manner [156–162,335]. Since the impairment of the integrity of the 
F-actin network by utilizing pharmacological drugs leads to decreased secretion of cytotoxic 
granules in human NK cells rather than an increase, Rak et al. suggested that F-actin in NK 
cells acts as a facilitator of secretion rather than a barrier [159]. Consistent with this idea, my 
data strongly indicate an indispensable role of the actin cytoskeleton for the cytotoxicity of 
murine NK cells. The inhibition of actin polymerization utilizing latrunculin B or cytochalasin D 
during NK cell activation resulted in an almost complete prevention of cytolytic granule 
release. Similar effects were observed upon treatment of cells with jasplakinolide, supporting 
a crucial role of F-actin reorganization for NK cell cytotoxicity. Further evidence for a 
contribution of the actin cytoskeleton and its reorganization not only in early but also in late 
events of NK cell cytotoxicity were provided by the effects of actin-modulatory drugs added 
following NK cell activation. However, the impact of the treatment with the actin-modulatory 
drugs subsequent to activation on NK cell degranulation was not as pronounced as for the 
treatment at the time of activation.  
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Although the loss of function of various actin-regulatory proteins in NK cells was linked to an 
impaired cytotoxicity, only little is known about the contribution of these proteins to NK cell 
degranulation. My studies on NK cell degranulation revealed a crucial role of Coro1a for this 
process. Specifically, Coro1a-/- and Coro1a-/-Coro1b-/- NK cells exhibited decreased 
degranulation upon conjugation with YAC-1-target cells. In contrast, degranulation of 
Coro1b-/- NK cells was comparable to wild type counterparts. These observations are 
contrary to the previously described role of Coro1a and -1b in MC degranulation. Föger et al. 
recently demonstrated that in MCs the loss of Coro1a-function resulted in FcεRI-induced 
“hyperdegranulation” which was further increased upon the additional loss of Coro1b [222]. 
Indeed, this discrepancy is likely the result of the different functions of the cytoskeleton in the 
context of secretory processes. While in MCs, the cortical F-actin has been suggested to act 
as a barrier during exocytosis, supported by the fact that treatment of MCs with latrunculin B 
somehow mimics the “hyperdegranulation-phenotype” of Coro1a-deficient MCs [222], F-actin 
in NK cells operates as a facilitator of secretion rather than a barrier [159].  
Prior to docking and fusion with the plasma membrane, cytolytic granules have to pass 
through locally hypodense areas of the pervasive F-actin network within the cSMAC-region 
of the NK cell [158,159]. However, up to now it remains unclear how these hypodense areas 
within the actin network are formed. One potential mechanism is a local reorganization of 
F-actin filaments by actin-regulatory proteins like cofilin that mediates F-actin 
depolymerization and severing [172,245]. This seems to be important for the exocytosis of 
glucose transporter-containing vesicles in muscle cells [336]. Interestingly, class I coronins 
were linked to the regulation of cofilin in yeast as well as in mammals [186,200,232,233,244]. 
However, in this context coronins have been linked to both, the promotion as well as the 
inhibition of cofilin-mediated actin disassembly [229,246]. Thus, further investigations are 
required to resolve this discrepancy. A more simple explanation for the impaired capability of 
Coro1a-/- and Coro1a-/-Coro1b-/- NK cells to secrete cytolytic granules may be a disturbed 
integrity of the cortical actin network. A dysregulated F-actin organization in these cells has 
previously already been described for the steady-state F-actin content. Slight changes in the 
architecture of the cortical F-actin within the cSMAC may inhibit the myosin IIA-mediated 
transport of cytolytic granules or prevent the passage of granules through the pervasive actin 
network. In addition, docking of secretory vesicles to the plasma membrane strictly depends 
on the activity of docking and priming proteins like Rab27a [163,164]. Recent work 
demonstrated an interaction of Rab27a with Coro1a as well as Coro1c in HL-60 cells and 
pancreatic beta-cells, respectively [239,337]. However, so far there is no evidence for a 
Coro1a/Coro1b-Rab27a-interaction in NK cells. Thus, additional research is needed to clarify 
the role of coronins and in turn of the actin cytoskeleton in NK cell degranulation. 
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Besides their cytolytic function NK cells produce and secrete a variety of cytokines and other 
soluble factors, for instance IFN-γ and CCL5, which are important for the modulation of 
innate as well as acquired immune responses [57,58,300,302]. Despite their relevance, only 
little is known about the underlying mechanisms of cytokine secretion in NK cells. 
Coro1a-/- and/or Coro1b-/- NK cells showed a normal induction of IFN-γ mRNA and protein 
production upon activation. Importantly, however, the loss of Coro1a-function resulted in a 
dramatically impaired secretion of IFN-γ and CCL5 upon NK cell activation via crosslinking of 
the activating NK cell receptors NK1.1 as well as NKG2D or by treatment with 
PMA/ionomycin in Coro1a-/- and Coro1a-/-Coro1b-/- NK cells. In contrast, the loss of 
Coro1b-function had no impact on the capability of NK cells to secrete cytokines. Taken 
together, my data indicate a regulatory function of Coro1a on cytokine exocytosis in NK cells. 
Similar observations have previously been made for IL-6 and TNF-α secretion in 
Coro1a-deficient MCs [222], thus suggesting a general role of Coro1a for cytokine exocytosis 
in immune cells.  
Studies on various cell types revealed that the release of soluble factors may be mediated by 
prestored secretory vesicles or granules segregated from the Golgi in a regulated manner 
following activation or can occur rapidly upon their synthesis through recycling endosomes 
and small secretory vesicles through constitutive exocytosis with or without further regulation 
[338]. The cellular polarization of activated NK cells comprise not only the reorientation of 
cytolytic granules but also the translocation of the Golgi apparatus as well as recycling 
endosomes to the site of the cytolytic synapse [115,116,149,156,339]. Reefman et al. 
recently demonstrated that IFN-γ /TNF and perforin are located in separate structures upon 
cellular activation of NK cells and that the exocytosis of chemokines and perforin occurs in a 
distinct fashion. While perforin was released in a polarized manner through the 
cSMAC-region of the cytolytic synapse subsequent to conjugate formation, IFN-γ /TNF were 
recovered in the Golgi complex and the surrounding recycling endosome and were delivered 
to the site of the synapse but also to the periphery. Thus, demonstrating that release of these 
cytokines occurs all over the cell surface of NK cells [339]. Since cytokine secretion in NK 
cells seems to be carried out over the entire cell surface, the increased cortical F-actin levels 
observed in Coro1a- and Coro1a/Coro1b-deficient NK cells potentially impair the release of 
cytokines. In this context, the dysregulated cortical F-actin may act as a barrier which 
hampers the passage of vesicles and therefore inhibits cytokine secretion. This idea is 
supported by the observation that a disturbed F-actin reorganization impairs cytokine 
secretion in T cells [340]. 
In summary, my data demonstrate that Coro1a and to a lower extent Coro1b are strictly 
required for diverse cellular functions of NK cells and in turn implicates a crucial role of the 
actin cytoskeleton for the regulation of these processes 
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6.3 Conclusions and perspective 
NK cells are potent effector cells which are basically capable to respond against stressed 
endogenous cells in the absence of prior sensitization [9–12,23,37–40]. For that reason, an 
adequate regulation of NK cell activities is strictly required to avoid the injury of the host 
organism [39,341,342]. In this study I provide genetic evidence for an important role of two 
actin-regulatory proteins of the coronin family, Coro1a and Coro1b, in the regulation of NK 
cell development and function. By utilizing gene-deficient mice I demonstrated that the loss 
of Coro1a-function was directly linked to dysregulated F-actin organization in NK cells. My 
data indicate a direct inhibitory role of Coro1a in the regulation of F-actin levels in NK cells 
and reinforce the significance of coronins as actin-regulators. Furthermore, so far 
unrecognized regulatory mechanisms of coronins were revealed in the context of NK cell 
development and maturation. Consistent with previous reports [259,261,262], loss of Coro1a 
had no impact on NK cell numbers in the periphery, however influenced NK cell development 
in the bone marrow. Additionally, the loss of coronin-function negatively affected NK cell 
maturation in Coro1a-/- mice, not only in the bone marrow but also in the periphery. In this 
context, naïve Coro1a-/- bone marrow-, spleen- and liver NK cells were characterized by a 
more immature phenotype compared to wild type counterparts. Contrary to Coro1a, loss of 
Coro1b-function had no impact on NK cell development and maturation in Coro1b-/- mice. 
However, the immature phenotype of Coro1a-/- NK cells was further strengthened by the 
additional loss of Coro1b in Coro1a-/-Coro1b-/- mice. Thus, my data likely implicate a counter 
regulation or a compensatory effect of Coro1a in Coro1b-/- NK cells. Together, these data 
strongly indicate a so far unknown role of Coro1 as well as Coro1b and likely of the actin 
cytoskeleton in NK cell development and maturation. Though the underlying mechanisms still 
remains elusive, these findings open up a new interesting field for further research. 
Importantly, loss of coronin-function affected not only NK cell development but also NK cell 
functionality. In vitro, IL-15-expanded Coro1a-/- and Coro1a-/-Coro1b-/- NK cells matured 
comparably to wild type NK cells but exhibited clear defects in central NK cell functions like 
killing of tumor cells, chemokine-induced migration and cytokine secretion. All in all functions, 
that are also impaired upon loss of other proteins associated with actin regulation [165–
171,183]. By contrast, loss of Coro1b had no effect on NK cell functionality. My data strongly 
indicate that decreased cytotoxicity of Coro1a-/- and Coro1a-/-Coro1b-/- NK cells was 
associated with an impaired polarization of cytolytic granules and a reduced NK cell 
degranulation. By contrast, early steps of the cytolytic response, including the formation of 
the cytolytic synapse and the consequent activation of NK cells, seems to be unaffected by 
the loss of Coro1a and/or Coro1b. I further demonstrated that decreased cytokine secretion 
of Coro1a-/- and Coro1a-/-Coro1b-/- NK cells was likely associated with an impairment of 
exocytic pathways, whereas no major defects were revealed for the cytokine production. 
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Thus, distinct actin-associated processes involved in NK cell activities likely have different 
requirements on coronin proteins and the actin cytoskeleton. Furthermore, my data confirm 
the particular significance of the actin cytoskeleton for the regulation of distinct NK cell 
activities as emphasized by various studies [165–171,183]. 
My in vitro data strongly suggest an important regulatory role of Coro1a in NK cell activities. 
However, so far the functional impact of coronin-deficiency in an in vivo setting still remains 
elusive. To this end, further research is needed regarding the verification of the here 
presented results. A T cell-independent tumor model should be the method of choice to verify 
the role of the coronins in vivo because of the reported peripheral T cell-deficiency of 
Coro1a-/- mice [204,259]. A possible approach is provided by the RMA/RMA-S-tumor model 
[343–346]. In this assay, differently labeled NK cell-resistant RMA cells and NK-susceptible 
RMA-S cells are injected into the peritoneal cavity of mice and recovered after two days by 
lavage of the peritoneum. Subsequently, the amount of remaining tumor cells can be easily 
revealed by flow cytometry. Due to the short period of disposition, the elimination of RMA-S 
cells should be primarily mediated by NK cells. As Coro1a-/- and Coro1a-/-Coro1b-/- NK cells 
showed a decreased cytotoxicity in vitro, the prediction is that higher amounts of RMA-S cells 
should be recovered from these mice. This approach could also deliver important information 
about the role of the coronins in regard to the SCID-phenotype of patients with an inborn 
defect in Coro1a or of Coro1a-/- mice. So far, the pathological alterations observed in humans 
and mice resulting in the SCID phenotype, were mainly attributed to defective 
actin-regulation in T cells, since normal amounts of peripheral NK cells were assessed 
[204,259–262]. NK cells act as a first barrier against pathogens and are important regulators 
of adaptive immune responses [23,342]. Therefore, developmental- and functional 
impairments of NK cells upon loss of Coro1a-function as outlined above, may contribute to 
the establishment of the clinical symptoms observed in patients with an inborn defect of 
Coro1a. 
The demonstrated regulatory role of coronins, especially of Coro1a in NK cell development 
and function, displays a new aspect of NK cell research. I could show for the first time that 
coronins are important regulators of NK cell development as well as NK cell maturation and 
are required for the proper regulation of distinct NK cell activities. In this context, an 
important role of the actin cytoskeleton in processes like killing of tumor cells, chemotaxis 
and cytokine secretion is emphasized by various studies and further reinforced by the 
demonstrated data. Importantly, however, the discovery of the role of coronins and likely of 
the actin cytoskeleton in NK cell development and especially maturation reveals a novel level 
of NK cell regulation.  
Thus, this study opens up new approaches in NK cell biology and gathers first evidence on 
the possible role of NK cells in SCID patients with an inborn defect of Coro1a.
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8 Summary 
NK cells play an important role in the clearance of viral and intracellular bacterial infections 
as well as in the elimination of tumor cells and have also been implicated in the regulation of 
other immune cells. Recent work demonstrates a crucial role of actin cytoskeletal-activities in 
controlling NK cell function. In eukaryotic cells, the maintenance of the actin cytoskeleton and 
its quick remodeling in response to various stimuli is orchestrated by a cohort of 
actin-associated proteins. Coronin proteins are part of this complex network of 
actin-regulatory proteins and, as such, have been implicated in various actin-mediated 
cellular activities in different cellular systems. However, the role of coronins in the control of 
NK cell functions is yet unknown. 
In this thesis, I provide genetic evidence for an important role of two mammalian coronins, 
coronin 1a (Coro1a) and coronin 1b (Coro1b), in the regulation of NK cell development and 
function. By utilizing gene-deficient mice I could demonstrate that the loss of Coro1a-function 
was directly linked to dysregulated F-actin organization in NK cells. While Coro1a-/- mice had 
normal numbers of peripheral NK cells, Coro1a-/- NK cells generally were of a more immature 
phenotype compared to wild type counterparts. The impaired NK cell maturation in 
Coro1a-/- mice was additionally associated with developmental alterations in the bone 
marrow. Although the single loss of Coro1b-function did not affect NK cell development and 
maturation, the immature phenotype of Coro1a-/- NK cells was further augmented by the 
additional loss of Coro1b. In vitro, IL-15-expanded Coro1a-/- and Coro1a-/-Coro1b-/- NK cells 
exhibited a comparable maturation status as wild type NK cells, but showed clear defects in 
central NK cell functions like killing of tumor cells, chemokine-induced migration and cytokine 
secretion. The decreased cytotoxicity of Coro1a-/- and Coro1a-/-Coro1b-/- NK cells was 
associated with an impaired polarization of cytolytic granules and a reduced NK cell 
degranulation, whereas no major defects were found in early steps of the cytolytic response, 
including the formation of the cytolytic synapse and the consequent activation of NK cells. 
Thus, distinct actin-associated processes involved in NK cell activities have different 
requirements on coronin proteins and the actin cytoskeleton.  
In conclusion, this study expands our knowledge on the function of actin-regulatory coronin 
proteins, by demonstrating that they do not only regulate known actin-dependent processes 
in NK cells, such as cell migration and cytotoxic granule release, but also control NK cell 
development. As coronin proteins and actin regulation are highly conserved between mice 
and man, the results obtained from this study are relevant for the human system. Thus, 
defective NK cell responses may contribute to the clinical symptoms observed in SCID 
patients with an inborn defect of Coro1a. 
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9 Zusammenfassung 
NK Zellen übernehmen wichtige Aufgaben in der Abwehr viraler und intrazellulärer 
bakterieller Infektionen sowie bei der Eliminierung von Tumorzellen. Des Weiteren tragen sie 
zur Regulation anderer Immunzellen bei. In aktuellen Publikationen konnte gezeigt werden, 
dass das Aktin-Zytoskelett eine entscheidende Funktion bei der Kontrolle von NK 
Zell-Aktivitäten übernimmt. In eukaryotischen Zellen werden die Aufrechterhaltung und der 
Umbau des Aktin-Zytoskeletts durch eine Vielzahl von Aktin-assoziierten Proteinen 
gesteuert. Einen wichtigen Bestandteil dieses komplexen Netzwerkes Aktin-regulierender 
Proteine bilden die Coronine. Diese werden mit der Regulation einer Vielzahl 
Aktin-vermittelter Prozesse in unterschiedlichen Zellsystemen in Verbindung gebracht. Eine 
Beteiligung von Coroninen an der Steuerung von NK Zell-Funktionen ist bisher jedoch 
unbekannt. 
In dieser Arbeit konnte ich durch die Verwendung von Gen-defizienten Mausstämmen eine 
wichtige regulative Rolle zweier Säugetier Coronine, genauer Coronin 1a (Coro1a) und 
Coronin 1b (Coro1b), für die Entwicklung und Funktion von NK Zellen nachweisen. Des 
Weiteren konnte ich zeigen, dass der Verlust der Funktion von Coro1a in direkter Verbindung 
mit einer fehlgesteuerten Aktin-Zytoskelett-Organisation in NK Zellen steht.  
Coro1a-defiziente Mäuse wiesen eine normale Anzahl peripherer NK Zellen auf, diese waren 
jedoch im Vergleich zu den Wildtyp Kontrollen durch einen generell unreiferen Phänotyp 
gekennzeichnet. Ein vergleichbarer Effekt bezüglich des Reifegrades von Coro1a-/- NK Zellen 
wurde auch im Knochenmark beobachtet. Dieser war jedoch zusätzlich mit einer Steigerung 
der Anzahl der Coro1a-defizienten NK Zellen und somit einer veränderten NK 
Zell-Entwicklung im Knochenmark assoziiert. Der alleinige Verlust von Coro1b hatte 
hingegen keine Auswirkung auf die Entwicklung und Reifung der NK Zellen, jedoch wurde 
der unreife Phänotyp Coro1a-defizienter NK Zellen durch den zusätzlichen Verlust von 
Coro1b weiter verstärkt.  
IL-15-expandierte Coro1a-/- und Coro1a-/-Coro1b-/- NK Zellen zeigten im Vergleich zu 
Wildtyp-Zellen einen ähnlichen Reifegrad, wiesen allerdings in in vitro Studien klare Defizite 
bezüglich zentraler NK Zell-Funktionen wie der Abtötung von Tumorzellen, der 
Chemokin-induzierten Migration und der Zytokinfreisetzung auf. Die geminderte Zytotoxizität 
der Coro1a-/- und Coro1a-/-Coro1b-/- NK Zellen war assoziiert mit einer verringerten 
Polarisierung zytolytischer Granula sowie einer reduzierten NK Zell-Degranulation. Hingegen 
konnten keine nennenswerten Defekte im Bereich der frühen zytolytischen Antwort bezüglich 
einer gestörten Ausbildung der zytolytischen Synapse und einer daraus resultierenden 
verminderten Aktivierung der NK Zellen nachgewiesen werden. Daraus lässt sich schließen, 
dass Coronine und das Aktin-Zytoskelett differentiell bei unterschiedlichen Aktin-vermittelten 
Prozessen beansprucht werden.  
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Zusammenfassend lässt sich sagen, dass die Untersuchungen im Rahmen dieser Arbeit das 
Wissen um Aktin-regulierende Coronine erweitern, indem gezeigt wird, dass nicht nur 
nachweislich Aktin-abhängige Prozesse wie die Zellmigration und die Freisetzung 
zytotoxischer Granula durch diese Proteine in NK Zellen reguliert werden sondern zusätzlich 
auch die Entwicklung von NK Zellen durch Coronine gesteuert wird. Da die untersuchten 
Coronin-Proteine sowie generelle Aktin-regulierende Prozesse zwischen Maus und Mensch 
stark konserviert sind, sind die Ergebnisse dieser Arbeit ebenfalls für das humane System 
relevant. Fehlerhafte NK Zell-Antworten könnten somit als weitere Ursache für die klinischen 
Symptome in SCID Patienten, die einen angeborenen Coro1a-Defekt aufweisen, 
verantwortlich sein. 
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10 Appendix 
 
10.1 Protein alignments of mouse and human Coro1a and Coro1b 
The amino acid sequences of mouse Coro1a (accession no.: NP_034028, version: 
NP_034028.1) and Coro1b (accession no.: NP_035908, version: NP_035908.1) as well as 
human Coro1a (accession no.: NP_009005, version: NP_009005.1) and Coro1b (accession 
no.: NP_001018080, version NP_001018080.1) were aligned with ClustalW2 (EMBL-EBI; 
version: 2.1; http://www.ebi.ac.uk/Tools/msa/clustalw2/) using default settings. The 
calculated amino acid sequence homologies are shown in Table 10-1, the underlying 
protein-alignments are depicted in Figure 10-1 to 10-3. 
 
             Table 10-1. Amino acid sequence homologies of murine and human coronins 
Proteins Identities Similarity Gaps 
mCoro1a vs. hCoro1a 94% 97% 0% 
mCoro1b vs. hCoro1b 94% 95% 1% 
mCoro1a vs. mCoro1b 63% 79% 5% 
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Figure 10-1. Protein alignment of mouse Coro1a and Coro1b. 
Mouse Coro1a and Coro1b amino acid sequences were aligned using ClustalW (version 2.1.) Identical 
residues are highlighted by an asterisk, conserved substitutions are indicated by an colon and 
semi-conserved by an point. 
mCoro1a      MS-RQVVRSSKFRHVFGQPAKADQCYEDVRVSQTTWDSGFCAVNPKFMAL 49
mCoro1b      MSFRKVVRQSKFRHVFGQPVKNDQCYEDIRVSRVTWDSTFCAVNPKFLAV 50
** *:***.**********.* ******:***:.**** ********:*:
mCoro1a      ICEASGGGAFLVLPLGKTGRVDKNVPLVCGHTAPVLDIAWCPHNDNVIAS 99
mCoro1b      IVEASGGGAFMVLPLNKTGRIDKAYPTVCGHTGPVLDIDWCPHNDEVIAS 100
* ********:****.****:**  * *****.***** ******:****
mCoro1a      GSEDCTVMVWEIPDGGLVLPLREPVITLEGHTKRVGIVAWHPTAQNVLLS 149
mCoro1b      GSEDCTVMVWQIPENGLTSPLTEPVVVLEGHTKRVGIITWHPTARNVLLS 150
**********:**:.**. ** ***:.**********::*****:*****
mCoro1a      AGCDNVILVWDVGTGAAVLTLGPDVHPDTIYSVDWSRDGALICTSCRDKR 199
mCoro1b      AGCDNVVLIWNVGTAEELYRLD-SLHPDLIYNVSWNHNGSLFCSACKDKS 199
******:*:*:***.  :  *. .:*** **.*.*.::*:*:*::*:** 
mCoro1a      VRVIEPRKGTVVAEKDRPHEGTRPVHAVFVSEGKILTTGFSRMSERQVAL 249
mCoro1b      VRIIDPRRGTLVAEREKAHEGARPMRAIFLADGKVFTTGFSRMSERQLAL 249
**:*:**:**:***:::.***:**::*:*:::**::***********:**
mCoro1a      WDTKHLEEPLSLQELDTSSGVLLPFFDPDTNIVYLCGKGDSSIRYFEITS 299
mCoro1b      WDPENLEEPMALQELDSSNGALLPFYDPDTSVVYVCGKGDSSIRYFEITD 299
**.::****::*****:*.*.****:****.:**:**************.
mCoro1a      EAPFLHYLSMFSSKESQRGMGYMPKRGLEVNKCEIARFYKLHERKCEPIA 349
mCoro1b      EPPYIHFLNTFTSKEPQRGMGSMPKRGLEVSKCEIARFYKLHERKCEPIV 349
*.*::*:*. *:***.***** ********.******************.
mCoro1a      MTVPRKSDLFQEDLYPPTAGPDPALTAEEWLGGRDAGPLLISLKDGYVPP 399
mCoro1b      MTVPRKSDLFQDDLYPDTAGPEAALEAEDWVSGQDANPILISLREAYVPS 399
***********:**** ****:.** **:*:.*:**.*:****::.***.
mCoro1a      KSRELRVN-RGLDSARRRATPEPSGTPSSDTVS----------------- 431
mCoro1b      KQRDLKVSRRNVLSDSRPASYSRSGASTATAVTDVPSGNLAGAGEAGKLE 449
*.*:*:*. *.: *  * *: . **:.:: :*:                 
mCoro1a      RLEEDVRNLNAIVQKLQERLDRLEETVQAK----- 461
mCoro1b      EVMQELRALRMLVKEQGERISRLEEQLGRMENGDT 484
.: :::* *. :*::  **:.**** :
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Figure 10-2. Protein alignment of mouse Coro1a and human Coro1a. 
Mouse and human Coro1a amino acid sequences were aligned using ClustalW (version 2.1.) Identical 
residues are highlighted by an asterisk, conserved substitutions are indicated by an colon and 
semi-conserved by an point. 
 
mCoro1a      MSRQVVRSSKFRHVFGQPAKADQCYEDVRVSQTTWDSGFCAVNPKFMALI 50
hCoro1a      MSRQVVRSSKFRHVFGQPAKADQCYEDVRVSQTTWDSGFCAVNPKFVALI 50
**********************************************:***
mCoro1a      CEASGGGAFLVLPLGKTGRVDKNVPLVCGHTAPVLDIAWCPHNDNVIASG 100
hCoro1a      CEASGGGAFLVLPLGKTGRVDKNAPTVCGHTAPVLDIAWCPHNDNVIASG 100
***********************.* ************************
mCoro1a      SEDCTVMVWEIPDGGLVLPLREPVITLEGHTKRVGIVAWHPTAQNVLLSA 150
hCoro1a      SEDCTVMVWEIPDGGLMLPLREPVVTLEGHTKRVGIVAWHTTAQNVLLSA 150
****************:*******:***************.*********
mCoro1a      GCDNVILVWDVGTGAAVLTLGPDVHPDTIYSVDWSRDGALICTSCRDKRV 200
hCoro1a      GCDNVIMVWDVGTGAAMLTLGPEVHPDTIYSVDWSRDGGLICTSCRDKRV 200
******:*********:*****:***************.***********
mCoro1a      RVIEPRKGTVVAEKDRPHEGTRPVHAVFVSEGKILTTGFSRMSERQVALW 250
hCoro1a      RIIEPRKGTVVAEKDRPHEGTRPVRAVFVSEGKILTTGFSRMSERQVALW 250
*:**********************:*************************
mCoro1a      DTKHLEEPLSLQELDTSSGVLLPFFDPDTNIVYLCGKGDSSIRYFEITSE 300
hCoro1a      DTKHLEEPLSLQELDTSSGVLLPFFDPDTNIVYLCGKGDSSIRYFEITSE 300
**************************************************
mCoro1a      APFLHYLSMFSSKESQRGMGYMPKRGLEVNKCEIARFYKLHERKCEPIAM 350
hCoro1a      APFLHYLSMFSSKESQRGMGYMPKRGLEVNKCEIARFYKLHERRCEPIAM 350
*******************************************:******
mCoro1a      TVPRKSDLFQEDLYPPTAGPDPALTAEEWLGGRDAGPLLISLKDGYVPPK 400
hCoro1a      TVPRKSDLFQEDLYPPTAGPDPALTAEEWLGGRDAGPLLISLKDGYVPPK 400
**************************************************
mCoro1a      SRELRVNRGLDSARRRATPEPSGTPSSDTVSRLEEDVRNLNAIVQKLQER 450
hCoro1a      SRELRVNRGLDTGRRRAAPEASGTPSSDAVSRLEEEMRKLQATVQELQKR 450
***********:.****:**.*******:******::*:*:* **:**:*
mCoro1a      LDRLEETVQAK 461
hCoro1a      LDRLEETVQAK 461
***********
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Figure 10-3. Protein alignment of mouse Coro1b and human Coro1b. 
Mouse and human Coro1b amino acid sequences were aligned using ClustalW (version 2.1.) Identical 
residues are highlighted by an asterisk, conserved substitutions are indicated by an colon and 
semi-conserved by an point. 
 
 
10.2 Gating strategies used for flow cytometry 
The following representative gating strategies were used for the phenotyping and the 
analysis of naïve NK cells isolated from the spleen, the bone marrow and the liver (Figure 
10-4) as well as for the analysis of IL-15-expanded NK cells (Figure 10-5). 
  
mCoro1b      MSFRKVVRQSKFRHVFGQPVKNDQCYEDIRVSRVTWDSTFCAVNPKFLAV 50
hCoro1b      MSFRKVVRQSKFRHVFGQPVKNDQCYEDIRVSRVTWDSTFCAVNPKFLAV 50 
**************************************************
mCoro1b      IVEASGGGAFMVLPLNKTGRIDKAYPTVCGHTGPVLDIDWCPHNDEVIAS 100
hCoro1b      IVEASGGGAFLVLPLSKTGRIDKAYPTVCGHTGPVLDIDWCPHNDEVIAS 100 
**********:****.**********************************
mCoro1b      GSEDCTVMVWQIPENGLTSPLTEPVVVLEGHTKRVGIITWHPTARNVLLS 150
hCoro1b      GSEDCTVMVWQIPENGLTSPLTEPVVVLEGHTKRVGIIAWHPTARNVLLS 150 
**************************************:***********
mCoro1b      AGCDNVVLIWNVGTAEELYRLDSLHPDLIYNVSWNHNGSLFCSACKDKSV 200
hCoro1b      AGCDNVVLIWNVGTAEELYRLDSLHPDLIYNVSWNHNGSLFCSACKDKSV 200 
**************************************************
mCoro1b      RIIDPRRGTLVAEREKAHEGARPMRAIFLADGKVFTTGFSRMSERQLALW 250
hCoro1b      RIIDPRRGTLVAEREKAHEGARPMRAIFLADGKVFTTGFSRMSERQLALW 250 
**************************************************
mCoro1b      DPENLEEPMALQELDSSNGALLPFYDPDTSVVYVCGKGDSSIRYFEITDE 300
hCoro1b      DPENLEEPMALQELDSSNGALLPFYDPDTSVVYVCGKGDSSIRYFEITEE 300 
************************************************:*
mCoro1b      PPYIHFLNTFTSKEPQRGMGSMPKRGLEVSKCEIARFYKLHERKCEPIVM 350
hCoro1b      PPYIHFLNTFTSKEPQRGMGSMPKRGLEVSKCEIARFYKLHERKCEPIVM 350 
**************************************************
mCoro1b      TVPRKSDLFQDDLYPDTAGPEAALEAEDWVSGQDANPILISLREAYVPSK 400
hCoro1b      TVPRKSDLFQDDLYPDTAGPEAALEAEEWVSGRDADPILISLREAYVPSK 400 
***************************:****:**:**************
mCoro1b      QRDLKVSRRNVLSDSRPASYSRS-----GASTATAVTDVPSGNLAGAGEA 445
hCoro1b      QRDLKISRRNVLSDSRPAMAPGSSHLGAPASTTTAADATPSGSLARAGEA 450 
*****:************  . *      ***:**.  .***.** ****
mCoro1b      GKLEEVMQELRALRMLVKEQGERISRLEEQLGRMENGDT 484
hCoro1b      GKLEEVMQELRALRALVKEQGDRICRLEEQLGRMENGDA 489 
************** ******:**.*************:
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Figure 10-4. General gating strategy used for the analysis of freshly isolated naïve NK cells. 
Shown representative dot plots, histograms and contour plots demonstrate the general gating strategy 
used for the analysis of naïve NK cells isolated from bone marrow, spleen and liver. For dead cell 
exclusion, isolated naïve cells were stained with Fixable blue fluorescent reactive dye® (Live/Dead) 
and analyzed versus forward scatter (FSC) as shown in Figure 10-4 (a). Doublets were excluded using 
FSC and side scatter (SSC) height versus width (b and c). NK cells were identified by the expression 
of NK1.1 and the absence of CD3 expression (d) and used for further analysis (e and f). For data 
analysis, NK cells stained with isotype controls were used as reference.  
 
 
Figure 10-5. General gating strategy used for the analysis of IL-15-expanded NK cells  
Shown representative dot plots, histograms and contour plots demonstrate the general gating strategy 
to characterize IL-15-expanded NK cells based on FSC- versus SSC area to exclude cell debris (a) 
and NK1.1 and CD3 staining to identify NK cells (b). NK1.1+/CD3- NK cells were used for further 
analysis (c and d). For data analysis, either NK cells stained with isotype controls or sec. Abs or 
corresponding knockout NK cells were used as reference.  
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